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SUMMARY
This thesis explored the role of cell mediated immunity in 
the pathogenesis of extrinsic allergic alveolitis (EAA), 
using pigeon breeders disease (PBD) as a model. The first 
part of the thesis looked at the total and differential 
white blood cell count (WBCC) and lymphocyte subsets in 
the peripheral blood of pigeon breeders, grouped into well 
defined categories according to symptoms, presence of 
serum antibody to pigeon antigen and whether or not they 
were acutely symptomatic at the time of blood sampling. 
The aim was to determine whether there were any changes in 
peripheral blood leucocyte phenotypes and if these changes 
reflected the symptomatic status of the subjects.
The initial analysis revealed that symptomatic, antibody 
positive, pigeon breeders, who were acutely symptomatic at 
the time of blood sampling, had a leucocytosis, comprising 
neutrophils and T lymphocytes of the CD4+ and CD8+ 
subsets. The number of CD56+ cells was also increased, but 
B cell numbers were unchanged. Pigeon breeders who were 
normally symptomatic and antibody positive, but who were 
not acutely symptomatic at the time of blood sampling, had 
normal peripheral blood cell profiles. These results 
suggest that acute exacerbations of PBD lead to a 
transient leucocytosis.
An increased proportion of asymptomatic, antibody positive 
subjects had high CD4:CD8 ratios compared with controls, 
due to increased numbers of CD4+ cells. The increase in 
the numbers of CD4+ cells may reflect the presence of an 
active humoral immune response, in these subjects.
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Asymptomatic, antibody positive and asymptomatic, 
antibody negative pigeon breeders had normal peripheral 
blood cell profiles.
A proportion of pigeon breeders (41%) with severe 
longstanding PBD, had reversed CD4:CD8 ratios in their 
peripheral blood compared with controls. This was due 
predominantly to increased numbers of CD8+ cells, which 
were both CD3+ T cells and CD3” cells, possibly CD56+ NK 
cells. Further phenotypic analysis of these cells 
revealed increased percentages of CD3-CD16+ NK cells, 
which were predominantly CD8”, but this was not associated 
with increased cytotoxicity of these cells, as measured 
(against K562 target cells) in a chromium release assay. 
It is possible that these cells may be involved in an 
antibody dependent cellular cytotoxicity reaction in the 
lung. They might also act as inflammatory mediators. These 
pigeon breeders also had significantly reduced percentages 
of J S T cells, predominantly due to a decrease in BB3+ 
cells, the predominant subpopulation of JS T cells in the 
lung and the peripheral blood. Both CD8+ and CD8~ J S T 
cells were reduced. It is possible that these cells are 
being recruited to the lung. Although there was no change 
in the levels of "naive" (CD45RA+) CD4+ and "memory" 
(CDw29+) CD4+ cells in the peripheral blood of these 
pigeon breeders, total levels of CD45RA+ cells were 
increased, predominantly due to CD4"’CD45RA+ cells. These 
cells were not identified. The changes recorded, in the 
levels of different lymphocyte subpopulations in the 
peripheral blood of these pigeon breeders, with severe
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longstanding PBD, did not correlate with each other. This 
suggests that the changes occurring, in each lymphocyte 
subpopulation, are independent and may be associated 
with different pigeon breeders, who are perhaps at a 
different stage of disease.
The remaining part of the thesis attempted to determine 
the stimulus for the changes in the lymphocyte 
subpopulations, within the group of pigeon breeders with 
severe longstanding PBD. This was done by assessing 
whether antigens extracted from pigeon material could 
provoke cell mediated immune responses by lymphocytes in 
vitro. The initial studies used pigeon serum as an antigen 
source. This was found to stimulate lymphocytes from both 
pigeon breeders and controls. To determine whether this 
mitogenicity was masking an underlying antigenic response, 
pigeon serum was fractionated into a "globulin" and 
"albumin rich" fraction. The "globulin" fraction failed to 
induce a proliferative response in either pigeon breeders 
or controls. In contrast, the "albumin rich" fraction was 
found to possess significant mitogenicity, although with 
reduced activity, compared with whole pigeon serum. This 
mitogenicity was not masking a specific antigenic response 
to pigeon albumin, since a commercial source of pure 
pigeon albumin failed to induce lymphocyte proliferation. 
Therefore these studies did not identify any specific 
response of lymphocytes from pigeon breeders to pigeon 
serum antigens.
The nature of the mitogenic agent in pigeon serum was 
explored by testing the hypothesis that it was endotoxin,
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which could be detected in pigeon serum at a concentration 
of 5pg/ml. Equivalent doses of LPS, similar to those that 
would be present in a mitogenic dose of pigeon serum, were 
used to try to mimic the effect of pigeon serum. Although 
no proliferative response of lymphocytes from either 
pigeon breeders or controls was induced, the results were 
inconclusive, since recommended doses of LPS also failed 
to stimulate lymphocytes to proliferate. As an alternative 
approach, the endotoxin inhibitor, Polymyxin B was 
included in the cultures stimulated with pigeon serum. 
However, this did not inhibit the proliferative response 
induced by pigeon serum.
Pigeon droppings were used in in vitro lymphocyte 
proliferation assays, to determine whether the mitogenic 
agent in pigeon serum was excreted in the droppings and 
therefore likely to be inhaled. Although these studies did 
not find any mitogenic agent in pigeon droppings, they do 
not rule out the possibility that the mitogenic agent may 
be present in another source of pigeon antigen, such as 
bloom. A role for a non specific agent, as an initiator of 
an acute inflammatory reaction in the lung, prior to the 
induction of EAA, has been previously suggested.
The overall conclusions from this thesis are that there 
are changes in the phenotypes of peripheral blood 
lymphocytes in pigeon breeders. The cellular changes vary 
depending on the stage of disease and the symptomatic 
state at the time of blood sampling. The reduced levels of 
)S T cells and the lack of specific T cell responses to 
pigeon antigen in pigeon breeders with severe longstanding
24
PBD suggest that lymphocytes may be recruited to the lung. 
Analysis of cells from BAL fluid and peripheral blood in 
parallel after a controlled laboratory challenge or in the 
natural loft environment would allow a more accurate 
definition of the course of disease. However, it is 
important to stress that while sampling the airspaces of 
the lung for the local cell profile is likely to be more 
relevant, it is also invasive enough to be ethically 
doubtful as an experimental protocol and even if it was, 
repeated sampling during the course of an acute 
symptomatic episode would not be permitted. Under these 
circumstances repeated blood sampling would be the only 
way to identify the cellular changes.
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CHAPTER 1 
INTRODUCTION
26
The lung is a complex organ that comes into contact with 
large volumes of air, to accomplish its primary task of 
gas exchange. As a result, the respiratory epithelial 
surfaces are in virtually constant contact with airborne 
organisms and particles. To protect itself against injury, 
infection and antigenic stimulation, the lung has evolved 
a highly efficient system of pulmonary defence which 
includes mechanical, phagocytic and immune defence 
mechanisms.
1.1 ANATOMY OF THE LUNG
At the end of a deep breath, about 80 percent of the lung 
volume is air, 10 percent is blood and only the remaining 
10 percent is tissue (Weibel & Taylor, 1988).
The port through which blood vessels and airways enter the 
lungs is the hilus. The airways reach the two hili by the 
main bronchi, one leading to each lung. Inside the lungs 
the bronchi course downwards and divide sequentially to 
form a mass of very fine bronchioles. The bronchial tree 
terminates in air passages called respiratory bronchioles, 
which are about 0.5nm in diameter. These then branch into 
many short tubes of equal diameter called alveolar ducts 
which end in tiny hollow bags called alveolar sacs. The 
alveoli are the gas exchanging surface of a mammal.
Throughout this thesis, the upper respiratory tract will 
be considered to include the terminal bronchioles and the 
airways proximal to them, whereas the lower respiratory 
tract will be considered as the respiratory bronchioles 
and the distal alveolar spaces (Kaltreider, 1976a).
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The whole outer surface of each alveolus is covered by a 
dense network of capillary blood vessels. The epithelial 
lining of the lung in the alveoli is very thin, being 
usually only one cell thick and the basement membrane of 
the alveoli and capillary endothelium are fused, which 
aids gaseous exchange.
1.2 MECHANICAL AND PHAGOCYTIC DEFENSE MECHANISMS 
Since the vast majority of airborne antigenic material is 
non-pathogenic, the immune system of the lung has devised 
a series of mechanical and phagocytic exclusion barriers 
to limit contact between inhaled antigens and the local 
immune cell populations situated beneath the respiratory 
epithelium. This normally prevents unnecessary immune 
responses to non invasive antigens (pollens, animal 
danders, insect excretions etc), and limits active 
immune responses to those inhaled antigens, which are 
capable of breaching these barriers (pathogenic antigens 
such as viruses and bacteria).
In the upper respiratory tract, goblet cells produce 
mucous which covers the ciliated epithelium and acts as a 
protective barrier to block adherence of microbial and 
other foreign particles to epithelial cells. The 
epithelial cells of the lower respiratory tract are 
covered in a thin layer of liquid surfactant, which as 
well as serving to block the adherence of foreign 
particles to epithelial cells and maintaining the 
stability of the alveoli, contains several non specific 
factors which defend the lower airways, including alpha^-
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antitrypsin, lysozyme, interferon, lactoferrin and trace 
amounts of C3, C4 and Cg of the complement system (Clarke 
& Pavia, 1988).
The inhaled particles and organisms attached to the mucous 
in the upper respiratory tract are removed mechanically by 
ciliary movement, coughing and sneezing. By contrast, the 
lower respiratory tract most of the clearance of small 
particulate matter and microorganisms relies on the 
phagocytic system. Alveolar macrophages (discussed in more 
detail in 1.4.2a) are the principal scavengers of the 
alveoli. The inhaled particles which are phagocytosed by 
alveolar macrophages may then experience one of several 
fates (Reynolds, 1985, Gee, 1970):
i) Complete degradation within the phagosome of the 
macrophage, which prevents interaction of intact antigenic 
material with the elements of the specific immune response 
located beneath the respiratory epithelium.
ii) Macrophages containing undegraded material may migrate 
up the distal airways to reach the mucociliary escalator 
for elimination. Again this allows inhaled material to 
bypass the specific immune system.
iii) Alternatively, the macrophages may migrate into the 
interstitium and peribronchial lymphatics. In this case, 
engulfed material has the potential of interacting with 
cells of the specific immune system (discussed later, 
1.4) .
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1.3 PARTICLE DEPOSITION
The fate of inhaled particles is determined by their 
dimension (Turner-Warwick, 1 9 7 8 ) .
The hairs of the nasal mucosa trap the majority of 
particles over 20/zm, as well as up to 50% of those with a 
diameter of >5/um. Particles of 10/Ltm and over will also 
lodge in the trachea and become trapped on the mucociliary 
blanket. They are then eliminated by swallowing or 
expectoration. Smaller particles (3-5/zm diameter) tend to 
be deposited further down the bronchial tree, but again 
are cleared by ciliary action. Usually, the only particles 
which reach the alveolar space and hence are dependent on 
alveolar macrophages for clearance, are 1-2/zm in diameter 
(Brain & Valberg, 1 9 7 9 ) . This group of particles includes 
the organic dusts responsible for the various syndromes of 
Extrinsic Allergic Alveolitis (EAA) (Austwick, 1 9 6 6 ) .
1.4 PULMONARY IMMUNE SYSTEM
The elements of the specific immune system form a second 
layer of defence which deals with organisms or particles 
that breech the non specific exclusion barriers.
T lymphocytes are essential for almost all lung immune 
reactions, including the stimulation of B lymphocytes to 
secrete antibodies, directly exerting cytotoxic activity, 
regulating the activity of other lymphocytes and 
stimulating the proliferation, recruitment and activation 
of inflammatory cells. The activation of T lymphocytes is 
an antigen specific event which requires antigen to be 
presented to T cells in the form of a peptide bound to
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cell surface glycoproteins of the major histocompatibility 
complex (MHC) present on accessory cells such as 
dendritic cells and macrophages (Clevers et al, 1988, 
Davis & Bjorkman, 1988) . Lymphocytes and mononuclear 
phagocytes are present at or near the air-tissue interface 
at all levels of the respiratory tract extending from the 
submucosa of the nasopharynx to the interstitium and 
alveolar spaces of the pulmonary parenchyma.
1.4.1 ORGANISATION OF PULMONARY LYMPHOID TISSUE
Lymphoid tissue within the lung falls into four main 
categories: i) lymph nodes ii) bronchus associated
lymphoid tissue iii) lymphoreticular aggregates; and iv) 
Bronchoalveolar cells. The degree of structural 
organisation of lymphatic tissue decreases progressively 
from the upper to the lower respiratory tract.
i) Lymph nodes
Encapsulated lymph nodes are mainly located adjacent to 
large bronchi and are situated in the peribronchial 
tissues. They do not come into direct contact with the 
respiratory epithelium, but they receive lymphatic 
drainage both from the mucosa of the conducting airways 
and from the lung parenchyma (Morrow, 1971). These nodes 
are similar to those found elsewhere, containing antigen 
presenting cells, and T and B lymphocytes, required to 
react to foreign antigens.
ii) BALT
Small collections of lymphoid tissue may be found in the 
submucosa of the transbronchial tree. These are referred
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to as bronchus associated lymphoid tissue (BALT) 
(Bienenstock et al, 1973a,b) and are the pulmonary 
equivalent of the Peyer's patches in the gut. The 
formation of BALT is thought to be largely dependent on 
antigenic stimulation, since it has been found in some 
patients with chronic pulmonary inflammation but not in
i
the lungs of healthy individuals (Pabst, 1992) . It is 
however, present in the lungs of healthy rabbits and 
rats, and therefore its functional anatomy has been 
studied in these animals (Sminia et al, 1989). BALT has a 
structure of a conventional secondary lymphoid organ, with 
B cells in central follicles, surrounded by rims of T 
cells.
BALT has a specialised epithelium, referred to as follicle 
associated epithelium (FAE) (Bienenstock et al, 1973a, 
Chamberlain et al, 1973, Bienenstock & Johnston, 1976), 
which consists of a single layer of flattened, nonciliated 
epithelial cells, and is devoid of glandular and goblet 
cells. This specialised epithelium seems to be capable of 
actively transporting, potentially antigenic materials, up 
to the size of bacteria, into the lymphoid follicle 
(Tenner-Racz et al, 1979, Fournier et al, 1977). It has 
also been suggested that alveolar macrophages, 
transported by the ciliated epithelium, enter the BALT via 
the FAE (Lipscomb et al, 1981). BALT is particularly 
prominent at branchings in the tracheobronchial tree, 
where there is increased turbulence of airflow, 
increasing the probability for particle deposition 
(Bienenstock et al, 1973a).
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iii) lymphoreticular aggregates
Small collections of lymphoid cells are present in the 
bronchi, interlobular septa and pleura and are also found 
in the alveolar interstitium. Like BALT they tend to 
appear between the bronchial epithelium and the 
accompanying pulmonary artery. However, they are not as 
well organised into lymphoid follicles (Kradin 1985). 
These structures are particularly prominent in persons 
with heavy exposure to dusts and atmospheric pollutants 
(Kradin, 1985).
iv) Bronchoalveolar cells
Bronchoalveolar cells are those cells retrieved from 
distal lung tissue by bronchoalveolar lavage (BAL) and are 
assumed to be representative of the cells present 
within air spaces of alveoli and peripheral bronchioles. 
BAL cells from normal subjects consist of 80-85% 
macrophages, 10-15% lymphocytes and 5% neutrophils and 
eosinophils (Reynolds, 1987). Of the lymphocytes, the vast 
majority are T cells (Hunninghake et al, 1981, Reynolds,
1987), with a similar ratio of CD4+ :CD8+ cells to that 
found in the peripheral blood (Costabel et al, 1984). 
During acute and chronic inflammatory processes of lung 
parenchyma the total yield of all cell types is increased 
and the percentages of lymphocytes and/or 
polymorphonuclear leukocytes are generally increased, 
while the percentage of macrophages is proportionately 
decreased (Crystal et al, 1984a,b).
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1.4.2 MONONUCLEAR CELLS IN THE LUNG
a) Pulmonary macrophages
Different kinds of macrophage have been recognised in the 
lung and play a variety of important roles (Brain, 1988, 
Sibille & Reynolds, 1990) including antigen processing and 
presentation to T cells, as well as phagocytosis and 
killing of microbial organisms.
The pulmonary alveolar macrophage is the best 
characterised and most extensively studied, simply because 
it can be easily recovered by bronchoalveolar lavage. The 
alveolar macrophage is the resident phagocyte of the 
alveolar space (DuBois, 1986) and like all macrophages it 
possesses Fc receptors for IgG (Reynolds, 1975a) and has a 
greater number of receptors for IgG^ and IgG3 than IgG2 
and IgG4 (Naegel, 1984). Since alveolar macrophages also 
possess a receptor for the activated component of 
complement, C3b (Reynolds, 1975a), antigen, antibody and 
complement complexes can also interact with the C3b 
receptor, resulting in optimal phagocytosis and killing. 
IgE receptors are also expressed by the alveolar 
macrophage (Joseph et al, 1980, Melewicz et al, 1982) and 
are particularly abundant on these cells from asthmatic 
subjects (Joseph et al, 1983) More recently, alveolar 
macrophages have been shown to express an Fc receptor for 
IgA (Sibille et al, 1989) .
During phagocytosis alveolar macrophages may release into 
the lung tissue, large amounts of toxic oxygen 
metabolites, believed to be directly involved in bacterial 
killing, and arachadonic acid metabolites (reviewed in
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Sibille & Reynolds, 1990, Holtzman, 1991). Thromboxane A2 
(TXA2) and LTB4 appear to be the major arachadonic acid 
metabolites produced by alveolar macrophages and are 
potent proinflammatory mediators. TXA2 is a constrictor of 
pulmonary vessels and airways and LTB4 is a potent 
chemoattractant for neutrophils and eosinophils and 
increases vascular permeability. PGD2 a
bronchoconstrictor, is also secreted from alveolar 
macrophages. However, given that it is not desirable to 
have hypersensitivity responses in the lung air spaces, 
the secretion of PGE2 by alveolar macrophages, which can 
suppress different cell functions like the proliferation 
of lymphocytes and the chemotaxis of neutrophils, serves 
to counteract the proinflammatory properties of TXA2 and 
LTB4. Indeed the alveolar macrophages are thought to play 
an important role in the maintenance of homeostasis at the 
airway surface, by inhibiting the inductive phase of local 
T cell responses to incoming antigens (Holt, 1986) . The 
exact mechanism of inhibition is not clear but may 
involve the secretion of lymphostatic mediators, such as 
prostoglandin E2, defective processing and presentation of 
antigen or deficient IL1 production (Holt 1986). The 
inhibitory role of the alveolar macrophage is particularly 
effective at high macrophage/T cells ratios as occurs in 
vivo on the alveolar surface (Holt, 1978). However, the 
situation can be readily reversed by pathogenic antigens, 
which induce inflammation and an influx of mononuclear 
cells from the peripheral blood (Holt, 1978).
In contrast, to the alveolar macrophages, interstitial
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macrophages are located in the connective tissue of the 
lung and are not directly exposed to airborne particles. 
The interstitial macrophages are obtained from minced lung 
explants but are not recovered by BAL (Bowden & Adamson, 
1972). In vitro evidence suggests that tissue macrophages 
are also capable of inhibiting T cell proliferation and 
therefore appear to provide another layer of protection 
against immune responses to inhaled antigens (Holt et al, 
1988). Pulmonary macrophages resident in the intravascular 
structures are also found in human lungs (Dehring & 
Wismar, 1989). These cells are morphologically different 
from blood monocytes and adhere firmly to the endothelial 
cells. In experimental models these macrophage appear to 
remove particles and bacteria from the circulation (Warner 
et al, 1987). Finally lung macrophages are also present in 
the lumen of the upper respiratory tract. Some of these 
macrophages are likely to correspond to alveolar 
macrophages transported by the mucociliary escalator. 
However, a certain number of these appear to be resident 
cells of the airways adhering tightly to the epithelial 
cells (Brain et al, 1984). They could help in the removal 
of debris present in the large airways.
b) Dendritic cells
Dendritic cells, characterised by their dendritic 
morphology and intense staining for class II MHC antigen, 
are now thought to be the principal antigen presenting 
cells in respiratory tissues (Holt et al, 1988). These 
cells are found in large numbers and are widely 
distributed in the upper and lower respiratory tract 
(Soler et al, 1989). In the upper airways, the endogenous
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dendritic cell population appears intimately associated 
with the epithelial basement membrane, with class II rich 
dendritic processes reaching upwards between epithelial 
cells to the airway lumen (Holt et al, 1988). Tissue 
macrophages in the lung wall are capable of inhibiting T 
cell proliferation induced by antigen-bearing dendritic 
cells in vitro (Holt et al, 1988). The close proximity of 
dendritic cells and tissue macrophages within the micro­
environments in the airway wall suggests that such 
interactions are likely to occur in vivo (Holt et al,
1988) .
As both T lymphocytes and antigen presenting cells are 
present in the alveolar lumen, BALT, lung interstitium and 
draining lymph nodes, sensitisation of T cells could occur 
in any of these sites (McDermott et al, 1982). However, 
current evidence suggests that most primary immune 
responses against inhaled antigens are initiated in the 
draining lymph node (Hance, 1991). Once antigen reactive 
cells are generated in the intrathoracic nodes they 
migrate from the lymph nodes to the lung and thereby may 
allow secondary immune response to occur locally in the 
lung (Hance, 1991).
1.4.3 MAST CELLS
The largest numbers of mast cells in the human body are 
found at the interface of the internal and external 
environments, such as skin, conjunctiva and mucosal 
surfaces, such as the respiratory and gastrointestinal 
tracts. Mast cells are widely distributed in the
37
respiratory tract (McDermott et al, 1982) and have been 
estimated to be present in human lung at a concentration 
of between 1 and 7 x 106 cells per gram of lung tissue 
(Wasserman, 1980).
Two distinct types of human mast cell have been described 
based on neutral protease content of their granules. MC,pC 
cells contain chymase and tryptase whereas MCT cells 
contain only tryptase (Schwartz & Huff, 1991). MCT cells 
are the predominant type of mast cell in the lung, 
particularly alveolar septae, and in the small intestinal 
mucosa, while the MCTC cells are the predominant type 
found in the skin and in the gastrointestinal submucosa 
(Irani et al, 1986).
Immunological activation of mast cells results in the 
release of preformed granule associated mediators which 
include histamine. Histamine is responsible for 
vasodilation, contraction of smooth muscle, increased 
mucous secretion and increased epithelial permeability in 
the lung characteristic of a type I hypersensitivity 
reaction. Membrane derived lipid mediators, usually 
arachadonic acid metabolites are synthesised and released 
from mast cells following degranulation, to mediate the 
late phase of immediate hypersensitivity (Schwartz & Huff, 
1991). The characteristics of the late phase of immediate 
hypersensitivity include bronchial smooth muscle 
contraction, enhanced bronchial mucous secretion and an 
influx of eosinophils and neutrophils. In addition an 
array of different cytokines are produced by mast cells 
including IL1, IL3 , IL4 , IL5 IL6, IFN/ and GM-CSF
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(Schwartz & Huff, 1991), which extends their role as 
effector cells of immediate hypersensitivity reactions, to 
include an effect on the growth and regulation of many 
cells types.
Mast cells may play a role in the pathogenesis of chronic 
inflammatory conditions such as E A A , by increasing 
vascular permeability, sufficiently to allow increased 
access of inflammatory cells to the interstitial tissues, 
thus aiding the development of granulomas (Haslam et al, 
1987)
1.5 SPECIFIC IMMUNE RESPONSES IN THE LUNG
1.5.1 HUMORAL IMMUNITY
All major immunoglobulin isotypes are present in bronchial 
secretions (Daniele, 1988a). However, as at other mucosal 
surfaces, IgA predominates, usually exceeding levels of 
IgG. The proportion of IgG is lowest in the upper 
respiratory tract and rises progressively towards the 
lower respiratory tract (Kaltreider, 1976b, Young & 
Reynolds, 1984). In bronchoalveolar lavage fluid, IgG 
considerably exceeds IgA. The bulk of IgA, IgM and IgE in 
bronchial secretions is probably synthesised locally, 
while IgG is derived predominantly by transudation from 
serum (McDermott et al, 1982, Daniele, 1988).
The IgA in bronchial secretions neutralises respiratory 
viruses and toxins, agglutinates microbial organisms for 
efficient removal, blocks the uptake of antigens and 
inhibits the adherence of microbes to mucosal surfaces 
(Reynolds et al, 1975a). Since IgA antibody opsonises
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poorly and is an ineffective activator of the complement 
cascade, this enables it to fulfill these roles with 
limited tissue damage (Reynolds et al, 1975b). IgG and IgM 
antibodies are important components of the immunologic 
defence of the mucosal surface of the respiratory tract. 
They agglutinate particulate antigens, activate 
complement, and neutralise certain bacteria and viruses 
(Reynolds et al, 1975b). IgE antibody assists in host 
resistance to certain parasitic infections (Befus et al,
1982). In addition, there are IgE receptors on alveolar 
macrophage (Joseph et al, 1980, Melewicz et al, 1982) and 
bridging of IgE receptors on mouse alveolar macrophages 
causes the release of leukotriene C4 (Rankin, 1982). Thus, 
in previously sensitised individuals, inhaled allergens 
may initiate an inflammatory response directly within the 
airways, thereby increasing bronchial epithelial 
permeability and allowing allergens and particles to gain 
access to the submucosal immune system.
1.5.2 CELL MEDIATED IMMUNITY
T lymphocytes are central to the development of any cell 
mediated immune response. T lymphocytes (especially CD4+ T 
cells) regulate other T cells as well as B cells, NK cells 
and many non lymphoid cells. T cells are found throughout 
the pulmonary lymphoid tissue including the lymph nodes, 
BALT, lymphoreticular aggregates and BAL fluid. T cells in 
BAL fluid have been the most extensively studied since 
they can be easily recovered. 10% of cells recovered by 
BAL are lymphocytes and of these 60% are T cells (Costabel 
et al, 1984, Costabel et al, 1985, Agostini et al, 1988).
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T lymphocytes express receptors for antigen (TCR) that are 
associated in a molecular complex to CD3 surface proteins. 
Most CD3+ cells express a disulphide linked heterodimer 
formed by a and B chains that recognise antigen in an MHC- 
restricted fashion. Cell surface expression of CD4 and CD8 
"accessory” molecules divide mature afi T cells into 
distinct subsets, the expression of these molecules being 
mutually exclusive (Reinherz & Schlossman, 1980). CD4+ and 
CD8+ cells interact with different classes of major 
histocompatibility complex (MHC) molecules. CD8+ cells 
respond to antigen complexed with MHC class I molecules 
(Rosenstein et al, 1989) and CD4+ T cells react to 
antigens bound to MHC class II molecules (Swain, 1983).
CD4+ lymphocytes play a major role in delayed type 
hypersensitivity responses (DTH) in the lung. Immune CD4+ 
cells recognise microbial antigens displayed on the 
surface of infected class II positive phagocytes and 
secrete IFN/ and other cytokines to activate macrophages 
to kill intracellular pathogens. This process can initiate 
acute and chronic inflammatory responses including 
granuloma formation and is characteristic of a variety of 
lung disease including tuberculosis, EAA and sarcoidosis 
(duBois et al, 1991). CD4+ cells also play a role in 
regulating B cells, NK cells and T cells in the lung 
(Lipscomb, 1989, duBois et al, 1991). The majority of CD4+ 
cells in the lung have the memory phenotype consistent 
with chronic exposure to antigen (Saltini et al, 1990). 
In addition in diseases associated with chronic 
inflammation, such as tuberculosis, it is the local lung
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population of CD4+ cells, with the "memory” cell 
phenotype, that secrete IFN-/ and are therefore likely to 
play a major role in the local cell mediated immune 
response to M.tuberculosis (Barnes et al, 1989).
CD8+ lymphocytes play a major role in controlling viral 
infections in the lung, due to their cytotoxic 
capabilities (Kaltreider, 1991). In addition, it is now 
clear that CD8+ lymphocytes may play a role in controlling 
many lung infections originally considered to be largely a 
function of CD4+ lymphocytes, such as Listeriosis and 
tuberculosis (Lipscomb, 1989). Once activated, CD8+ 
cells can secrete IFN/ which can activate macrophages to 
kill intracellular pathogens. In addition, CD8+ cells may 
specifically lyse infected macrophages that cannot be 
activated by lymphokines. Lysis of these macrophages would 
release microorganisms that could be phagocytosed and 
killed by activated macrophages (Muller et al, 1987, 
DeLibero et al, 1988).
a) Gamma Delta T cells
A small population of T cells express a TCR formed of 
gamma (/) and delta (5) chains. A range of between 2-8% of 
lymphocytes from BAL fluid are ]S T cells (Balbi et al,
1990). In the human lung, as in the peripheral blood, the 
majority of JS T cells express the disulphide form of the 
JS T cell receptor (Balbi et al, 1990). These are thought 
to be the "memory/activated" population of J S T cells, 
since the majority of them also express CD45RO antigen 
(Miyawaki et al, 1990).
The functions of ]S T cells are unknown but may include
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cytolytic activity secretion of multiple cytokines and 
helper activity for immunoglobulin production. Evidence 
that ]S T cells might be involved in pulmonary immunity 
has come from studies which showed an increased proportion 
of these cells in chronic inflammatory diseases of the 
lung such as farmers' lung ( Trentin et al, 1990) and 
sarcoidosis (Balbi et al, 1990). In addition, recent 
evidence suggests that JS cells may be involved in 
specifically suppressing IgE responses to protein 
antigens presented via intact non inflamed epithelial 
surfaces in the respiratory tract, suggesting that they 
may provide another layer of protection against 
hypersensitivity reactions in the lung (McMenamin et al,
1991).
b) Natural killer cells
Up to 4 0% of lymphocytes derived from BAL fluid express 
neither T cell nor B cell antigens. It is likely that 
some of these cells are natural killer (NK) cells 
(Robinson et al, 1984).
Natural killer (NK) cells are a distinct subpopulation of 
non-T, non-B lymphocytes, that are able to lyse target 
cells without prior sensitisation or MHC restriction 
(Herberman et al, 1975a,b). The receptors mediating this 
recognition, remain elusive (Robertson & Ritz, 1990). In 
addition to spontaneous cell mediated cytotoxicity, NK 
cells mediate antibody dependent cellular cytotoxicity 
(ADCC), via the CD16 molecule (Fc/lII) (Robertson & Ritz,
1990).
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NK cells have been implicated in several activities in 
vivo, including destruction of tumour cells, resistance to 
viral infections, and regulation of haematopoiesis and 
antibody production (Herberman & Ortaldo, 1981, 
Trinchieri, 1989, Arai et al, 1983). Lung NK cells have 
been shown to limit pulmonary metastases in animal models 
(Wiltrout et al, 1985) and could therefore be important 
mediators of tumour defence in the human lung. NK cells 
may also play an important role in a protective immune 
response to viral infections in the lung such as influenza 
(Stein-Streilein & Guffee, 1986). IFN/ producing NK cells 
may also be involved in defence against bacterial 
infections in the lung, by providing a stimulus for 
macrophage activation (Bancroft et al, 1987).
Although NK cells are found throughout the lung, the cells 
capable of mediating spontaneous cytotoxicity appear to be 
restricted to the lung interstitium and are CD16+, (Fc/lII 
receptor) (Weissler et al, 1987) . Most NK cells in the 
alveoli and larger airways express CD57 (HNK1) and are 
functionally inactive (Robinson et al, 1984, Weissler et 
al, 1987). Thus NK cell activity is compartmentalised to 
the interstitium of the lung rather than the air spaces. 
Again this may reflect the regulatory mechanisms designed 
to prevent immune responses from interfering with gas 
exchange in the alveoli. In addition, these findings also 
provide evidence that not all immunocompetent cells in the 
human lung can be obtained by BAL and should encourage 
caution in the interpretation of lavage fluid studies in 
the evaluation of interstitial lung disease.
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1.6 HYPERSENSITIVITY STATES
When an immune response acts inappropriately and causes 
tissue damage, it is described as a hypersensitivity 
reaction. The classification of hypersensitivity 
responses, introduced by Coombs & Gell (1963), is now 
nearly 3 0 years old. While the actual reactions are now 
known to be more complex than those originally described, 
the Coombs & Gell scheme of four hypersensitivity states, 
still offers a reasonable framework. The lung is one of 
the principal tissues in which such reactions occur.
Type I reactions in the lung
Asthma is characterised by reversible obstruction of the 
airways and is usually assumed to be a manifestation of a 
type I hypersensitivity reaction localised to the lung 
(Jansen et al, 1991). The classic descriptions of asthma 
focus on the immediate asthmatic response (IAR) occurring 
10-20 minutes after antigen challenge and characterised 
by submucosal oedema and vessel dilation, increased mucous 
production and smooth muscle contraction. The IAR is a 
result of the release of various preformed mediators from 
sensitised mast cells, including histamine and is mediated 
by antibodies of the IgE class (Ishizaka & Ishizaka, 1975,
1984) .
In some patients the IAR is followed by a late asthmatic 
reaction (LAR). The clinical pattern of this LAR is 
marked by a slowly progressive bronchial obstruction, 
starting three to four hours after allergen inhalation and 
reaching its maximum after seven to eight hours (Jansen et 
al, 1991). In the LAR, polymorphonuclear and mononuclear
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cell infiltrates are superimposed on the more classic 
features of increased vascular permeability, smooth muscle 
contraction and increased bronchial mucous production. 
The precise mechanisms by which the LAR is induced are not 
yet known but may involve the newly formed mediators of 
mast cells such as prostaglandins and leukotrienes 
(Schwartz & Huff, 1991).
Type II and III reactions in the lung
These reactions both involve IgG or IgM antibody. 
Although, Type II reactions involve antibodies directed to 
auto-antigens on the surface of specific cells or tissues, 
whereas Type III reactions are due to the formation of 
immune complexes containing extrinsic antigens, the 
pathogenic mechanisms leading to tissue injury are 
similar. These involve activation of complement, which can 
damage tissue either directly, or via the attraction 
neutrophils, into the area.
In the lung, the best example of Type II hypersensitivity 
is Goodpastures syndrome, which is characterised by intra- 
alveolar haemorrhage (Dixon, 1968, Holdsworth et al,
1985), with linear deposits of IgG on glomerular and 
alveolar basement membranes. Thus far, the components 
basement membrane to which antibody binds, has not been 
formally identified.
Type III hypersensitivity in the lung is typified by 
idiopathic pulmonary fibrosis (reviewed in Crystal, 
1984a). It presents clinically with dyspnoea and cough in 
patients in their fifth decade of life. The course of the 
disease is progressive and usually fatal within an average
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of 3-6 years from the onset of symptoms. Lung histology 
varies with the stage of disease; an early alveolitis 
characterised by accumulation of mainly neutrophils and 
macrophages mixed with small numbers of lymphocytes and 
eosinophils, is followed by thickening and fibrosis of 
alveolar walls, with an increase in interstitial collagen. 
Immunofluoresence studies have shown immunoglobulin and 
complement deposition in the alveolar wall. In addition, 
immune complexes have been found in the blood and BAL of 
patients with marked alveolitis. Although the antigens in 
the immune complexes have not been identified, components 
of the alveolar wall, such as type I collagen have been 
proposed as candidates (Crystal, 1984a).
Type IV reactions in the lung
Type IV reactions, also referred to as cell mediated or 
delayed hypersensitivity responses, are so named because 
sensitised T cells can mediate reactions that develop over 
several hours without involvement of either circulating 
antibody or complement. Tissue damage involves the 
production of cytokines by T cells which can activate 
other cells, particularly macrophages, to be cytotoxic and 
thereby cause tissue damage.
The classic example of Type IV hypersensitivity in the 
lung is tuberculosis, in which cell mediated immunity 
against tuberculin accounts for many of the pulmonary 
histologic findings (Schatz et al, 1979, Lipscomb, 1989).
Sarcoidosis, a systemic granulomatous disease of unknown 
aetiology (Crystal et al, 1984b) is also an example of a
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disease caused by a type IV hypersensitivity response. 
Almost all organs of the body can be affected, but the 
respiratory tract is most commonly involved and this is 
the major cause of the morbidity and mortality. BAL in 
untreated patients with active disease reveals an 
alveolitis dominated by lymphocytes and macrophages 
(Campbell et al, 1985, Semenzato et al, 1985, Semenzato,
1991). The T cell population in the lung of sarcoid 
patients is characterised by increased percentages of CD4+ 
cells and an increased CD4:CD8 cell ratio.
Extrinsic allergic alveolitis is a lung disease in which 
there is evidence of both Type III and Type IV mediated 
hypersensitivity. The greater classification of the 
pathology of this disease should help in understanding 
the mechanisms of normal and hypersensitivity responses in 
the lung.
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1.7. EXTRINSIC ALLERGIC ALVEOLITIS
Extrinsic allergic alveolitis (EAA) is a pulmonary 
hypersensitivity disease caused by the repeated inhalation 
of naturally occurring environmental antigens (reviewed in 
Schatz et al, 1977, Roberts & Moore, 1977, Richerson, 
1983, Salvaggio, 1990). The antigens include bacterial, 
fungal and animal proteins, as well as a variety of 
chemical antigens. Immunologically, it has features of 
both Type III and Type IV hypersensitivity reactions.
1.7.1 CLINICAL FEATURES
The classic descriptions of EAA focus on the 
characteristic acute symptoms of the disease which occur 
some four to eight hours after exposure to the antigen and 
which usually resolve within 24-48 hours. There are both 
respiratory and systemic symptoms (Campbell, 1932, Reed, 
1965, Fink et al, 1968). Typical respiratory symptoms are 
a dry cough, breathlessness and chest tightness, (but 
without wheeze or sputum production). The systemic 
symptoms include fever, sweating, myalgia, arthralgia and 
a flu-like sensation. The main feature on clinical 
examination is the presence of fine crepitations 
throughout the lung fields.
Some patients also report more immediate symptoms, which 
occur less than 40 minutes after antigen exposure. In 
pigeon breeders, these include symptoms such as cough, 
wheezing, sneezing and watering of eyes shortly after 
entering the loft (Banham 1987). Most of these patients go 
on to develop typical acute symptoms occurring 4-8 hours 
after exposure. It is unclear whether these immediate
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symptoms represent a non specific irritant effect of dust, 
or whether they are mediated via an immediate type 
hypersensitivity response involving IgE or IgG4 antibody 
(Van Wijk et al, 1987, Pelikan & Pelikan-Filipek, 1983).
A proportion of patients develop a more chronic disease, 
in which the presence of symptoms is not necessarily 
related to antigenic exposure. Its features include 
chronic breathlessness, a persistent productive cough, 
tiredness, anorexia, weight loss and in children, failure 
to thrive (Boyd, 1982). Progressive pulmonary fibrosis 
and respiratory disability eventually develop. In contrast 
to these insidious manifestations, the disease may also 
present in a fulminant manner; Barrowcliffe & Arblaster 
(1968) described a case of a young man who died within 
weeks of initial exposure to mouldy hay.
Therefore it is clear that EAA is not a uniform disease, 
but rather a complex syndrome with differences between 
subjects in clinical presentation and subsequent course. 
As a result, Fink (1983) classified the disease into three 
forms; acute, subacute and chronic.
Fink classification
The acute form of EAA manifests as recurrent episodes of 
typical respiratory and systemic symptoms which develop 4- 
8 hours after exposure and resolve within 24-48 hours. 
Pulmonary function tests typically show restrictive 
ventilatory defect with impaired gas diffusion but may 
return to normal between episodes. The relationship 
between symptoms and antigen exposure is most apparent in
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this form of the disease.
The chronic form is characterised by the insidious 
development of respiratory symptoms such as persistent 
dyspnoea and productive cough. Chest X-rays show changes 
of pulmonary fibrosis while pulmonary function tests show 
a range of restrictive and obstructive defects. There is 
no clear evidence of the disease necessarily progressing 
from the acute to the chronic form in individual patients 
and some patients will present for the first time with 
established disability due to the chronic form of the 
disease without ever having experienced symptoms directly 
related to antigen exposure (Fink et al, 1968).
The subacute form is similar to the chronic form in that 
dyspnoea and cough develop insidiously, but there are 
usually also episodes of discrete chills and dyspnoea 
occurring after antigenic exposure as in the acute form. 
This form is often reversible and symptoms improve when 
antigenic exposure is discontinued. It is therefore an 
intermediate form between the acute and chronic forms of 
the disease.
1.7.2 CAUSATIVE AGENTS
The airborne particles which can cause alveolitis are in 
the order of one micron in diameter (Austwich 1966). This 
is the correct size to reach and settle in the alveoli 
(Brain & Valberg, 1979) and it is at the alveolar level 
that the disease process is most evident (Hensley et al, 
1969).
The number of dusts which are known to cause EAA form a
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list which is increasing with greater awareness of the 
disease (Table 1). Due to the widespread occurrence of the 
thermophilic Actinomycetes, the spores of these organisms 
are most frequently the causative agent of alveolitis, 
while the popularity of keeping different bird species has 
similarly resulted in widespread exposure to avian 
antigens (Hendrick et al, 1978).
1.7.3 PATHOLOGY
The first feature of EAA is a neutrophilic alveolitis 
(Barrowcliffe & Arblaster, 1968, Fournier et al, 1985) 
occurring within 24 hours of exposure to antigen, and in 
some cases, accompanied by vasculitis (Barrowcliffe & 
Arblaster, 1968, Ghose et al, 1974). Several days after 
inhalation challenge, the alveolitis becomes lymphocytic 
in nature and this is often held to be the classical 
feature of acute EAA (Costabel et al, 1984, 1985,
Leatherman et al, 1984, Mornex et al, 1984, Semenzato et 
al, 1986).
The chronic lesion of EAA becomes more evident after 
repeated exposure to antigen and is characteristically 
associated with the development of interstitial granulomas 
comprised of lymphocytes, foamy macrophage and fibrosis 
(Seal et al, 1968, Hensley et al, 1969, Chmelik et al, 
1974). Intra-alveolar buds were described as a prominent 
feature and consist of masses of loose connective tissue 
located within alveolar spaces and attached to the 
alveolar wall by a thin stalk (Kawanami et al, 1983). 
Vasculitis appears to be an unusual feature at this stage 
of the disease, present in only two of 18 cases of chronic
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EAA reported by Kawanami (1983)
Bronchiolitis is also a common feature of the pathology of 
EAA (Seal et al, 1968) and some authors favour the term 
"Extrinsic allergic bronchiolo-alveolitis".
1.7.4 IMMUNOPATHOGENESIS
There is evidence of both immune complex and cell mediated 
mechanisms in the pathogenesis of EAA. It is thought that 
immune complexes may play a role in the early phases of 
disease, whereas cell-mediated immunity may be involved in 
the later and more prolonged stages of disease. Most of 
the studies to explore the pathogenesis of EAA have used 
farmers* lung and pigeon breeders* disease as models.
a) Humoral immunity
The association of serum antibody with EAA was first 
described by Pepys et al (1961), when the serum of a 
farmer with disease was shown to precipitate an extract 
of thermophilic Actinomycetes grown from mouldy hay. Serum 
precipitins against pigeon serum were then described in 
subjects with interstitial lung disease caused by exposure 
to pigeons (Reed et al, 1965). It is now clear that high 
titres of specific serum antibody directed against the 
offending organic dust are found in patients with all 
types of EAA (Pepys, 1969, Fink et al, 1971). These 
antibodies are primarily complement-fixing IgG antibodies 
(Fink et al, 1969a, 1971, Caldwell et al, 1973, Moore &
Fink, 1975, Marx & Flaherty, 197 6) , but low amounts of 
specific serum IgA and IgM antibody have also been 
demonstrated (Patterson et al, 1976a, 1976b). The presence
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of serum precipitins does not necessarily signify clinical 
disease, as these are present in up to half of exposed, 
but asymptomatic subjects (Fink et al, 1971, Barboriak et 
al, 1973, Moore & Fink, 1975, Roberts et al, 1976, DoPico 
et al, 197 6). However, symptomatic subjects, generally 
have higher specific serum antibody levels than their 
asymptomatic counterparts (Boyd 1978, McSharry et al, 
1984) and the severity of symptoms correlates well with 
antibody titre (Boyd, 1978).
There are also increased concentrations of IgG, IgM and 
IgA antibodies in BAL fluid of symptomatic and 
asymptomatic subjects with EAA (Reynolds et al, 1977, 
Patterson et al, 1979, Calvanico et al, 1980). 
Interestingly, specific IgA antibody levels were usually 
higher in the BAL of symptomatic subjects with PBD, 
whereas the IgG titre did not differ between symptomatics 
and asymtomatics (Patterson et al, 1979). Studies of IgG 
subclasses in BAL fluid have reported increases in 
total IgG4 subclass levels in symptomatic subjects with 
PBD compared with asymptomatics, (Calvanico et al, 1980), 
but no difference in the levels of specific IgG4 antibody 
between the two groups (Kitt et al, 1986).
The development of the symptoms of EAA follows a similar 
time course to the local Arthus reaction which occurs in 
the skin of subjects with EAA challenged with appropriate 
antigens. Although this suggests that immune complex 
reactions might be involved in EAA, the significance of 
these Arthus type cutaneous reactions remains unclear. 
Some studies indicated that both symptomatic and
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asymptomatic individuals were skin test positive 
(Hargreave & Pepys, 1972, Moore et al, 1974, Schatz et al, 
1976) , but others found that the reactions were largely 
confined to subjects with alveolitis and high titre IgG 
antibodies to avian antigens (McSharry et al, 1983).
The role of immune complexes is also challenged by the 
fact that lung biopsies from patients with EAA usually 
show interstitial pneumonitis, alveolitis and 
bronchiolitis, with a primarily mononuclear infiltrate and 
granuloma formation, rather than the haemorrhagic 
necrosis, neutrophilic infiltration and vasculitis 
(Emanuel et al, 1964, Seal et al, 1968, Chemlik et al, 
1974), which would be more characteristic of Arthus 
reaction. In addition, immunofluoresence studies on lung 
biopsies from patients with alveolitis rarely demonstrate 
the presence of immune complexes and complement deposition 
(Turner-Warick et al, 1971, Meijer et al 1971, Barrios et 
al, 1979). However it should be noted that examination of 
acute cases of EAA early after challenge provides some 
evidence for vasculitis (Barrowcliffe & Arblaster, 1968, 
Ghose et al, 1974) and neutrophil infiltrates (Fournier et 
al, 1985), raising the possibility that a local Arthus 
reaction still may be present in these patients.
Intradermal skin testing of patients with EAA inducing 
antigens may also induce an immediate (15 min) wheal and 
flare reaction (Hargreave & Pepys, 1972, McSharry et al,
1983). Although both symptomatic and asymptomatic 
individuals may demonstrate this reaction (Hargreave & 
Pepys, 1972, McSharry et al, 1983), symptomatic subjects
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have higher grades of reaction (McSharry et al, 1983). The 
basis of the reaction is uncertain, as its size correlates 
with serum IgG rather than IgE antibody titres, against 
the test antigen (McSharry et al, 1983). Despite this, 
levels of specific reaginic IgG4 antibody to pigeon 
dropping extracts were not found to be increased in either 
BAL fluid or the serum of subjects with PBD (Kitt et al, 
1986). Thus, as there is no correlation between IgE 
antibody and disease, there is no evidence to suggest a 
role for a Type I hypersensitivity reaction in the 
pathogenesis of EAA.
b) Cellular immunity
Phenotypic Assessment
Histopathological studies which revealed mononuclear cell 
infiltrates and granuloma formation in the lung (Hensley 
et al, 1969, Chmelik et al, 1974, Seal et al, 1968) 
suggested a role for cell mediated immunity in the 
pathogenesis of pigeon breeders disease.
Total white cells recovered by BAL in subjects with EAA 
are increased on average fivefold, mainly due to a rise in 
the number of T lymphocytes (Costabel et al, 1984, 
Leatherman et al, 1984, Costabel et al, 1985). Similar 
increases in both the white cells and lymphocytes 
recovered by BAL have however been found in asymptomatic 
subjects (Leatherman et al, 1984) . A peripheral blood 
leucocytosis was also reported in symptomatic subjects 
with PBD who were acutely symptomatic at the time of blood 
sampling (Reed et al, 19 65) . However, most of the other 
studies using peripheral blood have failed to report total
56
WBCC and so it is not certain whether leucocytosis is a 
general feature (Costabel et al, 1984, Leatherman et al, 
1984, Costabel et al, 1985)
Investigations to determine the phenotype of lymphocytes 
in the lungs of subjects with extrinsic allergic 
alveolitis reported a predominance of CD8+ cells in the 
BAL fluid of symptomatic subjects compared with controls 
(Costabel et al, 1984, Agostini et al, 1984, Leatherman 
et al, 1984, Costabel et al, 1985, Semenzato et al, 
1986,). However, this was not restricted to symptomatic 
subjects, as similar reversed CD4:CD8 cell ratios were 
reported in the BAL fluid of similarly exposed, but 
asymptomatic subjects (Leatherman et al, 1984, Semenzato 
et al, 1986).
The results of studies which have looked at the phenotype 
of cells in the peripheral blood have been conflicting. 
Two studies reported reduced CD4:CD8 ratios in symptomatic 
subjects with EAA, compared with controls (Costabel et al, 
1984, Costabel et al, 1985), while another three studies 
found no difference (Leatherman et al, 1984, Agostini et 
al, 1984, Semenzato et al, 1986). Unfortunately, the two 
groups that did find reduced CD4:CD8 lymphocyte ratios in 
the peripheral blood of symptomatic subjects with EAA, did 
not include a group of asymptomatic subjects in their 
studies. As a result it is not known whether these changes 
reflect the symptomatic status of the subjects or whether 
they reflect exposure to a given antigen capable of 
inducing EAA in some subjects, regardless of symptoms 
(Costabel et al, 1984, Costabel et al, 1985).
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A number of factors may be responsible for the conflicting 
results of analysis of CD4:CD8 ratios in the peripheral 
blood of subjects with EAA. One possibility is that these 
varied results, reflect the use of small heterogeneous 
subject groups with various syndromes of EAA, ranging from 
Farmers* lung to mushroom workers* lung. It is also 
possible that differences in the time between blood 
sampling and the last exposure to antigen, in these 
studies, may have affected the results. Several studies 
have shown a predominance of CD8+ cells over CD4+ cells, 
after recent antigen exposure, which was found to decline 
with antigen avoidance in both BAL fluid (Trentin et al, 
1988, Costabel et al, 1984) and in the peripheral blood 
(Costabel et al, 1984) such that the CD4:CD8 cell ratio in 
the peripheral blood returned to normal 5 days after 
antigen exposure (Trentin et al 1988). In addition, it 
is possible that different groups were looking at subjects 
with EAA, that were at different stages of disease, since 
recent evidence has suggested that within a given syndrome 
of extrinsic allergic alveolitis there can be different 
cellular profiles depending on the stage of disease 
(Reynolds et al, 1989). These workers showed that subjects 
with chronic PBD had a reduced BAL lymphocyte subset 
CD4:CD8 cell ratio, while those with the acute PBD had a 
predominance of BAL CD4+ cells.
i) NK cells
Studies aimed at determining whether NK cells are 
involved in the pathogenesis of EAA have revealed 
increased percentages of CD57+ (HNK1+) cells in BAL fluid
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(Agostini et al, 1984, Semenzato et al, 1986, Semenzato et 
al, 1988) and in the peripheral blood (Trentin et al,
1986) of subjects with EAA compared with controls. 
However, similar findings were also reported for 
asymptomatic subjects in the one study that included them 
(Semenzato et al, 1986). An increase in NK cell activity 
(assessed in a K562 target cells assay) of peripheral 
blood mononuclear cells, associated with the rise in the 
level of CD57+ cells, was also reported in many of these 
studies (Trentin et al, 1986, Semenzato et al, 1986, 
Semenzato et al,1988). Although all these investigators 
concluded that the cells under examination were NK cells, 
it is now known that only 50% of cells that express CD57 
are actually NK cells (Lanier et al, 1983). Thus it is 
possible that at least some of these cells may have been 
non MHC restricted T cells.
ii) Expression of activation markers 
Increased proportions of lymphocytes expressing activation 
markers, such as Class II antigen (Mornex et al, 1984, 
Costabel et al, 1985, Trentin et al, 1990), the 
interleukin 2 (IL2) receptor and VLA-1 (Very Late
Activation) antigen (Trentin et al, 1990) have been found 
in the BAL fluid of symptomatic subjects with EAA compared 
with controls. It has been shown that both CD4+ and CD8+ 
lymphocytes account for the increase in the expression of 
class II on lymphocytes (Costabel et al, 1985). However, 
using UCHL1 as a marker for "activated/memory” CD4+ cells 
(Akbar et al, 1988), Johnson et al (1989) revealed 
increased expression of UCHL1 on lymphocytes in the lungs 
of both symptomatic and asymptomatic pigeon breeders.
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Johnson et al, (1989) also showed that when symptomatic 
pigeon breeders were relavaged after isolation from 
pigeons for three weeks, there was a significant reduction 
in the proportion of lymphocytes expressing UCHL1. Very 
few studies have looked at the levels of activation 
markers expressed on the lymphocytes in the peripheral 
blood of subjects with EAA. The few studies that have, 
used class II expression as a marker of lymphocyte 
activation but did not find any differences between 
symptomatics and controls. (Mornex et al, 1984, Costabel 
et al, 1985).
The use of cytokines as important indicators of the 
presence of an active immune response was utilised by 
Reynolds (1989) who reported increased levels of IL-1 and 
IL-2 in BAL fluid of symptomatic and asymptomatic pigeon 
breeders compared with controls. In addition, the same 
study showed that asymptomatic pigeon breeders had higher 
levels of soluble IL-2 receptor (IL-2R), expressed in 
terms of lymphocytes per ml of BAL fluid, compared with 
their symptomatic counterparts (Reynolds, 1989). He 
suggested that excess soluble IL-2R, on a cellular basis, 
in BAL fluid may be a mechanism by which some pigeon 
breeders remain asymptomatic. No difference in the 
absolute levels of soluble IL-2R were found in this study.
iii) Other inflammatory cells 
Little is known about the contribution of alveolar 
macrophages to the alveolitis of EAA. Due to the influx of 
T lymphocytes into the lungs of subjects with EAA, the 
percentages of macrophages derived by BAL are reduced from
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around 80% to about 20% of BAL cells (Costabel et al, 1984, 
Costabel et al, 1985, Haslam et al, 1987). However it is 
possible that these cells become more active since 
increased phagocytic and bactericidal activity of these 
cells occurs in rabbits after sensitisation and challenge 
with M.faeni (Stankus et al, 1978). In addition, the 
percentages of macrophages expressing RFD1 (associated 
with interdigitating cells) and RFD7 (associated with 
mature macrophages) are increased in both symptomatic and 
asymptomatic pigeon breeders compared with controls 
(Johnson et al, 1989). However, similar levels of class II 
antigens, expressed on macrophages from subjects with EAA 
and normal controls (Costabel et al, 1986). Therefore, 
further studies are needed to document the functional 
status of the alveolar macrophages in EAA.
Mast cells rarely exceed 0.5% of cells in BAL, in normal 
controls and it has been reported that mast cells may be 
as much as 10 fold higher in the BAL of subjects with EAA 
(Haslam et al, 1987). In addition, these cells showed 
signs of degranulation and mast cell counts fell after 
removal of the subjects from exposure, despite a 
persistent increase in the percentages of lymphocytes 
(Haslam et al, 1987). It has been suggested that the 
increased numbers of mast cells may be the result of the 
activity of lymphokines such as IL3, released by activated 
T cells, which can promote mast cell recruitment and 
maturation.
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Functional Assessment
Only a limited number of studies have investigated the 
role of cell mediated immunity in the pathogenesis of EAA.
An initial study by Caldwell et al (1973) demonstrated 
peripheral blood lymphocyte sensitivity to pigeon serum by 
measuring macrophage migration inhibition factor (MIF) in 
subjects with PBD. However, subsequent studies found that 
lymphocytes from both symptomatic and asymptomatic 
subjects, with various different syndromes of EAA, 
released MIF (Fink et al, 1975), leucocyte migration 
inhibitory factor (LIF) and leucocyte mitogenic factor 
(LMF) (Girard et al, 1978) when incubated with the 
appropriate antigen, although lymphokine release was more 
common in lymphocytes from symptomatic subjects.
Lymphocyte sensitivity to antigens in EAA, as measured in 
an in vitro proliferation assay, using pigeon serum and 
pigeon droppings as antigens, has been shown in many 
studies in both symptomatic and asymptomatic pigeon 
breeders (Schatz et al, 1976, Girard et al, 1978, Moore et 
al, 1980). Girard et al (1978) also looked at the subjects 
with farmers lung and hypersensitivity to exotic woods and 
similarly found that lymphocytes from both symptomatic 
and asymptomatic subjects responded to the relevant 
disease associated antigens. However, Hansen & Penny 
(1974), could only detect lymphocytes sensitivity in their 
symptomatic pigeon breeders. In the few studies that 
included lymphocytes from a control population of normal 
healthy individuals, no sensitivity has been found 
(Girard et al, 1978, Hansen & Penny, 1974).
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Therefore, the results of the functional studies are 
inconclusive and nothing has been done for many years 
despite the antigens not having been identified.
1.7.5. ANIMAL MODELS OF EAA.
The variabilty and limitation of clinical studies has 
engendered the use of animal models to study the 
immunopathogenesis of EAA.
These studies have used both defined antigens such as 
ovalbumin and proven aetiologic agents of disease, such as 
pigeon serum or Micropolyspora faeni. In most 
experimental models there is an additional need for an 
adjuvant (Richerson et al, 1971, Richerson, 1972, Joubert 
et al, 1976, Bernardo et al, 1979), mitogen (Moore et al,
1975) or other non specific inflammatory agent to induce 
disease. As a result, it has been suggested that under 
clinical conditions, an acute inflammatory reaction 
initiated by endotoxin contamination of inhaled dusts, 
plays an essential role in the induction of EAA (Burrel & 
Rylander, 1981).
Animal models have allowed longitudinal analysis of the 
changes in lung cell populations after controlled 
laboratory exposure to an antigen. This has confirmed the 
clinical impression that the first pathological feature is 
an early polymorphonuclear infiltrate, occurring within 4 
hours after inhalation challenge (Bernardo et al, 1979) 
and accompanied by the presence of chemotactic factors in 
BAL (Yoshizawa et al, 1982, Yoshizawa et al, 1988). 48-96
hours after challenge, a mononuclear cell infiltrate
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(Bernardo et al, 1979, Richerson, 1971, Joubert et al, 
1976) ensues and resolution of the alveolitis occurs after 
6 days (Richerson 1971).
An unusual feature of animal models is that repeated 
inhalation challenge with antigen following acute disease, 
fails to induce chronic EAA and indeed, the alveolitic 
lesions eventually disappear (Richerson 1978, Ratajczak et 
al, 1980, Richerson et al, 1981). This clearing of disease 
is antigen specific, but is not associated with decreased 
antibody responses or decreased antigen specific 
lymphocyte blastogenesis (Richerson et al, 1981, Ratajczak 
et al, 198 0) . This phenomenon may be the counterpart of 
chronically exposed human subjects who are asymptomatic, 
despite the presence of precipitating antibody (Do Pico et 
al, 1976) and lymphocyte sensitivity (Semenzato et al, 
1986) . Interestingly, desensitisation in experimental 
animals can be prevented if the repeated aerosol 
challenge with antigen is accompanied by muramyl 
dipeptide, suggesting that non-specific activation of T 
cells is also required for maintenenance of the disease 
(Chedid et al, 1978, Richerson et al, 1982).
Further studies of pigeon-sensitivity in monkeys have 
suggested that animals which became symptomatic lacked a 
population of antigen-specific suppressor T cells in 
their peripheral blood were present in asymptomatic 
animals (Keller et al, 1982). Moreover, depression of 
suppressor activity by low dose total body irradiation was 
accompanied by the appearance of clinical disease (Keller 
et al, 1982). The same group have presented functional
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evidence of suppressor cells in BAL fluid of asymptomatic 
humans (Keller et al, 1984), although this has been 
challenged by others who found that both symptomatics and 
asymptomatics had a population of suppressor cells 
(Semenzato et al, 1986). These apparently conflicting 
results may reflect the different experimental design.
Attempts to produce lung lesions in animals by means of 
passive transfer or selective immunisation with 
antibodies, have resulted in minimal pulmonary lesions 
such as infiltrates characterised only by mild haemorrhage 
and neutrophilia (Johnson & Ward, 1974, Richerson, 1972, 
Roska et al, 1977). In contrast, experimental alveolitis 
in rabbits, can be transferred with lymphocytes (Bice et 
al, 1976) . This has been confirmed more recently in a 
guinea-pig model of EAA, where transfer of cultured lymph 
node or spleen cells from sensitised animals could 
transfer susceptibility (Schuyler et al, 1987) . Antibody 
containing serum could not transfer susceptibility in this 
model.
Further evidence that mast cells may be important in the 
development of EAA have come from a study in mast cell 
deficient mice. Passive transfer of mast cells to these 
mice increased the severity of EAA-like lesions which 
developed after transnasal administration of antigen 
(Takizawa et al, 1989).
1.7.6 CONCLUSIONS
There is clinical evidence of both antibody and cell 
mediated immunity in the pathogenesis of EAA but the
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relative contributions are inconclusive. Functional 
studies are poor and inconclusive. Animal studies favour 
cell mediated immunity, but show that specific immune 
responses, are alone not sufficient to induce disease and 
that an adjuvant is needed. Animal models also indicate 
that specific down-regulation of the immune system, may 
control these responses.
The aim of this thesis was therefore to reassess the role 
of CMI in the pathogenesis of EAA, by performing parallel 
functional and phenotypic studies of peripheral blood 
lymphocytes from well defined groups of patients divided 
on the basis of their symptoms and antibody status. To do 
this, PBD was used as a model of EAA in general.
1.8. PIGEON BREEDERS DISEASE
1.8.1 HISTORICAL NOTE
Hypersensitivity to avian proteins was first described by 
Plessner in 1960, in workers employed in plucking duck and 
goose feathers. Subsequently, similar symptoms have been 
reported following exposure to parakeets (Pearsall, 1960) 
budgerigars (Hargreave et al, 1966), chickens (Korn et al, 
1968 and turkeys (Boyer et al, 1974).
PBD was first described in the "gaveurs de pigeons", 
people who force fed pigeons in Paris and who had daily 
contact with thousands of birds (Renon, 1897). However, it 
was not until the report by Reed et al (1965) that the 
clinical and serological findings were correlated and the 
association of the disease with pigeons was proven by
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controlled challenge with pigeons. The disease was 
subsequently reported worldwide (Boyd, 1975, Molina,
1976).
1.8.2 OCCURRENCE AND INCIDENCE
In 1968, the American Racing Pigeon Union reported that 
there were approximately 75,000 breeders in the United 
States, 180,000 in England and 250, 000 in Belgium (Fink 
et al, 1968). Estimates of the incidence of disease vary 
from 0-22%, depending on the population studied (Elgefors 
et al, 1971, Christensen et al, 1975, Boyd 1975, Banham et 
al, 1986, Fink et al, 1972).
1.8.3 ANTIGENS ASSOCIATED WITH PBD
Symptomatic and asymptomatic pigeon breeders have 
precipitating antibodies to a variety of pigeon materials, 
including droppings, serum (Barboriak et al, 1965, Reed et 
al, 1965), egg white, feathers (Fink et al, 1968) and egg 
yolk (Reed et al, 1965) . Pigeon serum is a good source of 
antigen for use in serological tests and inhalation 
provocation tests (Hargreave & Pepys, 1972, Hendrick et 
al, 1980), but pigeon droppings have been considered as a 
more clinically relevant source of antigen as they are 
found in the natural loft environment (Fredericks, 1978). 
However, pigeon droppings are hygroscopic and bulky, do 
not desiccate easily and are normally removed from the 
loft regularly to maintain overall cleanliness. 
Furthermore, many pigeon fanciers experience symptoms in 
circumstances, (eg shows) where excreta are kept to a 
minimum. Boyd (1978) has suggested that pigeon bloom, a
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waxy substance which coats the feathers and which is 
readily dispersed in the loft environment is a more likely 
source of antigen. This was later confirmed to be highly 
antigenic by radioimmunoassay (Banham et al, 1982).
Pigeon serum gammaglobulin and albumin were shown to be 
the major antigens in pigeon serum (Fink et al, 1969b). 
Specific serum antigens belonging to the gammaglobulin 
fraction were found which did not have antigenic identity 
to the serum proteins of other avian species (Faux et al, 
1971, Sennekamp et al, 1981) and as a result, pigeon serum 
gammaglobulin was considered to be the specific antigen 
associated with PBD. This antigen was further demonstrated 
to be more immunogenic in man than pigeon serum albumin in 
a quantitative precipitin test (Fink et al, 1969b).
Pigeon droppings were also shown to be a major antigen 
source by inhalation provocation tests (Reed et al, 
1965) and were later shown to contain both globulin and 
albumin (Barboriak et al, 1965, Edwards et al, 1970). In a 
series of papers, Berrens et al (1972 a-c) fractionated 
pigeon droppings extract (PDE) proteins and showed that 
the major antigen had gamma-mobi1ity on 
immunoelectrophoresis, and was later shown to be IgA 
(Fredericks & Tebo, 1980). Prior to this, IgA derived from 
pigeon droppings had been described as XPGG, since it 
cross reacted with the main serum gamma-globulin antigen 
(Edwards et al, 19 69) . My study used both pigeon serum 
and pigeon droppings as antigen sources.
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1.8.4 WHY STUDY PBD?
PBD is one of the most extensively studied of the disease 
syndromes of EAA. The population at risk is easily 
identifiable and very willing to participate in laboratory 
studies, enabling both symptomatic and asymptomatic 
individuals to be studied. This allows detailed study of 
the clinical, immunological and physiological changes 
associated with disease. In addition, sources of antigen 
which can produce symptoms of PBD in both humans (Reed et 
al, 1965) and animals (Barboriak et al, 1976, Fink et al, 
1970) have also been identified, allowing controlled 
laboratory challenges and longitudinal time course 
experiments to explore the full spectrum of the disease 
process.
As the clinical and immunological aspects of all syndromes 
of alveolitis are the same, PBD is a useful model for 
studying the immunopathogenesis of the disease process 
which could equally apply to the more individual syndromes 
of EAA listed in Table 1. In addition, the complex nature 
of the disease process, involving both the cellular and 
humoral arms of the immune response make it an ideal model 
to study hypersensitivity lung diseases in general and 
wider aspects of pulmonary and mucosal immunology.
1.9 SCOPE OF THIS THESIS
This thesis explores the role of the cellular immune 
response in the pathogenesis of acute PBD (Fink et al, 
1983 ) , that is PBD associated with systemic and 
respiratory symptoms, 4-8 hours after contact with pigeon
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antigen. The studies use peripheral blood to gauge the 
types of responses which might also be occurring in the 
lung. Because of the difficulties involved in obtaining 
BAL, peripheral blood was used to enable a much larger 
population of pigeon breeders to be studied.
The third chapter looks at the total and differential WBCC 
and lymphocyte subsets in the peripheral blood of pigeon 
breeders grouped according to symptoms, presence of serum 
antibody to pigeon antigen and whether or not they are 
acutely symptomatic at the time of blood sampling. The aim 
was to determine whether there were any changes in the 
peripheral blood and whether these changes reflected the 
symptomatic status of the subjects.
In the fourth chapter, symptomatic pigeon breeders who 
have severe longstanding PBD are selected for additional 
phenotypic and functional analysis of NK cells in their 
peripheral blood. The same subjects are then assessed for 
the level of |i T cells and cells expressing "memory” 
markers in their peripheral blood in the fifth and sixth 
chapters respectively, in an attempt to determine whether 
these cells are involved in the pathogenesis of disease.
Finally the function of T cells in the peripheral blood of 
pigeon breeders with severe longstanding PBD is explored 
in a lymphocyte proliferation assay (chapter 7). The 
results of this study lead to the studies of the final 
chapter which explore the possibility that endotoxin or 
some other mitogenic agent might be involved in the 
pathogenesis of PBD.
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TABLE 1
Varieties of Extrinsic Allergic Alveolitis (Schatz & Patterson, 
1983, Daniele, 1988b)
CLINICAL SYNDROME SOURCE TYPICAL ANTIGENS
Bacteria thermophilic actinomycetes
Mouldy hayFarmer's lung 
Humidifier lung
Bagassosis 
Mushroom worker's 
lung
Maple bark 
stripper's lung 
Suberosis
Sauna taker1s lung 
Sequoisis
Saxophonist1s lung
Summer-type
pneumonitis
Cheese washer's 
lung
Dry rot alveolitis 
Malt worker's lung
Micropolyspora faeni 
T. vulgaris 
Contaminated air T. Candidas 
conditioning Naegleria gruberi
(Anderson et al, 1985) 
Sugar cane bagasse T. saccharii 
Mouldy compost T. vulgaris
Mushroom spores 
(Nakazawa & Tochigi 1989)
Fungi
Mouldy maple bark Cryptostroma corticale
Mouldy cork PeniciIlium frequentans
Contaminated water Pullularia 
Mouldy wood dust Pullularia
Candida albicans 
(Lodha et al, 1988) 
Trichosporon 
cutaneum
(Yoshida et al, 1988) 
Penicillium caseii
Contaminated 
mouthpiece 
Home environment
Mouldy cheese
Contaminated moist Merulius lacrymans 
wood
Malt
Animal Antigens
Pigeon fancier's lung 
Budgerigar fancier's lung 
Rat lung
Pituitary snuff user's lung
Isocyanate
alveolitis 
Paulis reagent 
pneumonitis 
Pyrethrum 
pneumonitis
Coffee worker's lung 
Thatched roof lung
Chemicals
Industrial
exposure
Insecticide
Aspergillus clavatus
Avian protein 
Avian protein 
Rat serum protein 
Bovine and porcine 
protein
Toluene di-isocyanate
Sodium diazobenzene 
sulphate 
Pyrethrum
Unidentified Antigen
Coffee dust 
Thatch
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 SUBJECTS
2.1.1 DIAGNOSTIC CRITERIA FOR ACUTE PIGEON BREEDERS* 
DISEASE
Patients were selected by respiratory physicians with 
experience in EAA, on the basis of the criteria of Banham 
et al 1986 which "requires at least one typical delayed 
respiratory symptom (6-12 hours after exposure) of 
dyspnoea, cough or chest tightness, together with at 
least one of the systemic symptoms of fever, sweating or 
arthralgia, such symptoms occurring on at least three 
occasions".
2.1.2 PIGEON FANCIERS
The pigeon breeders used in this study were derived from 
two main sources.
a) Participants at pigeon fanciers conventions
(Winter Gardens, Blackpool, 1989 and 1990)
i) Subjects derived from the Blackpool 1989 pigeon 
fanciers convention were volunteers who approached a 
medical stand at the convention. Many were seeking advice 
on what they considered were pigeon-exposure related 
diseases but many others were asymptomatic, interested 
volunteers. The population was probably biased in favour 
of symptomatic subjects and would not represent the 
status of the general population who keep birds.
The subjects were divided into four groups based on their 
serum antibody status to pigeon antigen and on the basis 
of a positive or negative diagnosis of acute PBD as
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determined by a self administered symptom based 
questionnaire (Appendix), using the symptomatic criteria 
of Banham et al 1986, as outlined above.
ii) Subjects derived from Blackpool 1990 pigeon 
fanciers convention were volunteers selected on the basis 
that they were acutely symptomatic at the time of blood 
sampling in addition to being diagnosed as having acute 
PBD as determined by a questionnaire (Appendix), 
administered by an experienced respiratory physician, 
using the symptomatic criteria of Banham et al 1986 (see 
above, 2.1.1). All subjects had a positive serum antibody 
titre to pigeon antigen.
b) Patients attending a respiratory outpatients clinic
(Royal Infirmary, Glasgow).
Subjects from this source had well described PBD, with 
a positive serum antibody titre to pigeon antigen along 
with chest radiographic appearances and restrictive 
pulmonary defects consistent with PBD.
None of the pigeon breeders used in this thesis were 
taking oral steroids either at the time of study or in 
the preceding six months.
2.1.3 CONTROL SUBJECTS
Normal healthy laboratory workers were used as control 
subjects.
Further details of individual groups of pigeon breeders
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and controls used in this thesis, including their 
demographic details, are given in chapter 3.2.1.
2.2 PREPARATION AND ANALYSIS OF PIGEON DERIVED ANTIGENS
2.2.1 PIGEON ANTIGENS
a) Pigeon Serum
Pigeon serum was obtained from healthy laboratory-housed 
pigeons (Yorkhill Hospital, Glasgow), by exsanguination 
of the wing vein, sterilised by 0.2^m Millipore 
filtration (Millipore S.A., France) and stored at -20°C 
until use. Both pooled and individual serum samples were 
collected.
i) Ammonium Sulphate Fractionation 
In order to separate the globulin component of pigeon 
serum (PS) , the pH of a solution of cold, saturated 
ammonium sulphate was adjusted to pH 6.5 by the addition 
of a few drops of 0.1M NaOH just before use and then 
added dropwise to a sample of pigeon serum with constant 
stirring. 1ml of (NH3)2S04 was added for every 2mls of PS 
giving a resultant saturation of 3 3%, which was optimum 
for avian globulin separation (Hebert, 1974). After 
stirring for 3 0 minutes, the suspension was centrifuged 
at 400g for 30 minutes at 4°C and the supernatant 
(Fraction A) collected and stored at 4°C. The precipitate 
was reconstituted to the volume of the original serum 
sample with saline and then the above precipitation steps 
repeated followed by centrifugation at 400g at 4°C for 30 
minutes. The precipitate (Fraction B ) , was then 
reconstituted to a quarter of the volume of the original
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serum sample and both samples were then dialysed in 
phosphate buffered saline (PBS) at 4°C over 2 days with 
frequent changes of buffer. The solutions were then 
sterilised by Millipore filtration to 0.2^m (Millipore) 
and an estimation of protein content determined by Lowry, 
see below (2.2.2).
b) Pigeon serum albumin
Lyophilised pigeon serum albumin (Sigma pic) was 
reconstituted in PBS to a concentration of lmg/ml and 
stored at -20°C until use.
c) Pigeon Droppings
Fresh pigeon droppings were collected into sterile glass 
universals and stored at -20°C until use. Pigeon 
droppings were thawed and extracted in PBS with 0.2% 
sodium azide (PBS/azide). The protease inhibitors; ImM 
phenylmethylsulfonyl fluoride (PMSF), (Sigma) and luM 
pepstatin (Protein Research Foundation, Japan) were 
included in the PBS/azide extraction solution in one 
experiment. PMSF and pepstatin were diluted in dimethyl 
formamide and 50% ethanol respectively. lOOmls of the 
PBS/azide solution was used to extract 50g of pigeon 
droppings by constant stirring for 24 hours at 4°C. 
After centrifugation at 3000rpm for 60 minutes, the 
soluble proteins were extracted by pipetting off the 
supernatant and then centrifuging for a further 3 0 
minutes at 3000rpm to maximise the removal of fine 
sediment. The green suspension was then dialysed against 
PBS at 4°C with repeated changes of buffer,
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followed by millipore filtration using a 5/zm filter 
followed by a 0.8/m filter (Millipore SA, France) to 
remove particles. The suspension was then concentrated 
using an Amicon Dyaflow concentrator PM 10 (Amicon Ltd. 
Stonehouse, Great Britain) to approximately lOmls and 
then sterilised by filtration.
2.2.2 LOWRY METHOD OF PROTEIN QUANTIFICATION
A mixture of 1% copper sulphate pentahydrate and 2% 
sodium tartrate in equal proportions was made freshly on 
the day and 1ml of this was added to 50mls of 2% sodium 
carbonate in 0.1N NaOH on the day of use (solution 1). A 
series of 5 standards of bovine serum albumin (BSA, 
Fraction V, Sigma) in PBS was made from 100/xg/ml to 
20/xg/ml, to a final volume of 1ml in sterile glass tubes. 
A tube containing 1ml of PBS was used as a negative 
control. Appropriate dilutions of test samples were made 
in 1ml aliquots, such that they would have similar 
protein concentrations to the standards, using 
ultraviolet absorption (280nm) readings as a rough 
indication of protein content. Usually three different 
dilutions of test samples were assayed.
5mls of solution 1 was added to all tubes and mixed 
thoroughly. After incubating for 10 minutes at room 
temperature, 0.5ml of Folin Ciocalteau's reagent (Sigma) 
diluted 1:2 in distilled water was added to each tube and 
then mixed thoroughly. After 30 minutes the absorbance of 
each protein solution at 750nm was read in a
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spectrophotometer.
Using the BSA standards a plot of protein content (fig) 
against E750nm was drawn. The protein content of the 
test samples was then calculated using the standard 
curve. If a test sample was too concentrated it was 
diluted in PBS and a correction factor used to calculate 
the final result.
2.2.3 ANALYSIS OF PROTEINS BY POLYACRYLAMIDE GEL 
ELECTROPHORESIS
The discontinuous gel system of Laemmi 1970 was used,
a) 7.5% Separating / Resolving Gel
A 7.5% gel was used for the separation of proteins in 
the approximate molecular weight range between 40-250 
KDa.
A solution of 1.88mls of a 40% Bis Acrylamide solution, 
2.5mls of 1.5M Tris hydroxymethyl aminomethane (Tris) 
pH8.8, 100/xl of 12% sodium dodecyl sulphate (SDS) and
5.52 mis of water was added to a Buchner flask mixed 
thoroughly and then degassed for 2 minutes to remove 
oxygen. Immediately after adding 50/xl of 10% ammonium 
persulphate and 5 /x 1 of Temed, the catalyst for the 
polymerisation reaction, the solution was poured into 
the space between the glass plates on the casting stand, 
using a needle and syringe. The gel was then immediately 
overlayed with a small layer of water-saturated 
isobutanol, to exclude oxygen, an inhibitor of 
polymerisation and to reduce the meniscus forming on the
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gel surface. The gel was then allowed to set for 1 hour 
at room temperature before the butanol solution was 
carefully poured off and the top layer of the gel rinsed 
with distilled water which was removed with a piece of 
filter paper before the addition of the stacking gel. The 
stacking gel was added immediately to avoid the resolving 
gel drying out.
b) 5% Stacking gel
A 5% acrylamide solution was used to concentrate the 
proteins before separation and to increase the resolution 
of bands.
A solution of 0.75mls of 40% Bis /Acrylamide, 0.68mls of 
0.65M Tris/HCL pH6.8, 0.05mls of 12% SDS and 4.52 mis of 
water was added to a Buchner flask mixed and degassed for 
2 minutes. Immediately after adding 50 fil of 10% ammonium 
persulphate and 5.8/zl of Temed , the mixture was than 
poured onto the resolving gel with the comb, which 
generates separate wells, ready to be pushed firmly into 
position once the gel had been poured. The gel was then 
allowed to set for 1 hour before the comb was removed and 
the samples applied.
c) Sample preparation
Samples and standards including a sample containing 
various proteins of known molecular weight (high MW 
standards, Sigma) were diluted in an equal volume of 
sample buffer containing the reducing agent: 132-
mercaptoethanol and glycerol to increase the viscosity of 
the sample (50% glycerol, 0.25M Tris HCL, 5% SDS, 5% 132- 
mercaptoethanol, 0.025% bromophenol blue and water). The
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samples were then heated at 95°C for 5 minutes, to allow 
protein reduction before being applied to the wells of 
the gel under the electrode buffer (30.3g Tris, 14.4g 
Glycine, lg SDS in 1 litre water, pH 8.3).
d) Running conditions
Gels were run in the electrode buffer at a constant 
voltage of 2 00V for approximately 3 0 minutes, until the 
marker dye had reached the bottom of the gel.
e) Fixing and staining
The gel was carefully removed from the glass plates and 
soaked in fixative/destaining solution (3 0% ethanol, 5% 
glacial acetic acid, and water) for 30 minutes before 
being transferred to staining solution (45% ethanol, 10% 
glacial acetic acid, 0.1% PAGE Blue and water) for 2 
hours. The gel was then destained in fixative/destaining 
solution and could be preserved in this until it was 
photographed.
2.3 DETECTION OF SERUM ANTIBODY TO PIGEON DERIVED 
ANTIGENS
2.3.1 COLLECTION OF PIGEON BREEDERS' SERUM SAMPLES FOR 
ENZYME-LINKED IMMUNOSORBENT ASSAY
Serum samples collected at pigeon fanciers conventions 
were frozen on dry ice before being transferred to a 
-20°C freezer, until use. Serum samples from hospital out 
patients were immediately frozen at -20°C until use.
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2.3.2 ENZYME-LINKED IMMUNOSORBENT ASSAY
The indirect microplate enzyme immuno- assay method of 
Voller et al (1976) was employed using Titertek 
microtitration strips (Flow Laboratories ,Irvine).
The wells of the plate were coated with 20/xg/ml of pigeon 
serum in carbonate buffer 0.1M, pH 9.6 at lOOul per well 
overnight at 4°C. The plate was washed three times by 
immersion in wash buffer PBS 0.1M pH 7.2 containing 0.5% 
Tween-20 (PBS-T). The test and control sera, diluted 1 in 
100 in PBS-T, were added in duplicate at lOOul per well 
and incubated for 1 hour at room temperature. The plates 
were washed three times as before and lOOul of alkaline 
phosphatase conjugated rabbit anti-human IgG (ICN 
Immunobiologicals) used at 1 in 1000 dilution in PBS-T 
was added to each well and incubated for a further 1 hour 
and 30 minutes. After a further three washes, a substrate 
solution of p-nitropheny1 phosphate (104 phosphate 
substrate, Sigma) at 2.5 mg/ml in 10% diethanolamine 
pH9.6 was added at lOOul per well. After approximately 30 
minutes, when sufficient colour had developed in the 
positive control samples, the absorbance of each well at 
405nm, was read using a spectrophotometer (Multiskan Flow 
Laboratories). Values were calculated from the standard 
curve made up of the absorbance readings of serially 
doubly diluted, reference, high titre serum , quantified 
as having an absolute level of lOOug/ml of IgG antibody 
to pigeon globulin antigen in a quantitive precipitin 
test (Boyd, 1975).
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2.4 ANALYSIS OF CELL-MEDIATED IMMUNITY
2.4.1 COLLECTION OF BLOOD AND MONONUCLEAR CELL 
SEPARATION
Peripheral blood mononuclear cells, for functional 
studies, were prepared from heparinised venous blood from 
patients and normal volunteers by density gradient 
separation. Blood was collected into plastic universals, 
containing 10 units of preservative free-heparin (Leo 
Laboratories, Bucks, UK) per 1ml of blood and two 
volumes of blood were layered over three parts Lymphoprep 
(Nycomed Pharma As, Norway) before centrifuging at 400g 
for 35 minutes at room temperature. Interface cells were 
then removed using a pasteur pipette and washed twice 
with buffered culture medium (RPMI 1640, Gibco BRL, 
Paisley, Scotland) containing 200 units/ml penicillin, 
2 00 jitg/ml streptomycin and 2mM L-glutamine.
Blood for flow cytometric analysis was collected into 
tubes containing EDTA and analysed within 24 hours.
2.4.2 WHITE BLOOD CELL COUNT AND MONONUCLEAR CELL COUNT
All WBCC were performed in a Coulter counter (Coulter 
Electronics, England). Mononuclear cell counts were 
performed in a haemocytometer (Improved Neubauer, Weber, 
England).
2.4.3 FLOW CYTOMETRY
A Becton Dickinson flow cytometer (FACScan) was used,
a) Differential cell count by flow cytometry
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LeucoGATE reagent (Becton and Dickinson, Belgium) which 
consists of a mixture of MAbs to the common leucocyte 
antigen CD45 and the monocyte specific antigen CD14 was 
used to stain the first aliquot of whole blood from each 
subject. The light scatter and fluorescence parameters of 
the cells in this tube allowed SimulSET software (Becton 
Dickinson) to analyse data from the flow cytometer and to 
determine the percentages of lymphocytes, neutrophils and 
monocytes .
b) Lymphocyte subset analysis
The optimal settings on the flow cytometer, for 
demonstrating peripheral blood lymphocytes were; forward 
scatter: detector E00 and amplifier 1.23 on a linear 
scale, side scatter: detector 325 and amplifier 1.00 on a 
linear scale. For FL1 (FITC) : detector 535 and the 
amplifier on a log scale and FL2 (PE): detector 458 and 
amplifier on a log scale. The thresholds were all set at 
52 with compensation FL1-FL2 = 0.6% and FL2-FL1 = 23.2%.
LeucoGATE analysis allowed gating of consistently more 
than 95% of the total lymphocytes with less than 10% 
contamination by debris, granulocytes and monocytes. 
Fluorescence was standardised using a control reagent, 
NAME (Becton Dickinson, Belgium) in order to determine 
the level of nonspecific background staining of cells 
with either Fluorescein isothiocyanate (FITC) or 
Phycoerythrin (PE) labelled mouse monoclonal 
immunoglobulins with no known specificity.
c) Antibody reagents
Fluorescein isothiocyanate (FITC)-conjugated anti-CD3
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(Dakopatts, Denmark) and phycoerythrin (PE)-conjugated 
anti-CD3 (Coulter Immunology, Florida) were used as pan T 
cell markers. FITC-conjugated anti-CD4, FITC-conjugated 
anti-CD8, both from Coulter Immunology (Florida) and PE- 
conjugated anti-CD8 (Becton-Dickinson,CA) were used to 
identify the appropriate T cell subset. A combination 
of FITC-conjugated anti-CD4 and PE-conjugated 2H4 
(Coulter Immunology) was used to identify CD45R+4+ T 
cells, while CDw29+4+ T cells were identified using a 
similar combination of FITC-conjugated anti CD4 and PE- 
conjugated 4B4 (Coulter Immunology).
FITC conjugated anti-TCR<Sl (T cell sciences, Cambridge 
MA.) was used to stain all JS T cells and FITC conjugated 
anti-5TCS-l (T cell sciences) used to stain the 
subpopulation of |5 T cells expressing the nondisulphide 
linked form of the }S TCR.
B cells were identified using PE-conjugated anti-CD19 
(Dakopatts).
Cells expressing the NK cell markers CD56 and CD16 were 
identified using PE-conjugated anti-CD56 (Coulter 
Immunology) and PE-conjugated anti Leullc (Becton 
Dickinson) respectively.
b) Immunofluorescence staining
5/il of all of the above antibodies were used except for 
the antibody specific for CD19 which was used at 10/xl and 
the cocktails of antibodies to CD4 and CD45R or CDw29 
which were used at 20/li1. The antibodies were used alone 
or in combinations, where both antibodies were added
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together.
A whole blood method of labelling and lysing cells was 
used. lOOul of whole blood was mixed and incubated at 
37°C with the appropriate amount of each antibody in 
separate tubes. Erythrocytes were then removed by lysis 
through the addition of 2mls of FACS Lysing solution 
(Becton and Dickinson, Belgium) diluted 1 in 5 in 
distilled water. After incubation at room temperature 
for 10 minutes in the dark (to prevent quenching of the 
fluorochrome) and centrifugation at 300g for 10 minutes, 
the lysing reagent and cell debris were removed and the 
cell pellet washed in 2mls of PBS containing 0.2% sodium 
azide. After centrifuging for a further 10 minutes at 
3 00g, the PBS was pipetted off and the samples fixed in 
200ul of 1% paraformaldehyde in PBS pH7.4.
i) Additional step for Gamma Delta cells:
Due to the low numbers of ]6 cells, lOOul of PBS 
containing 0.2% bovine serum albumin (Fraction V, Sigma) 
with 0.1% sodium azide (PBS-BSA-azide buffer) was added 
to 100/liI of whole blood prior to the addition of 5ul of 
anti gamma delta MAb and the mixture incubated for the 
longer period of 3 0 minutes with a mix after 15 minutes, 
in order to optimise specific binding while reducing the 
possibility of non-specific binding. After the incubation 
period, the tubes were then washed with 2mls of PBS/azide 
and centrifuged for 10 minutes at 3 00g at 4°C.
2.4.4 LYMPHOCYTE CULTURES
Lymphocytes were cultured with various pigeon proteins
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and with Pokeweed mitogen (PWM) (Gibco BRL, Paisley) as a 
positive control. The culture systems had to be 
standardised in a number of experiments and these are 
described in detail in Chapters 7 and 8. Only the outline 
of the assays is given here. Peripheral blood 
mononuclear cells (PBMC), from Ficoll, were resuspended 
in RPMI 1640 (Gibco BRL), supplemented with penicillin 
(200 units/ml) , streptomycin (200/xg/ml) and L-glutamine 
(2mM) (Gibco BRL, Paisley). PBMC were cultured in 0.1ml 
volumes in conical bottomed microtitre plates (Titertek, 
Flow Laboratories) at a cell concentration of 
lxl05/well. Various concentrations of pigeon antigens and 
mitogen were added in a volume of 25/zl and each well was 
given an appropriate volume of heat inactivated FCS 
(Gibco BRL, Paisley and later Biological Industries, 
Glasgow), each tested for low intrinsic mitogenic 
activity, such that each well would contain 10% FCS. The 
plates were sealed with Titertek non- toxic films (Flow 
Labs., Irvine) and incubated at 37°C in 5% C02 in an air 
humidified incubator (Amersham) for 6 days. 6 hours 
before harvesting, the plates were pulsed with ljuCi of 
H-Thymidine (Amersham) and after reculture, cell bound 
DNA was harvested using a multi-cell harvester (Titertek 
Cell Harvester, Skatron, Norway). Cell extracts were 
placed in scintillation fluid (L K B , Scintillation 
Products, Loughborough, England) and radioactivity 
measured in a scintillation counter (Packard, United 
Technologies, USA). Cultures were performed in triplicate 
and the results are presented as the mean counts per 
minute per well.
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2.4.5 NATURAL KILLER CELL ASSAY
a) Target Cells
The target cells were K562, a human erythroleukaemic cell 
line. The target cells were maintained in continuous 
culture in RPMI 1640, with 200 units/ml penicillin, 200 
/xg/ml streptomycin, 2mM L-glutamine and 10% heat 
inactivated fetal calf serum ("complete" RPMI). The cells 
were subcultured routinely every 2 days and 24 hours 
prior to being used in a cytotoxic assay.
b) Labelling of target cells
An aliquot of culture medium containing 3x10 target 
cells was centrifuged at 400g for 5 minutes and the 
supernatant discarded to leave a cell pellet which was 
then incubated with 0.2ml [51Na] sodium chromate
(specific activity 2 0 MBq/ml, Amersham pic., Aylesbury, 
U.K.) at 37°C for 1 hour. The cells were then washed six 
times with "complete" RPMI. The final concentration was 
then adjusted to 2xl04/ml.
c) Cytotoxic Assay
The cytotoxic assay was carried out in V-bottomed 
microtitre plates (Flow labs, Rickmansworth, U.K.) at 
effector-to-target cell ratios of 100:1, 50:1 and 25:1. 
To achieve these ratios, 0.1ml of each of the patients 
mononuclear effector cell concentrations (2xl06, lxlO6 
and 5xl05 per ml) were incubated with 0.1ml of PBMC at a 
concentration of 2xl0/ml. Effector cells and target cells 
were incubated together for 4hours at 37°C in an 
atmosphere of 5% C02.
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Two controls were included: the first estimated the 
spontaneous release (SR) of isotope from 0.1ml labelled 
target cells that had been incubated with 0.1ml of medium 
alone without effector cells; and the second estimated 
the total activity (TA) by completely lysing 0.1ml target 
cells by the addition of 0.1ml of 5 N NaOH. All tests and 
controls were carried out in quadruplicate.
Following the incubation, 0.1ml of cell-free supernatant 
were removed from each well and counted for 3 minutes in 
a gamma counter (LKB 1282 Compugamma, Milton Keynes, 
U.K.) to assess radio-isotope release. The results were 
expressed as a percentage lysis according to the 
following formula:
percentage lysis =
mean c.p.m. of sample - mean c.p.m. of SR
--------------------------------------------  x 100
mean c.p.m. of TA - mean c.p.m. of SR
2.5 STATISTICAL METHODS
Data expressed as "mean±SEM" are normally distributed. 
Data expressed as median and range are not normally 
distributed. Comparison of two sets of normally 
distributed data was made using Student's t test. 
However, if the two sets of data were not normally 
distributed then a non-parametric Mann-Whitney U test was 
used. Comparison of more than two sets of normally 
distributed data was made using a Scheffe"' s test. 
Comparison of more than two sets of data that were not
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normally distributed was made using a Kruskal and Wallis 
test.
A paired t test was used to compare total and 
differential WBCC, lymphocyte subpopulations (chapter 3) 
and CD56+ cells (chapter 4) before and after overnight 
incubation.
A comparison of the number of subjects in each group with 
CD4: CD8 ratios; <1.0, 1.0<:r^2.5, >2.5, was made using a 
Chi-squared test.
A P value of <0.05 was considered to be significant in 
all tests.
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CHAPTER 3
PERIPHERAL BLOOD LEUCOCYTE PHENOTYPES 
AMONG PIGEON BREEDERS
90
3.1 INTRODUCTION
In an attempt to determine the role of cell mediated 
immunity in the pathogenesis of EAA, several studies have 
looked for changes in the phenotypes of leucocytes in the 
BAL fluid and in the peripheral blood of subjects with 
EAA. Symptomatic subjects with EAA (Costabel et al, 
1984, Leatherman et al, 1984, Agnostini et al, 1984, 
Costabel et al, 1985, Semenzato et al, 1986) and in 
some cases also asymptomatic subjects (Leatherman et al, 
1984, Semenzato et al, 1986) were shown to have a 
predominance of CD8+ cells in their BAL fluid compared 
with controls. However phenotypic analysis of cells in 
the peripheral blood has revealed conflicting results. 
Reduced CD4:CD8 ratios in symptomatic subjects with EAA 
were reported in two studies (Costabel et al, 1984, 
Costabel et al, 1985), while other groups found no 
differences (Leatherman et al, 1984, Agnostini et al, 
1984, Semenzato et al, 1986). A contributory factor to 
the variability may have been the use of heterogeneous 
subject groups with various forms of EAA, ranging from 
Farmer's lung to Mushroom worker's lung and the grouping 
together of subjects at different stages of disease.
The present study used pigeon breeders disease as a well 
defined model to study EAA in general. The first part of 
this chapter looks at the total and differential WBCC and 
lymphocyte subsets in the peripheral blood of 131 pigeon 
breeders grouped into well defined categories.
The second part of the study analysed the cellular 
phenotypes of peripheral blood leucocytes in an
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additional group of pigeon breeders, chosen on the basis 
of those patients, shown by the initial study, to have 
cellular changes. This smaller study group allowed a more 
detailed phenotypic analysis of peripheral blood 
leucocytes.
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Pigeon breeders in group 1 were taking low dose inhaled steroids 
(not more than 200/zg of beclomethasone daily) to alleviate the 
symptoms of PBD.
3.2 EXPERIMENTAL PROTOCOL 
3.2.1 SUBJECTS
131 pigeon breeders and 21 controls were included in the 
first part of this study and 17 pigeon breeders and 17 
controls in the second part. Respiratory physicians with 
experience in EAA placed the pigeon breeders in seven 
groups, according to their symptoms, antibody status and 
whether or not they were acutely symptomatic at the time 
of blood sampling. The symptomatic criteria were that of 
Banham et al (1986) (outlined in 2.1.1). All pigeon 
breeders except those in groups 1 and 8 were 
volunteers, attending pigeon fanciers' conventions and 
were diagnosed on the basis of a questionnaire 
(Appendix). Subjects in groups 1 and 8 were hospital 
outpatients attending a respiratory clinic at Glasgow 
Royal Infirmary. Two control groups of normal healthy 
individuals with no avian exposure, were also included 
(groups 7 and 9) . Relevant clinical details of these 
groups are listed in Tables 3.1 and 3.8.
GROUP 1
These subjects were symptomatic and antibody positive, as 
well as having restrictive pulmonary function defects and 
chest radiographic appearances consistent with EAA. These 
were subjects with more severe longstanding disease than 
the equivalent symptomatic antibody positive subjects 
selected from pigeon fanciers' conventions (Groups 2 and 
3)  .
GROUP 2
These symptomatic, antibody positive subjects were
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acutely symptomatic at the time of blood sampling and 
were therefore valuable in terms of analysing the 
cellular changes associated with a symptomatic episode.
GROUPS 3-6
Subjects in groups 3, 4, 5 and 6 were split into four 
groups depending on their antibody and symptomatic 
status.
Group 3 comprised symptomatic, antibody positive subjects 
who differed from group 2 subjects in that they were not 
acutely symptomatic at the time of blood sampling.
Group 4 comprised asymptomatic, antibody positive 
subjects. This group was important in terms of 
establishing whether alterations in the cellular 
phenotype required the presence of an active specific 
immune response.
Group 5 comprised subjects who had symptoms suggestive 
of acute PBD, but lacked specific antibody to pigeon 
antigen. This group of subjects enabled analysis of 
whether the cellular changes were due to the presence of 
respiratory disease or whether they were a specific 
result of a hypersensitivity response to pigeon antigen.
Group 6 comprised asymptomatic, antibody negative pigeon 
breeders.
GROUP 7
The control group comprised normal healthy laboratory 
workers from the Department of Immunology, Western 
Infirmary, Glasgow, who had not been exposed to avian
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antigen. None of these subjects were smokers. The median 
age of the subjects was 34 years with the range from 
21 to 58 years.
GROUPS 8 AND 9
Group 8 subjects, selected after the initial analysis of 
groups 1-7, comprised an additional 17 symptomatic 
antibody positive subjects with severe longstanding PBD 
similar to group 1 subjects.
Group 9 subjects comprised 17 controls selected from the 
same population as the controls comprising group 7 in the 
previous study group. The median age of the subjects was 
31 years of age and the age range was from 21 to 56 
years.
The smaller study groups allowed a more detailed analysis 
of peripheral blood leucocytes and permitted direct 
comparison between a patient and control group for a 
larger number of parameters.
3.2.2 GENERAL PROTOCOL
Total and differential WBCC and evaluation of the 
percentages of CD19+ , CD3+ , CD4+ and CD8+ lymphocytes 
were determined in peripheral blood cell samples by flow 
cytometry. Subjects in Groups 8 and 9 were also 
evaluated for levels of CD3+8+ cells in their peripheral 
blood by two colour flow cytometry, to distinguish 
between CD3+8+ T cells and CD3~8+ NK cells. Absolute 
numbers of B cells, T cells and T cell subsets were 
derived from the total lymphocyte count. The serum was
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collected and used to measure antibody to pigeon-derived 
antigens by ELISA.
3.3 RESULTS
3.3.1 LEVELS OF SPECIFIC IgG ANTIBODY TO PIGEON ANTIGEN 
AMONG PIGEON BREEDERS
The mean antibody titre of group 2 symptomatic antibody 
positive subjects, was significantly higher than that of 
group 3 (symptomatic, antibody positive subjects) and 
group 4 (asymptomatic antibody positive subjects), (Table
3.1).
3.3.2 THE EFFECT OF AN OVERNIGHT INCUBATION AT ROOM 
TEMPERATURE ON PERIPHERAL BLOOD LEUCOCYTES COLLECTED IN 
EDTA.
The logistical problems of travelling 250 miles to a 
pigeon fanciers' convention to collect a large number of 
peripheral blood samples meant that peripheral blood 
samples collected from subjects in groups 2-6 had to be 
held overnight at room temperature before the cellular 
analysis was performed. However the samples from hospital 
patients (groups 1 and 8) and control subjects (groups 7 
and 9) were analysed immediately and therefore I 
assessed whether an overnight incubation would affect 
peripheral blood leucocytes. Thus, total and differential 
WBCC and the percentages of CD3 + , CD19+ , CD4+ and CD8+ 
cells in the peripheral blood of additional pigeon 
breeders and controls were determined before and after a 
24 hour incubation period at room temperature.
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The results in Tables 3.2 - 3.4 indicate that the total 
and differential WBCC and lymphocyte subsets are not 
significantly altered after an overnight incubation. This 
ensures that any differences between the patient groups 
were not likely to have been caused by a difference in 
the method of blood collection and analysis.
3.3.3 CELLULAR ANALYSIS OF PERIPHERAL BLOOD IN PIGEON 
BREEDERS
Group 1
These symptomatic, antibody positive pigeon breeders with 
severe, longstanding PBD had normal WBCC, normal 
percentages and absolute numbers of neutrophils and 
lymphocytes of both B and T cell subsets (Tables 3.5 and
3.6). However, these subjects had the lowest percentages 
of CD4+ cells, the highest percentages of CD8+ cells and 
the lowest CD4:CD8 lymphocyte ratio of all groups. 36% 
of subjects in this group had reversed CD4+ :CD8+ 
lymphocyte ratios, compared with only 10% in the
control group (Table 3.7). However, this was not 
significantly different from the control group or the 
other symptomatic antibody positive groups (groups 2 and 
3). Figure 3.1 shows that the reversed CD4:CD8 cell 
ratios in both the pigeon breeders and controls were due 
to increased percentages of CD8+ cells.
Group 2
These symptomatic antibody positive pigeon breeders who 
were symptomatic at the time of blood sampling had
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significantly higher WBCC than controls or pigeon 
breeders who were symptomatic and antibody positive, but 
who were not displaying symptoms at the time of blood 
sampling (Group 3), (P<0.005, P<0.05 respectively, Table
3.5). This increase in the WBCC was reflected in an 
increase in the absolute number of both neutrophils and 
lymphocytes, although only the absolute number of 
lymphocytes was significantly higher than the control 
group (P<0.02, Table 3.5). The increase in the absolute 
number of lymphocytes comprised mainly CD3+ T-cells 
(P<0.05 Table 3.6). B cell numbers were unchanged. The 
increase in the absolute number of T cells comprised both 
CD4+ and CD8+ cells, whose counts were significantly 
higher than those in control subjects or subjects in 
group 3, (P<0.01 and P<0.02, respectively, Table 3.6). 
However, the proportions of all cell types were normal.
Group 4
Subjects who were asymptomatic but antibody positive had 
normal WBCC as well as normal percentages and absolute 
numbers of neutrophils and lymphocytes (Table 3.5). The 
percentages and absolute numbers of B and T cells of both 
CD4 and CD8 positive phenotypes were also normal (Table
3.6). Although the median CD4+:CD8+ T cell ratio was not 
significantly different from that of the controls , 31% 
of subjects in this group had a CD4:CD8 T-cell ratio >2.5 
compared with only 14% in the control group (Table 3.7). 
Figure 3.1 shows that the altered ratio in these pigeon 
breeders was due to an increase in the percentages of 
CD4+ cells and a decrease in the percentage of CD8+ 
cells.
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Group 5
Symptomatic, but antibody negative subjects in group 5 
had significantly higher WBCC than the control group 
(P<0.05, Table 3.5). This was reflected in increased 
absolute numbers of all cell types studied, although only 
the absolute numbers of CD3+ T cells were significantly 
different from the controls (P<0.05 Table 3.6). The 
percentage of all cell types was normal.
Groups 3 and 6
Despite being symptomatic and having specific serum 
antibody, subjects in group 3 had normal cellular 
profiles as did subjects in group 6, the asymptomatic 
antibody negative pigeon breeders (Tables 3.5 and 3.6).
Group 7 : controls
The absolute numbers and percentages of cells and the 
median and range of CD4 : CD8 T cell ratios in the 
peripheral blood of control subjects fell within the 
normal established ranges (England & Bain, 1976, Simmons 
et al, 1974, Costabel et al, 1984, 1985, Hannet et al, 
1992) .
3.3.4 FURTHER PHENOTYPIC ANALYSIS OF PERIPHERAL BLOOD 
LEUCOCYTES IN PIGEON BREEDERS
The results above (3.3.3) indicated that subjects with 
severe longstanding PBD had increased percentages of CD8+ 
cells and decreased percentages of CD4+ cells compared 
with controls. However, as the differences were not 
statistically significant, I decided to repeat the
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studies in an additional group of pigeon breeders with 
similar symptoms of PBD (group 8) to those in group 1 and 
in a further group of controls (group 9) . In addition, 
double staining immunofluoresence was used to determine 
levels of CD3+8+ T cells and CD3~8+ NK cells.
The results of this study showed no difference in the 
WBCC and the percentages and absolute numbers of 
neutrophils and lymphocytes between pigeon breeders and 
controls (Table 3.8). As shown in the previous study, 
the percentages and absolute numbers of T cells, B cells 
and CD4+ , CD8+ and CD3+CD8+ cell subsets were also 
similar in the patient and control groups (Table 3.9), as 
were the CD4+ :CD8+ cell ratios (Table 3.10). However, 
as before 41% of pigeon breeders had a reversed 
CD4+ :CD8+ T cell ratio compared with only 19% in the 
control group (Table 3.11). This was again due to 
increased percentages of CD8+ cells.
In an attempt to establish whether the increased 
percentage of CD8+ cells in pigeon breeders with a 
reversed CD4:CD8 ratio was due to either CD3+CD8+ T cells 
or CD3”CD8+ NK cells, double staining immunofluoresence 
was used to detect CD3 and CD8 antigens on cells. The 
number of CD3+CD8+ cells was expressed as a percentage of 
the total number of CD8+ cells, for 4 pigeon breeders 
with reversed CD4+ :CD8+ ratios and 6 pigeon breeders 
with "normal" CD4+CD8+ cells ratios (1.0^r^2.5), all from 
group 8 and in 10 controls from group 9. The results 
(Table 3.12) show that all three groups had similar 
proportions of CD3+CD8+ and CD3”CD8+ cells, indicating
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that the increased percentage of CD8+ cells was probably 
due to both CD3+CD8+ T cells and CD3-CD8+ NK cells.
3.3.5 THE EFFECT OF AGE ON THE DISTRIBUTION OF PERIPHERAL 
BLOOD LEUCOCYTES IN PIGEON BREEDERS
The median age of the patients in groups 1, 3, 4 and 8 
was significantly higher than that of the controls in 
groups 7 and 9 (Tables 3.1 and 3.8), while the age range 
of both control groups was also much narrower than those 
of the patient groups (Tables 3.1 and 3.8).
To determine if these age differences could have 
accounted for the phenotypic differences reported above, 
I examined whether the cellular indices of the PBD 
patients in groups 1 and 8 were influenced by their age. 
However, the results revealed no age effects on the 
phenotypes of peripheral blood leucocytes in these 
subjects.
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3.4 CONCLUSIONS
The results of this chapter showed that two separate 
groups of symptomatic, antibody positive pigeon breeders, 
with severe longstanding PBD, had a greater proportion of 
subjects with reversed CD4+ :CD8+ ratios than two groups 
of controls. The reversed ratios were due to increased 
percentages of CD8+ cells. Although these differences 
were not statistically significant, the fact that they 
were found in two separate groups strengthens these 
findings. Further analysis revealed that both CD8+ T 
cells and NK cells contributed to the overall rise in 
CD8+ cells.
A different group of pigeon breeders, who were acutely 
symptomatic at the time of blood sampling and with 
positive antibody titres to pigeon antigen (group 2), 
displayed increased WBCC. This increase was reflected in 
raised absolute numbers of neutrophils, lymphocytes, CD3 
positive T cells, CD4 and CD8 positive cells. B cell 
numbers were unchanged in this group and in all other 
groups. Increased WBCC were not found in symptomatic 
antibody positive pigeon breeders, who differed from 
group 3 subjects in that they were not showing symptoms 
at the time of blood sampling (group 3) . They had normal 
cellular profiles. The difference seemed to reflect the 
symptomatic status of the subjects at the time of blood 
sampling which suggests that acute exacerbations lead to 
alterations in peripheral blood leucocytes.
Subjects in Group 2 also had significantly higher 
antibody levels compared with groups 3 and 4, the other
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two community based, antibody positive subject groups.
This study also showed that symptomatic pigeon breeders 
without serum antibody to pigeon antigen (group 5) had 
statistically significant increases in WBCC compared with 
control subjects. The significance of this is not known 
but it is possible that the subjects in this group 
actually had Organic Dust Toxic Syndrome and not PBD (see
9.1) .
An increased number of asymptomatic antibody positive 
subjects (group 4), had high CD4:CD8 T cell ratios (>2.5) 
in their peripheral blood compared to the controls. Their 
raised numbers of CD4+ cells might reflect the presence 
of an active humoral immune response.
These findings demonstrate that phenotypic analysis of 
cells in the peripheral blood of pigeon breeders within 
well defined symptom groups, reveals differences between 
groups at varying stages of disease, and also differences 
in some groups when compared to control cell profiles. 
This study emphasises the need to categorise pigeon 
breeders into well defined groups before attempting to 
evaluate their laboratory profiles.
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Group 1 2 3 4 5 6 7
n 11 27 41 36 8 8 21
M:F 11:0 26:1 38:3 34:2 7:1 8:0 13:8
median age 50* 46* 48* 49* 50 45 34
(range) (32-90) (20-75) (27-79) (16-69) (35-71) (37-55) (21-58)
smokers 0 0 4 5 8 7 0
Ab + + + + - -
(titre) (44±5) (54±6)** (34±5)** (25±3)**
symptoms Yes Yes Yes No Yes No Controls
Ab
(titre)
*
* *
symptoms 
M: F
serum IgG antibody positive or negative 
mean ± SEM (jLig/ml) .
Significant difference between groups 1,2,3,4 
versus group 7. (P<0.05 groups 1 & 3 and
P<0.01 groups 2 & 4)
Significant difference between group 2 versus 
groups 3 and 4, P< 0.05 .
Symptomatic criteria of Banham et al (1986). 
Male to female ratio
TABLE 3.1
The number of subjects, the ratio of males to females and 
the symptomatic, antibody and smoking status of six 
groups of pigeon breeders and one group of controls.
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WBCC
0
( c m r j
24
c 6379 5855
c 5376 5993
c 5978 7062
c 7199 6889
c 6848 6710
Mean±SEM 6356±321 6502+243
C - control
P - pigeon breeder
0 - analysed immediately
24 - analysed after a 24 hour incubation period
TABLE 3.2
Peripheral blood WBCC before and after a 24 hour 
incubation at room temperature.
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% Neutrophils 
0 24
% Lymphocytes 
0 24
p 53 70 39 23
p 42 37 52 57
p 57 53 32 36
c 48 42 47 52
Mean±SEM 50 + 3 51±7 43±4 42±8
C - control
P - pigeon breeder
0 - analysed immediately
24 - analysed after 24 hour incubation
TABLE 3.3
Percentages of neutrophils and lymphocytes in peripheral 
blood samples before and after a 24 hour incubation at 
room temperature.
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CD19 CD3
Positive cells
CD4 CD8
0 24 0 24 0 24 0 24
p 4 3 86 86 18 20 51 55
p - 5 76 76 45 47 21 23
p 10 7 64 65 23 26 39 44
c 10 7 70 74 41 39 23 17
c 22 24 65 63 41 44 20 21
M ean iS E M 12±4 9 ± 4 72±4 73+4 3 4 ±5 35± 5 31± 6 3 2 ± 7
C - control
P - pigeon breeder
0 - analysed immediately
24 - analysed after 24 hour incubation
TABLE 3.4
Percentages of lymphocyte subsets in peripheral blood 
samples before and after a 24 hour incubation at room 
temperature.
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Group WBCC Neutrophils Lymphocytes
1 6990 ±1 16 0 47 ± 6 45 ± 6
(3483 ±987) (2992 ± 755)
2 8576 ± 406* 56 ± 2 36 ± 2
(4859 ±321) (3390 ±382)*
3 6424 ±259* 53 ± 1 40 ± 2
(3416 ±201) (2526 ±133 )
7093 ±4 34 52 ± 1 40 ±1
(3787 ±342) (2732 ±145 )
5 9225 ± 1330* 57 ± 4 38 ± 4
(5726 ± 1257) (3453 ±316 )
6 7862 ± 690 55 ± 3 39 ± 3
(4386 ±515) (2256 ± 244)
7 5407 ±3 53 * 56 ±1 36 ±1
(3042 ± 238) (1909 ±  146)*
group 2 and 7 No (2 and 7)
differences 2 and 3 Difference
5 and 7
* Group value differs from another group
values are mean ± SEM
() mean absolute numbers (cmm-1)
TABLE 3.5
WBCC, mean percentages and (absolute numbers) of 
lymphocytes and neutrophils in the peripheral blood of 
six groups of pigeon breeders and one group of controls.
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Group CD19 + CD3 + CD4 + CD8 + CD4+ : CD8 +
1 11±2 
(374±187)
70±3
(1950±352)
33 ±3 
(893±239)
3113
(9081246)
1.2 
(0.5-3.0)
2 9±1 
(321 ±52)
75±1
(2518±275)*
40±2 
(1347±183)*
2812
(9581117)*
1.6 
(0.6-2.7)
3 12±1
(403±78)
75±2 
(1894±100)
42±1
(809154)*
2712
(523153)*
1.5 
(0.3-4.0)
4 14±1 
(387±31)
75±1 
(2078±119)
45±1 
(918±119)
2411
(523146)
1.9 
(0.6-5.3)
5 13±2
(463±86)
79±1
(2729±284)*
48±2
(1276±105)
2512 
(7371156)
2.2 
(1.1-2.9)
6 13±2
(409±74)
77±2
(2256±244)
43±3
(9911135)
2712
(583164)
1.7 
(1.0-2.7)
7 13±1
(238±24)
71 ±2 
(13371142)*
41 ±2 
(673158)*
2412
(404139)*
1.5 
(0.9-4.2)
group
differences
(2 and 7) 
(5 and 7)
(2 and 3) 
(2 and 7)
(2 and 7) 
(2 and 3)
* group value differs from another group
values are mean ± SEM, or in the last column median and 
(range).
TABLE 3.6
The mean percentages and (absolute numbers) of lymphocyte 
subsets and the median and (range) of ratios of 
CD4+ :CD8+ cells in the peripheral blood of six groups of 
pigeon breeders and one group of controls.
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GROUP N
number and (percentage) of subjects 
with CD4 : CD8 ratio
<1.0 U rs 2.5 >2.5
1 11 4 (36) 6 (55) 1 (9)
2 27 7 (26) 17 (63) 3 (1)
3 41 3 (7) 32 (78) 6 (15)
4 36 4 (11) 21 (58) 11 (31)
5 8 0 (0) 6 (75) 2 (25)
6 8 1 (12) 5 (63) 2 (25)
7 21 2 (10) 16 (76) 3 (14)
N - number of subjects in each group
r - ratio
TABLE 3.7
The numbers and percentages of subjects in six groups of 
pigeon breeders and one control group with a CD4+ :CD8+ 
cell ratio >2.5, between 2.5 and 1.0 and <1.0.
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Group Age Ab.titre WBCC Neutrophils Lymphocytes
Pigeon
breeders
8
48*
13-71
47 ± 7 7838±665 60±5
(4SS5±751)
30±4 
(2136±1 96)
Control
9
31
21-56
6486±520 60±2
(4G24±471)
33±2 
(2009±131)
values are mean ± SEM except for age which are median and 
range
() - absolute numbers (cmm-1)
WBCC (cmm-1)
* - significant difference between pigeon
breeder and control group 
Ab.titre - antibody titre (/zg/ml)
TABLE 3.8
The mean ages, WBCC and percentages and absolute numbers 
of neutrophils and lymphocytes in the peripheral blood of 
17 subjects with PBD and 17 controls.
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Group CD19+- CD3+ CD4+ CD8+ CD3+CD8+
Pigeon
breeders
8
11±1 
(238±41)
64±3 
(1367±133)
36±3 
(762±91)
30±2
(647±71)
23+2 
(521 ±63)
Control
9
11±1
(207±30)
68±2 
(1420±95)
38±2
(770±51)
29±2 
(611 ±65)
25±2 
(561 ±82)
values are mean ± SEM
() - absolute numbers (cmm”1)
TABLE 3.9
The mean percentage and absolute numbers of lymphocyte 
subsets in the peripheral blood of 17 subjects with PBD 
and 17 control subjects.
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Group CD4+: CD8+
Pigeon
breeders 1.3
8 (0.5 - 2.6)
Control 1.4
9 (0.6 - 2.2)
values are medians 
() - ranges
TABLE 3.10
The median ratio and the (range of ratios) of CD4+ :CD8+ 
cells in the peripheral blood of 17 subjects witti PBD and 
17 controls.
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Group N
number and (percentage) or subjects 
with CD4 : CD8 ratio
<1.0 1.0$n<2.5 >2.5
Pigeon
breeders
8
17 7(41) 9(53) 1 (6)
Controls
9
16 3(19) 13(81) 0(0)
N - number of subjects in each group
r - ratio
TABLE 3.11
The number and percentage of subjects in a group of 
pigeon breeders with PBD and a group of controls with a 
CD4+ :CD8+ cells ratio >2.5, between 1.0 and 2.5 and 
<1.0.
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%CD3+CD8+
CD8+
Pigeon breeders (r) Pigeon breeder (n) Controls
80 79 84
(39-93) - (63-95) (59-92)
"normal" - CD4+ cells predominate over CD8+ cells,
(r) - reversed
(n) - "normal"
TABLE 3.12
The median and (range) of percentages of CD3+CD8+ cells 
expressed as a percentage of the total number of CD8+ 
cells in the peripheral blood of 4 pigeon breeders with 
reversed CD4+ :CD8+ cell ratios, 6 pigeon breeders with 
"normal" CD4+ :CD8+ cell ratios and 10 controls.
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Figure 3.1
The absolute number of CD4+ and CD8+ cells in the 
peripheral blood of 2 controls (Group 7) and 4 pigeon 
breeders (Group 1) with reversed CD4+:CD8+ cell ratios 
and 10 pigeon breeders with CD4+:CD8+ cell ratios >2.5 
(Group 4).
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CHAPTER 4
PHENOTYPIC AND FUNCTIONAL STUDIES OF 
NATURAL KILLER CELLS IN PIGEON BREEDERS
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4.1 INTRODUCTION
NK cells kill a variety of target cells without prior 
stimulation or MHC restriction, either directly or via 
FcR (reviewed by, Robertson & Ritz, 1990). As NK cells 
are activated non-specifically by cytokines such as IL2 
and IFN/ (Trinchieri et al, 1984, London et al, 1986) 
their number and activity may be a marker of the overall 
level of the immune response in a given disease process, 
as well as a possible indicator of the involvement of 
non-specific cellular immunity. In addition, the release 
of TNFa and IFN/ by activated NK cells has implicated a 
role for them in the pathogenic process of chronic 
inflammation in rheumatoid arthritis (Hendrich et al, 
1991) and in the destructive phases of graft versus 
host disease (Mowat & Felstein, 1987).
Previous reports on the number and activity of NK cells 
in EAA have been conflicting , which may reflect the use 
of poor NK cell markers (Agostini et al, 1984, Semenzato 
et al, 1986, Semenzato et al, 1988, Trentin et al, 1986). 
It is now known that no single surface antigen 
identifies all human NK cells unambiguously. The CD57 
(HNK-1, Leu7) antigen is known to be expressed by only 
50-60% of peripheral blood NK cells and only 50% of 
peripheral blood lymphocytes that express CD57 are 
actually NK cells (Lanier et al, 1983). CD56 (NKH-1), the 
neural cell adhesion molecule (NCAM 1) (Lanier et al, 
1989) and CD16 (Leu 11) , the low affinity receptor for 
the Fc region of IgG (Fc/RIII) (Perussia et al, 1983a, 
Perussia et al, 1983b, Lanier et al, 1986), are now two 
of the most extensively used NK cell markers. However,
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although CD56 is expressed by virtually all human 
peripheral blood NK cells (Griffin et al, 1983, Hercend 
et al, 1985) , it is also expressed on a small proportion 
of CD3+ T cells which are sometimes referred to as "non- 
MHC restricted T cells" (Lanier et al, 1986, Schmidt et 
al, 1986) . In addition, CD16 is also expressed on some 
macrophages and granulocytes (Perussia et al, 1983a, 
Perussia et al, 1983b, Perussia et al, 1984).
The first part of this chapter uses PBD as a model of EAA 
and measured levels of CD56+ cells in the peripheral blood 
of pigeon breeders in groups 1-6 and in controls (group
7), described in chapter 3. The second part of this 
chapter performed a more detailed analysis of NK cell 
markers in a smaller group of subjects with PBD (group
8) and controls (group 9), described in chapter 3, in an 
attempt to differentiate between CD3+ "non MHC restricted 
T cells" and CD3“ true NK cells, expressing CD56 or CD16. 
Finally the functional activity of the peripheral blood 
NK cells from these patients was measured.
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4.2 EXPERIMENTAL PROTOCOL
This study involved the pigeon breeders and controls 
used in chapter 3 (Groups 1-9). The first part of the 
study examined the level of CD56+ cells in the 
peripheral blood of subjects in Groups 1-7. The second 
part used two colour flow cytometry to detect the levels 
of CD16+ and CD56+ cells in the peripheral blood of 
subjects in groups 8 and 9 and the co-expression of CD3 
and CD8 on each population of cells. The cytotoxic 
activity of peripheral blood mononuclear cells from 
subjects in groups 8 and 9 were also determined in an in- 
vitro cytotoxic assay using K562 target cells.
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4.3 RESULTS
4.3.1 THE EFFECT OF A 24 HOUR INCUBATION AT ROOM 
TEMPERATURE ON THE LEVEL OF CD56 + CELLS IN 
PERIPHERAL BLOOD STORED IN EDTA.
As explained in chapter 3, peripheral blood samples 
collected from subjects in Groups 2-6 had to be incubated 
for 24 hours at room temperature before any phenotypic 
analysis of peripheral blood lymphocytes was performed. 
Therefore, in order to assess whether this had any affect 
on the levels of CD56+ cells, peripheral blood samples 
were collected in EDTA from an additional 4 subjects. The 
levels of CD56+ cells in these samples were then measured 
before and after the blood had been incubated at room 
temperature for 24 hours. As shown in Table 4.1, there 
was a slight reduction in the level of CD56+ cells in the 
peripheral blood after a 24 hour incubation at room 
temperature, but this was not statistically significant.
4.3.2 LEVELS OF CD56+ CELLS IN THE PERIPHERAL BLOOD OF 
PIGEON BREEDERS AND CONTROLS.
The percentages and absolute numbers of CD56+ and CD16+ 
cells were not normally distributed and so median values 
and ranges are shown.
As shown in Table 4.2, symptomatic antibody positive 
patients (group 1), who had restrictive pulmonary 
function defects and chest radiographs consistent with 
EAA and the symptomatic antibody positive subjects 
(group 2) , who were acutely symptomatic at the time of
121
blood sampling, had a significant increase in absolute 
numbers of circulating CD56+ cells compared with the 
control group (group 7) (P<0.05 and P<0.02,
respectively). No significant differences were found in 
the numbers of CD56+ cells in other groups, nor in the 
percentages of these cells.
4.3.3 THE COEXPRESSION OF CD56, CD16, CD3 AND CD8 
ANTIGENS ON PERIPHERAL BLOOD LYMPHOCYTES IN PBD
The following experiments attempted to characterise 
further the CD56+ cells which were found to be increased 
in the pigeon breeders comprising group 1 of the 
previous study. This was done using the additional group 
of pigeon breeders (group 8) and controls (group 9), 
described in chapter 3. Coexpression of CD3 and CD8 on 
CD56+ and CD16+ cells was examined. Figure 4.1 shows the 
typical flow cytometer profiles obtained by two-colour 
flow cytometry analysis of CD56 (NKH1), CD16 (Leull), CD3 
and CD8 antigen on peripheral blood lymphocytes in both 
pigeon breeders and controls.
a) CD3+CD56+ T cells and CD3“CD56+ NK cells and the 
expression of CD8 on CD56+ cells.
As shown above, the median absolute number of CD56+ cells 
was higher in the group of pigeon breeders (group 8) , 
compared with the controls (group 9) (Table 4.3). 
However, unlike the previous findings, the difference 
was not significant. In addition, the median percentage 
of CD56+ cells was higher in the peripheral blood of the 
pigeon breeder and control groups in this study (21% and
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20%, respectively), compared with the median percentages 
of these cells detected in group 1 and group 7, described 
previously (14% and 11% respectively). The percentages 
and absolute numbers of CD3+CD56+, CD8+CD56+ and CD8~56+ 
cells were similar in both the pigeon breeders and the 
controls. Although the pigeon breeders had slightly 
increased percentages and absolute numbers of CD3”56+ 
cells compared with controls, the differences were not 
statistically significant (Tables 4.3 and 4.4).
b) CD3+CD16+ T cells and CD3“CD16+ NK cells and the 
expression of CD8 on these cells
A median of 19% of peripheral blood lymphocytes were 
CD16+ in pigeon breeders compared with 11% in the 
control group and there was an increased absolute number 
of CD16+ cells in the pigeon breeders (Table 4.5). 
However due to a wide scatter of values, these 
differences did not reach significance. As very few CD16+ 
cells expressed CD3 in either the pigeon breeders or 
controls, pigeon breeders also had an increased median 
percentage and absolute number of CD16+CD3“ cells 
compared with controls (Table 4.5, 18%, 412cmm”1 and 10%, 
187cmm”1, respectively). An increase in the percentage 
and absolute number of CD8” CD16+ cells was also found, 
while the percentage and absolute numbers of CD8+CD16+ 
cells were almost identical to control group levels 
(Table 4.6). In consequence, the proportion of CD16+ 
cells which expressed CD8, was significantly lower in 
pigeon breeders compared with controls (25% vs 46%,
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P<0.05).
4.3.4 THE EFFECT OF AGE ON THE LEVEL OF CELLS EXPRESSING 
CD56 AND CD16 ANTIGENS IN THE PERIPHERAL BLOOD.
As noted earlier (3.3.5), the median ages of patients in 
groups 1, 3, 4 and 8 were significantly higher than the 
median age of the control groups 7 and 9 (Tables 3.1 and 
3.8) .
In order to determine whether the age differences between 
pigeon breeders and controls could have caused the 
differences in the percentages of CD56+ and CD16+ cells, 
I correlated the ages of subjects in group 8 with the 
percentages of CD56+ and CD16+ cells in their peripheral 
blood.
The results of this analysis revealed that the ages of 
subjects in group 8 did not correlate with the levels of 
CD56+ and CD16+ cells in their peripheral blood.
4.3.5 CYTOTOXIC ACTIVITY OF PERIPHERAL BLOOD 
MONONUCLEAR CELLS FROM SUBJECTS WITH PBD AND NORMAL 
HEALTHY CONTROLS
The in vitro cytotoxic activity of peripheral blood 
mononuclear cells from 11 pigeon breeders from group 8 
and 10 controls from group 9 is shown in Figure 4.2. No 
differences in the levels of NK activity were recorded 
between patients and controls at any effector to target 
cell ratios.
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4.4 CONCLUSIONS
The results of this study revealed increased percentages 
and absolute numbers of CD56+ cells in the peripheral 
blood of pigeon breeders with severe longstanding PBD 
(group 1) and symptomatic pigeon breeders who were 
acutely symptomatic at the time of blood sampling (group 
2) compared with controls (group 7) and other groups of 
pigeon breeders with less severe disease. Similar 
differences were found in an additional group of pigeon 
breeders (group 8) with similar disease to subjects of 
group 1 and another group of controls (group 9), although 
in this study they did not reach significance. In 
addition, higher percentages of CD56+ cells were found in 
both group 8 and group 9 compared with the levels 
detected in group 1 and group 7 of the previous study. 
The inconsistencies in the two sets of results may 
reflect sampling variation. Further phenotypic analysis 
showed that the CD56+ cells in these pigeon breeders were 
mainly CD3"CD56+ NK cells, rather than CD3+56+ " non-MHC 
restricted T cells" and were both CD8+ and CD8”. Analysis 
of CD16+ cells in these subjects also revealed 
increased percentages and absolute numbers of CD16+ cells 
compared with controls and these were CD8~CD16+ . These 
were also probably not T cells, as there were only small 
numbers of CD3+CD16+ cells in either pigeon breeders or 
controls.
Despite the increased percentages of CD16+ cells (and to 
a lesser degree CD56+ cells) in the peripheral blood of 
subjects with severe PBD, this was not associated with 
increased cytotoxic activity of their peripheral blood
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mononuclear cells. It is possible that these cells may 
play a role in the pathogenesis of PBD as inflammatory 
mediators given that activated CD16+ NK cells produce 
inflammatory cytokines such as TNFa and IFNj. They may 
also be involved in an antibody dependent cellular 
cytotoxicity (ADCC) reaction in the lung.
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% CD56 +
0 24
p 13 11
p 18 16
p 13 5
c 28 19
Mean ± SEM 18.0±3.5 13.0 ±3.1
P - pigeon breeder
C - control
TABLE 4.1
The percentage of CD56+ cells in the peripheral blood of 
3 subjects with PBD and 1 control before and after a 24 
hour incubation at room temperature.
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G ro u p n S ym p to m s Antibody % C D 56+
cells
A b .n o .C D 5 6 +
ce lls
1 11 + + 14 40 7*
(5-47) (30 -22 18)
2 27 + + 14 34 9*
(3-33) (18 1 -1 918 )
o 41 + + 13 260
(1-37) (29 -957)
4 36 j- 11 313
(1-37) (31 -12 58)
5 8 + 8 226
(1-17) (45 -452)
6 8 - 9 22 7
(4-13) (11 4 -5 32)
7 21 - 11 198
(2-24) (21 -618)
Group - group number as given in chapter 3
n - number of subjects in a given group
symptoms - of acute PBD as defined by Banham et al 1986
* - group value differs from control group P<0.05
Ab.no - absolute number (cmitf1)
TABLE 4.2
Median values and (ranges) for the percentage and 
absolute number of CD56+ cells in the peripheral blood of 
pigeon breeders (Groups 1-6) and controls (Group 7).
128
CD56+ CD56+ CD3+ CD56+ CD3- CD56+ CD3+ 
CD56+
piaeon
breeders
%
median 21 4 13 17
range 5-57 0-8 2-50 0-71
Ab.no
median 419 106 374
range
controls
30-930 0-415 42-1037
%
median 20 5 10 35
range 10-53 0-21 5-30 0-53
Ab.no
median 331 95 199
range 106-1579 0-626 112-894
Ab.no - absolute number (cmm 1)
TABLE 4.3
The median percentage and absolute number of CD56+ , 
CD56+CD3+ and CD56+CD3” cells and the levels of CD56+CD3+ 
cells expressed as a percentage of the total number of 
CD56+ cells,in the peripheral blood of 12 subjects with 
PBD and 13 controls.
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!
i
CD56+ CD8+ CD56+ CD8“ CD56+ CD8+ 
CD56+
Pigeon
breeders
%
median 8 8 46
range 4-17 4-38 31-56
Ab.no
median 216 234
range
Controls
75-518 75-726
%
median 8 9 44
range 4-24 6-30 36-58
Ab.no
median 172 205
range 94-715 101-894
Ab.no - absolute number (cmm"*1)
TABLE 4.4
The median percentage and absolute number of CD56+CD8+ 
and CD56+CD8~ cells and the level of CD56+CD8+ cells 
expressed as a percentage of the total number of CD56+ 
cells in the peripheral blood of 8 subjects with PBD and 
9 controls.
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CD16+ CD16+CD3+ CD16+ CD3' CD16+CD3+  
CD16+
Pigeon
breeders
%
median 19 0 18 0
range 5-54 0-8 4-55 0-30
Ab.no
median 394 0 412
range
Controls
%
106-1065 0-136 85-2177
median 11 0 10 0
range 6-32 0-3 5-29 0-17
Ab.no
median 206 0 187
range 112-954 0-89 90-864
Ab.no - Absolute number (cmm ■*■)
TABLE 4.5
The median percentage and absolute number of CD16+ , 
CD16+CD3+ and CD16+CD3~ cells and the level of CD16+CD3+ 
cells expressed as a percentage of the total number of 
CD56+ cells in the peripheral blood of 12 subjects with 
PBD and 13 controls.
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Patients CD16+ CD8+ CD16+CD8" . CD16+CD8+
CD16+
Pigeon
breeders
%
median 5 16 25*
range 1-12 4-40 7-57
Ab.no
median 120 310
range
Controls
%
21-232 66-1659
median 6 6 46
range 2-10 3-26 22-56
Ab.no
median 103 110
range 52-220 56-775
* P<0.05 V S controls
Ab. no - absolute number (cmm’1)
TABLE 4.6
The median percentage and absolute number of CD16+CD8+ 
and CD16+CD8“ cells and the level CD16+CD8+ cells 
expressed as a percentage of the total number of CD16+ 
cells in the peripheral blood of 11 subjects with PBD and 
12 controls.
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FIGURE 4.1
Two-colour flow cytometry analysis of CD56 (NKH1) , C D16 
(Leull) , CD3 and CD8 antigen on peripheral blood 
lymphocytes in a representative subject.
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FIGURE 4.2
Cytotoxic activity of peripheral blood mononuclear cells 
at effector to K562 target cell ratios of 100:1, 50:1 and 
25:1 in 11 subjects with PBD and 10 controls.
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CHAPTER 5
PHENOTYPIC STUDIES OF GAMMA DELTA T CELLS IN
PIGEON BREEDERS
135
II
[ 5.1 INTRODUCTION
A subset of T cells (1-5%) express TCRJ S (Lew et al, 
1986, Weiss et al, 1986) . In humans, two major J S T cell 
subsets have been identified, namely the V<S1 subset, 
which express V<S 1 chains, recognised by 5TCS1 mAb (Wu et 
al, 1987) most of which are non covalently associated 
with V/l chains (Casorati et al, 1989, Bottino et al,
1988) and the VS2 subset, which express VS2 chains, 
recognised by BB3 mAb (Ciccone et al, 1988) most of which 
are linked by disulphide bridges to V]2 chains (Cassorati 
et al, 1989, Bottino et al, 1988, Borst et al, 1989, 
Parker et al, 1990). In humans, 90% of ) S T cells in the 
peripheral blood (Falini et al, 1989) and the majority 
of J S T cells in the lung (Balbi et al, 1990) are BB3+.
It has been suggested that J S T cells may protect 
epithelial surfaces (Janeway et al, 1988, Janeway, 1988, 
Raulet, 1989). In support of this idea, increased numbers 
of J S T cells have been reported in coeliac disease 
(Halstensen et al, 1989) and in chronic inflammatory 
diseases of the lung such as farmers' lung (Trentin et 
al, 1990) and sarcoidosis (Balbi et al, 1990). In 
addition, recent evidence suggests that JS T cells may be 
involved in specifically suppressing IgE responses to 
protein antigens presented via intact non inflamed 
epithelial surfaces in the respiratory tract, suggesting 
that they may provide another layer of protection against 
hypersensitivity reactions in the lung (McMenamin et al, 
1991).
To investigate the possibility of the involvement of J5 T
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cells in the inflammatory immune response in PBD, this 
chapter measured total J S T cell levels and determined 
}S T cell subsets, in the peripheral blood of subjects 
with severe, longstanding PBD and controls. In addition 
the coexpression of CD8 antigens with the J STCR was also 
determined since intraepithelial JS T cells appear to be 
predominately CD8“ (Halstensen et al, 1989).
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5.2 EXPERIMENTAL PROTOCOL
One and two colour flow cytometry was used to quantify 
percentages of all ]S T cells using Mab TCR£1 (Band et 
al, 1987), their nondisulphide-linked subpopulations 
using MAb 5TCS1 (Wu et al, 1987, Faure et al, 1988) and 
the coexpression of CD8 on these cells, in the 
peripheral blood of 12 patients with severe, longstanding 
PBD (group 8, chapter 3) and 14 controls (group 9, 
chapter 3). In addition, absolute numbers of cells were 
derived from the total lymphocyte counts.
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5.3 RESULTS
The percentages and absolute numbers of J S T cells 
(TCR£1+) and the subpopulation of these cells expressing 
the nondisulphide-linked form of the JS TCR (5TCS1+) 
were not normally distributed and so median values and 
ranges are shown. Figure 5.1 shows the typical FAC's 
profiles obtained by two-colour flow cytometry analysis 
of TCR£1, 5TCS1, CD3 and CD8 on peripheral blood 
lymphocytes in a representative subject.
5.3.1 LEVELS OF JS T CELLS
Pigeon breeders had significantly fewer )S T cells than 
controls (1.5% vs 6%, respectively, P<0.01, Table 5.1). 
This was associated with a significantly lower 
absolute number of TCR<S1+ cells in the pigeon breeders 
compared with the controls, P<0.05 (Table 5.1). As 
anticipated, all TCR51 staining cells coexpressed CD3 
(Figure 5.1).
Similar percentages and absolute numbers of <STCS1+ cells 
were found in the peripheral blood of pigeon breeders and 
controls (0.4% and 0.2%, respectively, Table 5.1). In 
addition the percentages of Jfi T cells which were £TCS1+ 
were not significantly different in pigeon breeders and 
controls (16% and 2% respectively, Table 5.1).
5.3.2 EXPRESSION OF CD8 ON JS T CELLS
The percentages and absolute numbers of both TCR51+CD8+ 
and TCR<S1+CD8“ cells were significantly lower in the 
peripheral blood of pigeon breeders compared with
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controls (P<0.02 and P<0.05, respectively, Table 5.2). As 
a result, there was no difference in the proportion of 
J ST cells which expressed CD8 in pigeon breeders and 
controls (Table 5.2). Due to the relatively low numbers 
of <STCS1+ cells, subpopulations of £TCS1+ cells 
coexpressing CD8 were not quantified.
5.3.3 THE EFFECT OF AGE ON THE LEVELS OF )6 T CELLS
As was discussed in chapter 3 (3.3.5) and chapter 4
(4.3.4), the median ages of patients in group 8 were 
significantly higher than the median ages of the control 
group 9 (Table 3.8).
In order to determine whether this could have accounted 
for the differences in the levels of ]S T cells, I 
examined whether the percentage of JS T cells in pigeon 
breeders was affected by their age. No correlation was 
found between age and the percentage o f J S T  cells in 
these subjects.
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5.4 CONCLUSIONS
This study found decreased percentages and absolute 
numbers of JS T cells in the peripheral blood of subjects 
with severe longstanding PBD compared with control 
subjects. The percentages of both CD8+ and CD8” JS T 
cells were reduced and therefore similar proportions of 
]S T cells expressed CD8 antigen in the peripheral blood 
of pigeon breeders and controls. The percentages and 
absolute numbers of the subpopulation of J5 T cells 
expressing the nondisulphide-linked receptor (5TCS-1) 
were similar in the peripheral blood of patient and 
control groups, although the levels were very low, as 
reported earlier (Falini et al, 1989).
These results suggests that 5TCS-1"* cells are leaving the 
blood, as their absolute number decreased, while <STCS-1+ 
cells numbers stayed the same.
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FIGURE 5.1
Two colour flow cytometry analysis of TCR61, 6TCS1, CD3 
and CD8 antigen oji peripheral blood lymphocytes in a 
representative subject.
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I
TCR51 +
% Ab.no
5TCS1 +
% Ab.no
%
8TCS1 + 
TCR51 +
Pigeon
breeders
1.5* 50* 0.4 9 16
(0-11.0) (0-415) (0-2.0) (0-207) (0-56)
Controls
6.0 90 0.2 5 2
(1.7-12.0) (34-328) (0-3.5) (0-86) (0-41)
* - value differs significantly from the
corresponding control value 
Ab.no - absolute number (cmm-1)
TABLE 5.1
The median and (range) of percentages and absolute 
numbers of total T cells (TCR<S1 + ) and the
subpopulation of ]S T cells expressing the nondisulphide 
linked form of the TCR (<STCS1+) and the median and range 
of percentages of <5TCS1+ cells expressed out of the total 
number of ] S T cells in the peripheral blood of 12 
subjects with PBD and 14 controls.
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TCR51 +
%
CD8+
Ab.no
TCR51 +
%
CD8-
Ab.no
TCR81+ CD8+ 
TCR51 +
Pigeon
breeders
0.5* 13* 1.0* 25* 23
(0-3.0) (0-51) (0-7.0) (0-119) (0-83)
Controls
1.6 34 4.0 52 27
(0.5-5.0) (9-149) (1.1-12.0) (23-311) (12-63)
* - value differs significantly from the
corresponding control value 
Ab.no - absolute number (cmm”1)
TABLE 5.2
The median and (range) of percentages and absolute 
numbers of TCR<S1 + CD8+ and TCR£l + CD8” cells and the 
percentage of TCR<S1+CD8+ cells expressed as a percentage 
of the total number of TCR51+ cells in the peripheral 
blood of 12 subjects with PBD and 14 controls.
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CHAPTER 6
EXPRESSION OF ACTIVATION AND/OR MEMORY 
MARKERS BY T CELLS IN PBD
145
6.1 INTRODUCTION
Human T cells can be divided into two populations based 
on their expression of isoforms of the leucocyte common 
antigen (CD45), a high molecular weight (180-220 KDa) 
membrane glycoprotein expressed on cells of 
haematopoietic origin (Sanders et al, 1988a). 
Differential expression of these alternately splicing 
exons (A, B and C) leads to low and high molecular weight 
isoforms of CD45 (Streuli et al, 1987) . Most of the work 
on the subdivision of these cells has been based on CD4+ 
T cells. CD4+ T cells expressing the high molecular 
weight isoform of CD45 (CD45RA) and recognised by anti- 
CD45RA antibodies, do not respond to recall antigens and 
do not provide help for B cell responses (Morimoto et al, 
1985b) . In contrast, CD4+ T cells expressing the low 
molecular weight isoform (CD45RO) and recognised by anti- 
CD45RO antibodies, respond by proliferation to soluble 
recall antigens and provide help for pokeweed mitogen or 
antigen induced immunoglobulin synthesis (Smith et al, 
1986, Akbar et al, 1988).
After in vitro stimulation, CD45RA+ cells acquire CD45RO 
and lose CD45RA (Akbar et al, 1988). This, together with 
the ability of CD45RO+ T cells to respond to recall 
antigens, supports the view that the CD4 5RA+ subset 
represent "naive" cells, whilst the CD45RO+ subset 
contains "memory" CD4+ T cells. Given more recent 
findings that CD45R” ("memory") cells can revert to 
CD45R+ ("naive") cells in mice, it is possible that the 
two populations of cells may better be defined as 
"activated" and "resting" respectively (Bell &
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Sparshott, 1990), although they will not be referred to 
as such in this thesis. The switch in expression of low 
to high molecular weight isoforms of CD45 is usually 
accompanied by the expression of novel adhesion 
molecules, one of which is CDw29 (VLA B) (Sanders et al, 
1988b). Therefore a substantial proportion of CD45RO+ 
cells can be identified using anti-CDw29 antibodies 
(Sanders et al, 1988b, Morimoto et al 1985a, Serra et al,
1988). More limited data suggests that the same 
distinctions may also hold true for CD8 (Merkenschlager 
et al, 1989) and JS T cells (Hayward et al, 1989).
A large number of studies have found increased 
proportions of CD4 5RO+ memory CD4+ T cells in a variety 
of human chronic inflammatory disease, such as rheumatoid 
arthritis (Emery et al, 1987, Lasky et al, 1988), 
tuberculosis (Barnes et al, 1989) and coeliac disease 
(Halstensen et al, 1990). Increased levels of "memory" 
cells have also been reported in the BAL fluid of 
symptomatic and asymptomatic pigeon breeders (Johnson et 
al, 1989) but levels in the peripheral blood have not 
been studied.
Therefore, the aim of this chapter was to quantify total 
numbers of CD45RA+ , and CDw29+ cells and the levels of 
CD45RA+CD4+ and CDw29+CD4+ cells in the peripheral blood 
of subjects with PBD and control subjects, to determine 
whether there were any changes and if so, whether these 
changes mirrored the previous findings of increased 
numbers of "memory" T cells in the lung (Johnson et al,
1989) .
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6.2 EXPERIMENTAL PROTOCOL
Two-colour flow cytometry was used to quantify the 
percentage of CD4+ T cells co-expressing the CD45RA+ and 
CDw29+ markers. The pigeon breeders used had severe 
longstanding PBD and were the same as those used in 
chapters 3, 4 and 5 (group 8). The controls were also the 
same as those studied in chapters 3, 4 and 5 (group 9).
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6.3 RESULTS
Figure 6.1 shows the typical FACS profile obtained by 
two- colour flow cytometry analysis of CD45RA, CDw29 and 
CD4 on peripheral blood lymphocytes in both pigeon 
breeders and controls. It is clear from these profiles 
that there are CD4 5RA- lymphocytes and lymphocytes 
which have varied expression ("low" to "high") of CD45RA. 
CD45RA+ were gated to include both the "CD45RA-low" and 
"CD45RA-high" population of lymphocytes. Expression of 
CDw29 on lymphocytes varied between "low" and "high" with 
no CDw2 9“ population, consistent with previous reports 
(Sanders et al, 1988a). Therefore CDw29+ lymphocytes were 
gated to exclude the "CDw29-low" population of 
lymphocytes.
6.3.1 EXPRESSION OF C045RA
A median of 72% of peripheral blood lymphocytes were 
CD45RA+ in subjects with PBD compared with a median of 
only 60% in controls (P<0.05, Table 6.1). There was also 
a higher absolute number of CD45RA+ cells in the 
peripheral blood of pigeon breeders compared with those 
in the control group although this difference was not 
statistically significant (Table 6.1).
When the expression of CD4 by CD45RA+ cells was examined 
by two-colour flow cytometry, no significant differences 
between the percentage and numbers of CD4 5RA+CD4+ or 
CD45RA+CD4” populations were detected in controls and 
subjects with PBD (Table 6.2). However, most of the 
increase in total CD45RA+ cells in subjects with PBD 
appeared to be due to an increase in the CD45RA+CD4”
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subset, which was 57% in subjects with PBD compared with 
46% in controls. In contrast, the percentage and absolute 
number of CD45RA+CD4+ cells in subjects with PBD were 
virtually identical to controls (18%, 334cmm”1 and 15%, 
288cmm~1, respectively Table 6.2). The proportion of CD4+ 
cells which co-expressed CD4 5RA was also similar (Table 
6.2) .
6.3.2 EXPRESSION OF CDW29
Similar percentages and absolute numbers of CDw29+ 
lymphocytes were recorded in subjects with PBD and 
controls (70%, 1412cmm” 1 and 65%, 1297cmm“ 1 ,
respectively, Table 6.1). In addition, similar 
percentages and absolute numbers of CDw29+CD4+ and 
CDw29+CD4~ cells were found in subjects with PBD and 
controls (Table 6.3). The proportion of CD4+ cells which 
coexpressed CDw29 was also similar (Table 6.3).
6.3.3. RATIO BETWEEN "NAIVE : MEMORY" T CELLS
The median ratio of CD45RA+:CDw29+ cells ("naive:memory") 
in the peripheral blood of subjects with PBD and controls 
was identical (0.9, Table 6.4). Ratios of 
CD45RA+CD4+ :CDw29+CD4+ ("naive:memory" CD4+ T cells) in 
the peripheral blood of patients and controls were also 
similar (0.5 and 0.7, respectively, Table 6.4).
6.3.4 THE EFFECT OF AGE ON CD45RA+ AND CDw29+ CELLS IN 
THE PERIPHERAL BLOOD
As previously mentioned, the median ages of pigeon 
breeders (group 8) used in this study, were significantly 
higher than those of the controls (group 9).
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In order to determine whether the age differences between 
the patients and controls would have had an effect on the 
levels of CD45RA+ and CDw29+ cells reported in this 
study, I correlated the ages of subjects in group 8 with 
the levels CD45RA+ and CDw29+ cells in their peripheral 
blood.
The results of this analysis revealed that the ages of 
subjects in group 8 did not correlate with the levels of 
CD45RA+ and CDw29+ cells in their peripheral blood.
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6.4 CONCLUSIONS.
The results of this study showed that subjects with 
severe longstanding PBD have significantly higher median 
percentages and higher absolute numbers of CD45RA+ cells 
in their peripheral blood than controls. Analysis of the 
expression of CD4 on these cells, did not reveal any 
significant differences in the percentages of CD45RA+CD4” 
cells and CD45RA+CD4+ cells, although the increased 
percentage of CD45RA+ cells was due mainly to increased 
levels of CD45RA+CD4- cells. The proportion of CD4+ T 
cells expressing CD45RA was similar in pigeon breeders 
and controls.
No differences in the percentages and absolute numbers 
of CDw29+ were found in the peripheral blood of patients 
compared to controls. Analysis of the expression of CD4 
on these cells revealed no differences in the percentages 
of either CDw29+CD4” cells or CDw29+CD4+ T cells.
Similar ratios of CD4 5RA+ :CDw2 9+ lymphocytes and 
CD45RA+ :CDw29+ CD4+ T cells were recorded in the 
peripheral blood of subjects with PBD and controls, 
suggesting that the balance of "naive:memory" cells in 
the peripheral blood is not altered in subjects with PBD.
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FIGURE 6.1
Two-colour flow cytometry analysis of CD45RA, CDw29, and 
C d 4 antigen on peripheral blood lymphocytes in a 
representative subject.
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%
CD45RA+
Ab.no %
CDw29+
Ab.no
Pigeon
b rew ers
72* 1560 70 1412
(49-98) (900-7671) (39-86) (800-8500)
Controls
60 1218 65 1297
(54-75) (794-2235) (42-80) (470-2121)
* value differs significantly from control value
Ab.no absolute number (cmm )
TABLE 6.1
The median and (range) of percentages and absolute 
numbers of CD45RA+ cells and CDw29+ cells in the 
peripheral blood of 12 subjects with PBD and 14 controls
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CD45RA+CD4 + CD45RA+C D 4‘
%
CD45RA+ CD4 + 
CD4+
% Ab.no % Ab.no
PIGEON
BREEDERS 18 334 57 1259 36
(4-31) (82-1890) (31-73) (582-6531) (16-100)
CONTROLS 15 288 46 945 38
(7-28) (154-605) (30-64) (503-1907) (20-66)
Ab.no absolute number (cmm-1)
TABLE 6.2
The median and (range) of percentages and absolute 
numbers of CD45RA+CD4+ and CD45RA+CD4~ cells and the 
percentage of CD45RA+CD4+ cells expressed as a percentage 
of total CD4+ cells in the peripheral blood of 12 
subjects with PBD and 14 controls.
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CDw29 +CD4 + CDw29 + CD4'
%
CDw29 + CD4 + 
CD4+
% Ab.no % Ab.no
PIGEON
BREEDERS 22 494 44 1066 73
(16-39) (261-2384) (19-64) (347-6166) (37-85)
CONTROLS 23 441 38 756 61
(11-35) (123-716) (26-60) (347-1405 (28-74)
Ab.no absolute number (cmm ■*■)
TABLE 6.3
The median and (range) of percentages and absolute 
numbers of CDw29+CD4+ and CDw29+CD4_ cells and the 
percentage of CDw29+CD4+ cells expressed as a percentage 
of the total number of CD4+ cells in the peripheral blood 
of 12 subject? with PBD and 14 controls.
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2H4+: 4B4+ 2H4+ CD4+ : 4B4+ CD4+
PIGEON
BREEDERS 0.9 0.5
(0.7-1.8) (0.2-1.6)
CONTROLS
0.9 0.7
(0.7-1.7) (0.3-2.4)
Table 6.4
The median and (range) of ratios of 2H4+ :4B4+ cells and 
2H4+CD4+ :4B4+CD4+ cells in the peripheral blood of 12 
subjects with PBD and 14 controls.
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CHAPTER 7
FUNCTIONAL ACTIVITY OF PERIPHERAL BLOOD 
LYMPHOCYTES IN PIGEON BREEDERS
158
7.1 INTRODUCTION
Studies of specific cell mediated immunity in PBD have 
been stimulated because of the mononuclear cell 
infiltrates which are found in the lungs of affected 
subjects. Most studies have reported that peripheral 
blood mononuclear cells (PBMC) from both symptomatic and 
asymptomatic pigeon breeders proliferated in response to 
either pigeon serum protein (Moore et al# 1980, Schatz 
et al, 1976) or pigeon dropping extract (PDE) (Schatz et 
al, 1976, Girard et al, 1978). However, one study did 
suggest that a significant response only occurred with 
PBMC from symptomatic pigeon breeders stimulated with 
pigeon serum or PDE (Hansen & Penny, 1974). In addition, 
those studies which examined a normal control population 
found no proliferative response of control PBMC to pigeon 
droppings (Hansen & Penny, 1974, Girard et al, 1978) or 
pigeon serum (Girard et al, 1978), unless there was a 
history of exposure to birds other than pigeons, (Schatz 
et al, 1976).
The variability in these results and the fact that 
different groups used different culture conditions, 
makes it difficult to determine the role of specific cell 
mediated immunity in PBD. In addition, these studies were 
done more than 10 years ago and have not been repeated. 
The aim of this chapter was to establish a reliable 
lymphocyte proliferation assay using pigeon serum as an 
antigen since this is the most complete antigen source 
and is capable of inducing symptoms of PBD in symptomatic 
breeders after controlled aerosol exposure (Reed et al, 
1965, Hargreave et al, 1972) . This assay would then be
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used to compare the proliferative response by PBMC from 
subjects with severe longstanding PBD and controls cells 
to pigeon serum. This would also indicate whether 
lymphocyte proliferation would be a useful monitor for 
clinical staging of PBD. My intention was then to try 
and identify the antigen or antigens causing 
proliferation.
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7.2 EXPERIMENTAL PROTOCOL
PBMC were obtained from subjects with severe longstanding 
PBD, with similar symptoms of PBD to subjects in group 1 
and group 8 of the previous studies (chapters 3-6) . 
Controls were from the same population used to select 
controls for the previous chapters.
PBMC were stimulated with whole pigeon serum and two 
fractions of pigeon serum; "globulin” and "albumin rich", 
separated by a 33% ammonium sulphate precipitation 
procedure. A commercial source of pigeon albumin was 
also used in the lymphocyte proliferation assay.
Stimulation indices were calculated by dividing the mean 
counts per minute (cpm) 3H Thymidine incorporation of 
three stimulated cultures with the mean cpm of the 
appropriate unstimulated cultures.
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7.3 RESULTS
7.3.1. ESTABLISHMENT OF OPTIMAL CULTURE CONDITIONS FOR 
MEASURING PROLIFERATIVE RESPONSES TO PIGEON SERUM
a) Effects of varying the concentrations of PBMC and 
pigeon serum protein.
To establish the optimal concentration of pigeon serum, 
doubling dilutions of pigeon serum were used to obtain 
pigeon serum protein concentrations ranging from 775/Ltg of 
protein per well to 3/zg of protein per well, based on the 
range of concentrations which had been used in previous 
studies (Hansen & Penny, 1974, Moore et al, 1980, Schatz 
et al, 1976). These dilutions were incubated with PBMC at 
concentrations of 5xl04 or 1x10s cells per well and in 
this series of experiments an incubation period of 6 days 
was used, as previous work had suggested this to be the 
optimal time, (Schatz et al, 1976). In the first 
experiment, using 1 pigeon breeder and 1 control, it was 
immediately established that PBMC from both the pigeon 
breeder and control proliferated in response to pigeon 
serum (Figure 7.1). Therefore to establish further the 
optimal concentration of PBMC and pigeon serum protein, 
PBMC from 3 controls and 1 subject with PBD were used and 
the data pooled, since it was easier to get cells from 
controls, (Figure 7.2).
It is clear from Figure 7.2 that when cells were cultured 
in the presence of pigeon serum, a dose dependent 
proliferative response occurred at both concentrations of 
responder cells. However, the responses were usually
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greater using lxlO5 cells per well, compared with cells 
at a concentration of 5xl04 cells per well, apart from at 
the highest concentration of pigeon serum protein 
(775jLtg/well) , when the stimulation index was similar for 
the two concentrations of PBMC. Maximum stimulation was 
achieved when lxlO5 cells were incubated with 388/xg of 
pigeon serum protein per well, although concentrations 
of pigeon serum protein as low as 6/xg of protein per well 
with lxlO5 cells per well induced significant 
stimulation.
b) Time course for the proliferative response of PBMC to 
pigeon serum
I next examined whether six days was the optimal 
incubation period for maximum proliferation. To do this, 
lxlO5 PBMC per well, were cultured for 3, 6 or 8 days 
with a range of concentrations of pigeon serum protein 
which covered the optimal dose established above (13/xg to 
412/xg per well) .
The results summarised in Figure 7.3, indicate that at 
day 3, Si's were less than 5 over the range of 
concentrations of pigeon serum protein used. On day 6, 
significant stimulation of PBMC occurred in wells 
containing between 103/xg and 412jug of pigeon serum 
protein per well. At day 8, only wells containing pigeon 
serum protein at a concentration of 412/xg per well had a 
stimulation index of greater than 5 and no significant 
response was seen with any other concentration. Thus, an 
incubation period of 6 days was chosen as being optimal 
for proliferation of PBMC to pigeon serum protein.
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A fuller time course covering every day between 3 and 8 
days was not feasible due to the shortage of cells and 
pigeon serum. However, a limited study looking at 4 and 6 
day incubation periods showed that only a small degree 
of proliferation had appeared by day 4 and confirmed 
that 6 days was the optimal incubation period (data not 
shown).
7.3.2 THE PROLIFERATIVE RESPONSE OF PBMC FROM 
SYMPTOMATIC PIGEON BREEDERS AND CONTROLS TO PIGEON 
SERUM
As the preliminary experiments indicated that both 
controls and subjects with PBD proliferated in response 
to pigeon serum, it was important to determine whether 
there was any quantitative difference between these 
groups. Therefore, PBMC from 6 subjects with PBD and 6 
controls were cultured at lxlO5 cells per well with 
pigeon serum for 6 days, using the range of 
concentrations of pigeon serum protein found to be 
stimulatory in the previous experiment (775/zg/well to 
6/xg/well) .
From Figure 7.4, it can be seen that the mean stimulation 
indices, are not significantly different using PBMC from 
subjects with PBD and controls, across the range of 
concentrations of pigeon serum used in this assay. It 
would therefore appear that pigeon serum is equally 
mitogenic to PBMC from subjects with PBD and controls.
The proliferative responses of PBMC from subjects with
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PBD and controls to pokeweed mitogen were also compared 
and found to be similar (Si's of 10.1±2 and 13.818.3, 
respectively)
7.3.3 THE MITOGENICITY OF OTHER SERUM SAMPLES
a) Mitogenicity of several different batches of pigeon
serum
As the previous experiments used pigeon serum from the 
same pigeon which was housed in the animal house at 
Yorkhill Hospital in Glasgow (PS1), it was necessary to 
establish whether other pigeon serum samples were also 
mitogenic for both controls and subjects with PBD.
Two additional serum samples were collected from 
pigeons also housed in the animal house at Yorkhill 
Hospital (PS2- 3), while a fourth serum sample was 
obtained from a different animal house (Stirling 
University) by pooling serum from four pigeons (PSS). 
The four serum samples were tested at four concentrations 
(675nq, 338/zg, 168/xg and 84/xg, per well) on the PBMC of 2 
subjects with PBD and 1 control.
Figure 7.5 and 7.6. shows that all four batches of pigeon 
serum were mitogenic to PBMC from subjects with PBD and 
controls, respectively. Indeed all four samples induced 
much higher responses by control PBMC than by PBMC from 
the two pigeon breeders. However, on this occasion, 
control PBMC also responded better to PWM (SI 81±7 cpm) 
compared with the PBMC from pigeon breeders (7±3), 
probably due to the lower background counts of control 
cells (139±15 and 16321260, cpm). The actual counts
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recorded for PWM and pigeon serum were similar for the 
control and the two subjects with PBD.
b) Mitogenicity of chicken serum
As this mitogenic effect on normal PBMC seemed to be a 
property of all pigeon serum, I decided to examine 
whether serum from another avian species has similar 
properties. I chose to look at the proliferative response 
of PBMC from 2 subjects with PBD and 1 control, incubated 
for 6 days, with concentrations of chicken serum 
protein similar to those used in the experiments with 
pigeon serum.
The results summarised in Figure 7.7 show that chicken 
serum failed to stimulate any PBMC at any of the 
concentrations used, despite a normal response by the 
same cells to PWM
7.2.4 FRACTIONATION OF PIGEON SERUM
The above studies have shown that although pigeon serum 
stimulates proliferation of PBMC, this is not specific to 
subjects with PBD. I next investigated whether the 
mitogenicity of pigeon serum was masking a specific 
response of pigeon breeders' PBMC to individual 
components of pigeon serum. As specific antibody to 
pigeon serum globulin and albumin has been found in 
pigeon breeders (Fink et al, 1969b) and because they are 
common components of several sources of crude pigeon 
material (Edwards et al, 1970), I fractionated pigeon 
serum into these two fractions, using a 33% ammonium 
sulphate precipitation method.
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a) Protein yield
After precipitation with 33% ammonium sulphate, 114mg of 
globulin were obtained from 2 0ml of pigeon serum, which 
had a total protein content of 28mg per ml. The protein 
which remained in solution amounted to 400mg (Albumin 
rich). From this it can be concluded that there was 
approximately 5.7mg of globulin per ml of pigeon serum, 
or that 2 0% of this pigeon serum protein was globulin. 
The recovery of protein from this extraction was 92%. The 
"globulin" and "albumin rich" fractions and the original 
serum sample were run on a zonal electrophoresis gel 
which is shown in Figure 7.8. The gel shows that one of 
the fractions was a relatively pure globulin fraction 
("globulin") and the other contained the rest of the 
serum proteins, including albumin ("albumin rich").
b) Proliferation assay
The "globulin" and "albumin rich" fractions and the 
original pigeon serum sample from which they were 
derived, were incubated at a range of concentrations with 
PBMC from subjects with PBD and controls. The 
concentrations of the fractions used were based on the 
amounts estimated to be present in a mitogenic dose of 
the whole pigeon serum.
Figure 7.9 shows the mean stimulation indices for the 
proliferation of PBMC from 5 controls and 4 subjects with 
PBD stimulated with whole pigeon serum. As before, 
significant stimulation of PBMC from subjects with PBD 
and controls was achieved at all four concentrations of
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pigeon serum. However, none of these PBMC responded to 
any concentration of the "globulin" fraction (Figure
7.10).
The albumin rich fraction induced significant stimulation 
of PBMC from both controls and subjects with PBD (Figure
7.11). This was maximal at a concentration of 45/xg of 
"albumin rich" protein per well for PBD cells and at 
90/xg/well for controls. The level of proliferation was 
lower than that obtained when the same PBMC were 
stimulated with pigeon serum.
Similar results were obtained with another pigeon serum 
sample which was fractionated into "globulin" and 
"albumin rich" fractions (data not shown).
These results indicate that the mitogenic component of 
pigeon serum was present in the "albumin rich" fraction, 
but no specific antigen could be identified.
7.3.5 ANTIGENICITY OF PURIFIED PIGEON SERUM ALBUMIN
Specific antibodies to pigeon serum albumin have been 
detected in the peripheral blood of pigeon breeders (Fink 
et al, 1969b). Since the previous studies did not 
determine whether the mitogenicity of pigeon serum was 
masking a specific response to pigeon albumin, the final 
experiments examined whether a specific response could be 
obtained using a commercial source of pigeon serum 
albumin. A sample of this extract was run on a zonal 
electrophoresis gel to determine its purity and this 
showed that it did not contain any major contaminants. 
(Figure 7.12). Various concentrations of albumin were
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used in proliferation assays, using concentrations 
likely to be found in pigeon serum as an approximate 
guide. PBMC from three subjects with PBD and four 
controls were tested with this protein.
Figure 7.13 shows that concentrations of pigeon serum 
albumin ranging from Ifig to 140/xg per well failed to 
stimulate PBMC from either subjects with PBD or 
controls. Therefore, pigeon serum albumin is unlikely to 
be the antigen responsible for the cellular response 
detected in subjects with PBD.
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7.4 CONCLUSIONS
This study revealed that pigeon serum stimulated 
proliferation by PBMC over a wide range of 
concentrations, although a concentration of approximately 
350/xg per well was optimal. These responses were maximal 
at 6 days of culture and occurred with PBMC from both 
controls and from subjects with PBD.
All of the batches of pigeon serum from a range of 
pigeons housed in different animal houses showed this 
mitogenicity, but chicken serum failed to stimulate PBMC 
from either subjects with PBD or controls.
A 3 3% ammonium sulphate fractionation of pigeon serum 
into a "globulin" and an "albumin rich" fraction revealed 
that at least some of the mitogenic activity in pigeon 
serum was present in the "albumin rich" fraction, 
although this fraction was unable to induce the same 
level of stimulation of PBMC as that achieved when using 
whole pigeon serum. The "globulin" fraction did not cause 
proliferation by PBMC from either subjects with PBD or 
controls and is therefore unlikely to be the antigen 
involved in the cellular response in PBD. Using a 
commercial source of pigeon serum albumin, no 
proliferative response by PBMC from either subjects with 
PBD or controls was found and therefore albumin is also 
unlikely to be the antigen causing the cellular immune 
response in PBD and also not the mitogen.
Therefore these results do not support a role for antigen 
specific CMI to pigeon serum in PBD. However they could 
suggest that pigeon serum contains a non-specific mitogen
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and it is conceivable that stimulation of lymphocytes by 
this agent could play some role in the pathogenesis of 
the disease. The next chapter will try to examine this in 
more detail.
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FIGURE 7.1
The proliferative response of PBMC from 1 pigeon breeder 
and 1 control incubated for 6 days with a range of 
concentrations of pigeon serum protein.
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FIGURE 7.2
The proliferative response of PBMC at concentrations of 
lxlO5 and 5xl04 cells per well incubated with a range of 
concentrations of pigeon serum protein for 6 days.
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Figure 7.3
Time course for the proliferative response of PBMC from 3 
controls incubated with a range of concentrations of 
pigeon serum protein.
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Figure 7,4
The proliferative response of PBMC from 6 pigeon breeders 
and 6 controls incubated with a range of concentrations 
of pigeon serum protein.
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Figure 7.5
The proliferative response of PBMC from 2 subjects with 
PBD incubated with four different batches of pigeon serum 
over a range of concentrations.
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Figure 7.6
The proliferative response of PBMC from 1 control 
incubated with four different batches of pigeon serum 
over a range of concentrations.
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Figure 7.7
The proliferative response of PBMC from 2 pigeon breeders
and 1 control incubated with a range of concentrations
of chicken serum protein.
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Figure 7.8
A zonal electrophoresis gel shoving the protein content 
of whole pigeon serum and the "globulin" and "albumin 
rich" fractions derived from it.
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Figure 7.9
The proliferative response of PBMC from 4 pigeon breeders
and 5 controls incubated with a range of concentrations
of pigeon serum protein
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Figure 7.10
The proliferative response of PBMC from 4 pigeon breeders
and 5 controls incubated with a range of concentrations
of the "globulin" fraction of pigeon serum
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Figure 7.11
The proliferative response of PBMC from 4 pigeon breeders
and 5 controls incubated with a range of concentrations
of the "albumin rich" fraction of pigeon serum.
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Figure 7.12
A zonal electrophoresis gel showing the protein content 
of whole pigeon serum and a commercial source of pigeon 
serum albumin.
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Figure 7.13
The proliferative response of PBMC from 4 pigeon breeders 
and 3 controls incubated with a range of concentrations 
of pigeon serum albumin.
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CHAPTER 8
ANALYSIS OF THE MITOGEN PRESENT IN PIGEON SERUM
185
8.1 INTRODUCTION
The previous chapter indicated that pigeon serum 
contained a mitogenic agent. Since in most animal models 
of EAA an additional inflammatory or mitogenic component 
is necessary to initiate and maintain disease, it is 
conceivable that stimulation of lymphocytes by this 
agent could play some role in the pathogenesis of PBD 
(Richerson et al, 1971, Richerson, 1972, Joubert et al, 
1976, Bernardo et al, 1979, Moore et al, 1975). This 
chapter attempts to identify this agent and explore its 
potential importance in PBD.
The first part of this study examines the possibility 
that endotoxin is the mitogenic agent in pigeon serum. 
Endotoxin was chosen because of the suggestions that it 
might play a role in the pathogenesis of other lung 
diseases, such as byssinosis (Neal et al, 1942, Cinkotia 
et al, 1977, Castellan et al, 1984, Rylander et al, 1985) 
and humidifier fever (Rylander et al, 1978, Rylander & 
Haglind, 1984, Muittari et al, 1980). In addition, Burrel 
and Rylander (1981) suggested that endotoxin might play a 
role as an initiator of the acute inflammatory reaction 
preceding the onset of EAA. The second aim was to 
determine whether the mitogenic element of pigeon serum 
could have a role in the pathogenesis of PBD. This was 
examined by investigating the mitogenicity of pigeon 
droppings, as they are a more clinically relevant 
antigen.
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8.2 EXPERIMENTAL PROTOCOL
PBMC used in this study were obtained from subjects with 
severe longstanding PBD, with similar symptoms of PBD to 
the pigeon breeders used in the previous chapter.
The molecular weight of the mitogenic agent in pigeon 
serum was established by dialysis and its thermostability 
determined by heating pigeon serum. Endotoxin levels in 
pigeon serum were measured in a Limulus lysate assay. To 
explore the possibility that the mitogenic agent was 
endotoxin, Polymyxin B, a known inhibitor of endotoxin, 
and purified LPS were used. Concentrations of Polymyxin B 
used were based on the principle that one molecule of 
polymyxin B binds to one monomer unit of LPS (Lipid A) 
and therefore 3.5/xg of polymyxin B should bind to 10/xg of 
LPS (Morrison & Jacobs, 1976). Finally, the proliferative 
response of PBMC to a protein extract from pigeon 
droppings (PDE) was examined. All of the cultures were 
incubated for 6 days unless otherwise stated.
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8.3 RESULTS
8.3.1 THE EFFECT OF TEMPERATURE AND DIALYSIS ON THE 
MIT06ENICITY OF PIGEON SERUM
a) Thermostability
Two different batches of pigeon serum were heated for one 
hour at 65°C and then cultured at four different 
concentrations (775jxg, 388/xg, 194/xg and 97/xg per well) 
with PBMC from 1 control.
The results for one batch of pigeon serum are summarised 
in Figure 8.1 and indicate that the mitogenicity was not 
affected by heating to a temperature of 65°C for one 
hour. Similar results were obtained with the other batch 
of pigeon serum (data not shown).
b) Effect of dialysis
Two different batches of pigeon serum were dialysed 
against PBS using dialysis tubing with a molecular weight 
cut off of lOKDa. After dialysis, the pigeon serum was 
reconcentrated to the original volume and four 
concentrations of dialysed and non-dialysed samples from 
each batch of pigeon serum were incubated with PBMC from 
1 control.
The results for one of the batches are summarised in 
Figure 8.2. These show that dialysis had no effect on the 
mitogenicity of pigeon serum sample and therefore the 
mitogenic agent is likely to have a molecular weight of
more than lOKDa. Similar results were obtained with the
other batch (data not shown).
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8.3.2 LEVELS OF ENDOTOXIN IN PIGEON SERUM
The levels of endotoxin in 1 sample of pigeon serum were 
measured in a Limulus lysate assay. Pigeon serum, with a 
total protein content of 30mg per ml, was found to 
contain 5pg of endotoxin per ml. Therefore mitogenic 
amounts of pigeon serum per well (approximately 350/xg 
protein) would contain approximately 0.06pg of endotoxin.
8.3.3 MITOGENIC EFFECTS OF LPS
The aim of this experiment was to establish whether the 
level of endotoxin found in pigeon serum could have been 
responsible for its mitogenic effects. PBMC were 
incubated with the pigeon serum above or with 
concentrations of commercially obtained LPS, at 
concentrations covering the quantity present in 
mitogenic amounts of pigeon serum, (0.015pg to 12pg of 
LPS per well). In addition, as a positive control, LPS 
was also used at the higher concentrations which are 
generally considered to be mitogenic in vitro (0.1/xg to 
1000/xg per well) .
Figure 8.3 shows that PBMC from 2 controls did respond to 
the pigeon serum containing 5pg of endotoxin per ml, 
described above. However, the results of the 
proliferative response of PBMC from 1 control, summarised 
in Tables 8.1 and 8.2 show that PBMC failed to respond 
to LPS at any of the concentrations used, over a six day 
period. The other control also failed to respond (data 
not shown). PWM used as a positive control induced 
significant stimulation of PBMC (SI 72), indicating that 
the conditions for the proliferation of lymphocytes were
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suitable.
Therefore this experiment failed to determine whether 
LPS accounts for the mitogenic effects as the positive 
control for the experiment did not work.
8.3.4 THE EFFECT OF POLYMYXIN B ON THE MITOGENICITY OF 
PIGEON SERUM
As an alternative approach, I examined whether the 
mitogenic effect of pigeon serum could be inhibited by 
Polymyxin B. Polymyxin B, an inhibitor of endotoxin, was 
added to cultures of PBMC stimulated with 340/xg per well 
of pigeon serum protein per well. Concentrations of 
Polymyxin B from 0.04/xg to 5/xg per well were used, which 
would have been sufficient to inhibit quantities of LPS 
from 0.12/xg to 15/xg of LPS per well. As high 
concentrations of Polymyxin B had been reported to be 
toxic to macrophages (Stokes et al, 1989), the 
proliferative response of PBMC to pokeweed mitogen, in 
the presence of polymyxin B, was used as a control.
The results of these studies using PBMC from 2 subjects 
with PBD and 1 control are summarised in Figures 8.4 
and 8.5. These show that Polymyxin B had no effect on the 
proliferative response of PBMC from either pigeon 
breeders or controls cultured with pigeon serum or 
pokeweed mitogen. Unfortunately, because of the failure 
to obtain a positive response with LPS, it was not 
possible to confirm that Polymyxin B would have blocked 
the mitogenic effect of endotoxin if present in pigeon 
serum.
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8.3.5 THE EFFECT OF A PROTEIN EXTRACT FROM PIGEON 
DROPPINGS ON PBMC
To determine whether the mitogenic component of pigeon 
serum is important in the pathogenesis of PBD, this study 
looked for its presence in pigeon droppings. Pigeon 
droppings were chosen as the likely medium through which 
this mitogenic component could be inhaled from the loft 
environment. This study examined the proliferative 
response of PBMC from subjects with PBD and controls to 
pigeon dropping extract.
Protein from lOOg of fresh pigeon droppings was extracted 
in PBS, followed by centrifugation to remove insoluble 
particles. After dialysis, concentration and filter 
sterilisation the protein content of the resulting 20mls 
of protein solution was 23mg per ml. The sample was then 
run on a 7.5% SDS-Page gel. Figure 8.6b shows that faint 
bands of protein were seen of molecular weight 116KDa, 
60KDa, 45KDa and 35KDa.
To determine the effect of this extract on PBMC, a range 
of concentrations of this were incubated with PBMC from 2 
subjects with PBD and 3 controls. Table 8.3 shows that no 
response of PBMC was apparent at any of the 
concentrations of PDE used in this assay. In fact, at 
some concentrations of PDE, the SI was below 1 and so it 
is possible that the PDE was toxic to the PBMC. Using 
pigeon serum as a positive control, significant 
proliferation of PBMC from the 2 subjects with PBD and 
the 3 controls was achieved (mean SI of 19±8 and 69±29 
respectively).
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In a second experiment, I attempted to improve the yield 
of intact protein obtained from pigeon droppings, by 
including the enzyme inhibitors, phenylmethylsulfonyl 
fluoride and pepstatin in the extraction process. However 
similar yields of protein were recovered (280mg per lOOg 
of pigeon droppings) and as before, four bands of 
protein with molecular weights of 116KDa, 60KDa, 45KDa 
and 30KDa were obtained (Figure 8.6a).
This extract was added to PBMC, from 5 controls, both at 
concentrations used in the first experiment and at lower 
dilutions, in an attempt to avoid possible toxic effects. 
The results in Table 8.4 show that no response to PDE was 
obtained from PBMC, over the range of concentrations 
used. Again using pigeon serum as a positive control, the 
lymphocytes from these subjects responded with a mean SI 
of 30±6.
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8.4 CONCLUSIONS
This study showed that the mitogenic agent in pigeon 
serum was thermostable at 65°C and was likely to have a 
molecular weight of more than lOKDa.
Measurement of the level of endotoxin in pigeon serum in 
a Limulus Lysate assay revealed that it contained 5pg of 
endotoxin per ml. However the study failed to determine 
whether the mitogenic agent was endotoxin.
Analysis of the protein content of pigeon droppings 
revealed that it contained four main proteins, of 
molecular weight 116KDa, 60KDa, 45KDa and 35KDa. The 
soluble constituents of pigeon droppings were neither 
antigenic or mitogenic to PBMC and therefore the 
mitogenic agent of pigeon serum is either not a 
constituent of pigeon droppings or is not present in 
sufficient amounts to be mitogenic in vitro. It remains 
to be determined if the mitogenic agent is present in 
another pigeon material.
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FIGURE 8.1
The proliferative response of lymphocytes from 1 control
incubated with a range of concentrations of "fresh" and
"heated" (65°C) pigeon serum.
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FIGURE 8.2
The proliferative response of lymphocytes from 1 control
incubated with a range of concentrations of "fresh" and
"dialysed" pigeon serum.
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FIGURE 8.3
The proliferative response of lymphocytes from 2 controls 
incubated with pigeon serum containing 5pg of endotoxin 
per ml
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FIGURE 8.4
The effect of a range of concentrations of Polymyxin B 
on the proliferative response of lymphocytes from 2 
subjects with PBD and 1 control incubated with pigeon 
serum
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FIGURE 8.5
The effect of a range of concentrations of Polymyxin B 
on the proliferative response of lymphocytes from 2 
subjects with PBD and 1 control incubated with pokeweed 
mitogen.
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FIGURE 8.6 a/b
7% SDS polyacrylamide gel. Lanes contain (from left to 
right) whole PDE, markers, whole PDE, markers. Gel 
stained with PAGE blue. Anode is at the bottom.
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Incubation time 12
pg LPS/well 
1 0.25 0.06 0.015
1 day 1.2±0.1 1.2±0.1 2.0±0.1 1.6±0.1 1.8±0.4
2 days 1.8±0.5 0.8±0.1 1.8±0.1 0.6±0.1 0.7±0.1
3 days 1.2±0.2 0.6±0.1 2.1±0.2 1.4±0.2 2.2±0.3
4 days 0.9±0.2 1.7±0.1 0.8±0.2 1.5±0.1 0.9±0.1
6 days - 1.3±0.2 1.8±0.3 1.7±0.8 1.6±0.5
SI - stimulation index
SEM - standard error of the mean
- - not done
figures are the mean SI ± 1 SEM
TABLE 8.1
Time course of the proliferative response of lymphocytes 
from 1 control incubated with a range of concentrations 
of LPS.
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Incubation time 1000 100
(ig LPS/well 
25 10 1.2 0.1
1 day 1.3±0.4 1.7±0.1 1.3±0.1 1.710.3 1.010.1 1.010.2
2 days 1.0±0.4 1.3±0.2 0.810.1 1.310.1 2.110.9 1.010.3
3 days 1.1±0.1 0.5±0.7 0.8±0.1 0.710.1 1.510.1 0.410.1
4 days 0.6±0.1 0.9±0.3 0.8±0.03 1.710.2 0.710.1 1.510.1
6 days 0.5±0.03 0.9±0.4 0.810.2 0.510.1 1.110.2 1.410.2
SI - stimulation index
SEM - standard error of the mean
figures are the mean SI ± 1 SEM
TABLE 8.2
Time course of the proliferative response of lymphocytes 
from 1 control incubated with a range of concentrations 
of LPS.
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pg PDE/well
2 5 10 21 42 85 170 340
pigeon
breeder
1.6±0.9 1.1 ±0.9 0.8±0.4 1.1 ±0.8 0.6±0.5 0.9±0.9 2.1 ±0.1 0.9±0.9
controls 0.5±0.1 1.0±0.1 0.7±0.2 0.3±0.02 0.5±0.4 0.6±0.5 0.3±0.1 0.1 ±0.1
SI - stimulation index
SEM - standard error of the mean
figures are the mean SI ± 1 SEM
TABLE 8.3
The proliferative response of lymphocytes from 2 subjects 
with PBD and 3 controls incubated with a range of 
concentrations of PDE.
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0.005 0.011 0.022
|xg PDE/well 
0.045 0.09 0.19 0.38 0.75
Incubation
time
6 days 1.4±0.1 2.0±04 1.0±0.4 1.3±0.1 1.3±0.3 1.2±0.1 0.9±0.2 0.710.1
1.5 3 6
jag PDE/well 
12 25 50 100 200
Incubation
time
6 days 0.710.2 0.710.1 0.610.1 0.510.05 0.610.1 0.710.1 0.410.1 0.310.07
SI . - stimulation index
SEM - standard error of the mean
figures are the mean SI ± 1 SEM
TABLE 8.4
The proliferative response of lymphocytes from 5 controls 
incubated with a range of concentrations of PDE.
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CHAPTER 9 
GENERAL DISCUSSION
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Group 1 pigeon breeders differed from the other pigeon breeders 
in that they were taking low dose inhaled steroids. The effect of 
low dose inhaled steroids on the phenotypes of ^er-ipheral blood 
cells is likely to be minimal but has not been formally studied. 
As a result, there is a slight possibility that the changes in 
the phenotypes of peripheral blood cells, such as increased 
percentages of CD45RA+ cells and decreased percentages of }6 T 
cells, found in group 1 pigeon breeders, may be a steroid effect. 
Future studies should look at a similar group of pigeon breeders 
who are not taking steroids.
The initial view of EAA was that it was an immune 
complex mediated disease, involving a Coombs and Gell 
(1963) Type III hypersensitivity reaction. However, it 
became apparent that many pigeon breeders had specific 
serum antibody, without clinical symptoms of disease. 
Furthermore, histopathological studies revealed that 
lymphocytic cellular infiltrates and granuloma formation 
occurred in the lungs. These observations prompted 
studies to explore the hypothesis that cell mediated 
immunity has a role in the pathogenesis of EAA.
Previous studies designed to explore the role of cell 
mediated immunity in the pathogenesis of EAA have 
assessed the phenotype or function of cells in small 
heterogeneous subject groups, often with different 
syndromes of EAA. As a result, the findings of these 
studies were variable and inconclusive. The aim of this 
thesis was to use PBD as a model of EAA and to perform 
phenotypic and functional studies of well defined 
categories of patients.
Peripheral blood was used in these studies as its ready 
availability enabled a larger population of pigeon 
breeders to be studied.
9.1 PERIPHERAL BLOOD LEUCOCYTE PHENOTYPES AMONG 
PIGEON BREEDERS
Chapter 3 examined whether there were alterations in 
total and differential WBCC and T and B cell numbers 
which correlated with disease.
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Increased WBCC were recorded in the peripheral blood of 
symptomatic antibody positive pigeon breeders who were 
acutely symptomatic at the time of blood sampling (group 
2) . This was reflected in increased numbers of 
neutrophils, total lymphocytes and CD4+ and CD8+ cells. B 
cell numbers were unchanged. However, Group 3 pigeon 
breeders with similar symptoms, but who were not acutely 
symptomatic at the time of blood sampling, had normal 
WBCC. These results suggest that acute exacerbations of 
PBD lead to a transient leucocytosis. This non-specific 
consequence of acute inflammation has been reported 
previously in symptomatic subjects with PBD, who had 
similar symptoms of fever and dyspnoea, at the time of 
blood sampling (Reed et al, 1965). In the lung, a 
transient polymorphonuclear cell infiltrate follows 
inhalation challenge (within 24 hours) (Fournier et al, 
1985) which is followed several days later by a 
lymphocytic alveolitis (Costabel et al, 1984, Leatherman 
et al, 1984, Agnostini et al, 1984, Costabel et al, 1985, 
Semenzato et al, 1986) . A leucocytosis is also found in 
the lung, within 24 hours of inhalation challenge with 
pigeon serum, in animal models of EAA. This consists of 
an early accumulation of neutrophils (Bernardo et al, 
1979), followed by a mononuclear cell infiltrate 48 to 
96 hours later (Bernardo et al, 1979). Therefore it is 
tempting to speculate that the increased numbers of 
leucocytes found in peripheral blood of subjects in group 
2 are being recruited to the lung. This could be tested 
by analysing cells from the peripheral blood and BAL in 
parallel, at a selected time interval after inhalation
206
challenge. However, given the invasive nature of BAL, it 
is unlikely that repeated BAL sampling during the course 
of an acute symptomatic episode would be permitted and 
therefore repeated blood sampling would be the only way 
to monitor cellular changes during a longitudinal time 
course study.
Symptomatic pigeon breeders without serum antibody to 
pigeon antigen also had significantly increased WBCC 
compared with control subjects. An increased WBCC in 
these individuals fits with the hypothesis that these 
subjects may have Organic Dust Toxic Syndrome, since 
increased WBCC have been recorded in subjects with this 
disease (May et al, 1986, doPico, 1986). Organic Dust 
Toxic Syndrome, presents with similar symptoms to PBD 
(eg, fever, myalgia, chest tightness etc) several hours 
after exposure to organic dusts (doPico, 1986). However, 
it differs from EAA in that it is not associated with 
precipitating antibody and the pulmonary function tests 
and chest radiographic appearances of affected subjects, 
are usually normal. Potential etiological agents are 
dusts containing mould and bacteria, endotoxins, or other 
unidentified agents. However a complicating factor in my 
group of patients is that they were all smokers. As 
smoking has an inhibitory effect on the antibody response 
to inhaled antigens (Boyd et al, 1977, McSharry et al, 
1985), this could have inhibited the antibody response in 
my subjects. A population of non-smoking symptomatic, 
antibody negative pigeon breeders would have been useful 
in my study. However it is important to emphasise that 
the increased WBCC count which I found was not itself
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due to the increase seen in smokers (Miller et al, 1982, 
Robertson et al, 1983), as although all PBD subjects with 
leucocytosis were smokers, 7/8 of the asymptomatic 
antibody negative pigeon breeders (group 7) were also 
smokers and yet they did not have significantly increased 
WBCC.
Two groups of antibody positive pigeon breeders with 
severe longstanding disease who had restrictive PFT's and 
typical chest radiographic appearances had evidence of 
reversed CD4:CD8 ratios compared with controls. This was 
due to increased numbers of CD8+ cells. Although the 
difference was not statistically significant in 
individual groups, similar findings were made in both 
studies suggesting that this is a genuine abnormality in 
at least a proportion of subjects with PBD. The 
variability in the CD4:CD8 ratios in subjects within the 
same group raises the question of the clinical 
significance of a reversed CD4:CD8 ratio in individual 
patients. One study showed that reversed CD4:CD8 ratios 
in peripheral blood and BAL fluid were a characteristic 
of symptomatic pigeon breeders with recent antigen 
exposure, while those who were studied more than 5 days 
after their last antigen exposure had normal CD4:CD8 
ratios (Costabel et al, 1984). This would suggest that 
the length of time between blood sampling and the last 
exposure to antigen may affect the cellular profile, a 
factor which was not controlled for in my subjects with 
severe longstanding PBD. It is possible that the 
generally less severe disease exhibited by group 2 pigeon
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breeders who were acutely symptomatic at the time of 
blood sampling may explain why they did not also have 
reversed CD4:CD8 ratios. A recent study by Reynolds et 
al (1989) showed that only subjects with chronic PBD had 
reduced CD4:CD8 ratios, while those with acute PBD showed 
no difference. Therefore it is possible that some of my 
subjects with severe longstanding PBD, have a mixed form 
of acute or chronic and acute PBD, similar to the 
subacute PBD, defined by Fink (1983). It would be 
important to analyse peripheral blood cells in distinct 
groups of pigeon breeders with acute, chronic and 
subacute forms of the disease.
Reduced CD4:CD8 ratios have previously been reported in 
BAL fluid of subjects with EAA, (Costabel et al, 1984, 
Leatherman et al, 1984, Agnostini et al, 1984, Costabel 
et al, 1985, Semenzato et al, 1986). However the results 
of studies analysing the levels of CD4 and CD8 cells in 
the peripheral blood have been conflicting. Two studies 
found reduced CD4:CD8 ratios in symptomatic subjects 
(Costabel et al, 1984, Costabel et al, 1985), while 
others found no abnormalities (Agostini et al, 1984, 
Leatherman et al, 1984, Semenzato et al, 1986). These 
conflicting results may reflect the fact that they did 
not distinguish between subjects with various syndromes 
of EAA and that the time between blood sampling and the 
last exposure to antigen was not controlled for in these 
studies.
Studies that have looked at the levels of CD4 and CD8 
cells in asymptomatic subjects have also reported
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similar reversed CD4:CD8 cells ratios in BAL fluid 
(Leatherman et al, 1984, Semenzato et all, 1986) but not 
in the peripheral blood (Leatherman et al, 1984, 
Semenzato et al, 1986) . This is consistent with my own 
study, which found no difference in the levels of CD4 
and CD8 cells in the peripheral blood of asymptomatic, 
antibody negative pigeon breeders (group 6). However, an 
increased proportion of asymptomatic, antibody positive 
subjects (group 4) had high CD4:CD8 ratios (>2.5) in 
their peripheral blood compared with controls. This was 
due mainly to increased numbers of CD4+ cells in these 
subjects. Increased numbers of CD4+ cells might be 
responsible for the presence of an active humoral immune 
response in these subjects. This could be tested by 
determining the functional activity of these cells in an 
in vitro antibody production assay. It is not clear 
whether these asymptomatic pigeon breeders have had or 
will develop clinical symptoms of disease. However, the 
pattern of no pathology, but high antibody is similar to 
that described in animal models of EAA, in which repeated 
inhalation challenge with antigen, fails to induce 
chronic EAA and any acute alveolitic lesions disappear 
(Richerson et al, 1978, Ratajczak et al, 1980, Richerson 
et al, 1981). This clearing of disease (waning) is 
antigen specific, but is not associated with decreased 
antibody responses or decreased antigen lymphocyte 
blastogenesis (Richerson et al, 1981, Ratajczak et al, 
1980). Therefore it is possible that some of these 
asymptomatic antibody positive subjects have the 
equivalent of waning disease. However, others may be at
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an early subclinical stage of disease and may still 
progress to develop clinical symptoms. A longitudinal time 
course study on these asymptomatic antibody positive 
pigeon breeders involving the collection of peripheral 
blood at defined intervals, together with clinical 
assessment of disease would be useful in resolving this 
question.
The level of specific antibody did not correlate with 
any of the cellular changes mentioned above. However, 
symptomatic antibody positive pigeon breeders who were 
acutely symptomatic at the time of blood sampling (group 
2) had significantly higher antibody levels than 
equivalent symptomatic patients who were not acutely 
symptomatic (group 3) or asymptomatic antibody positive 
pigeon breeders (group 4). In general, symptomatic pigeon 
breeders have higher antibody titres than their 
asymptomatic counterparts (Boyd 1978, McSharry et al, 
1984), which would explain the difference in antibody 
titres between symptomatic and asymptomatic pigeon 
breeders. The difference between group 2 and group 3 
subjects may reflect the fact that group 2 subjects are 
more likely to have a symptomatic episode (Boyd, 1978).
Taken together, these initial results suggested that 
there are changes in peripheral blood leucocytes 
associated with some groups of pigeon breeders depending 
on their symptoms. In addition, these results reveal that 
even within a group of symptomatic antibody positive 
pigeon breeders, there can be differences in their 
peripheral blood leucocyte profiles which may reflect
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differences in the stage of disease. My results also 
suggest that factors such as the symptomatic state at the 
time of blood sampling and the time between blood 
sampling and the last exposure to pigeon antigen, may 
affect the phenotypes of cells in the peripheral blood. 
Therefore future studies should attempt to monitor 
cellular changes at frequent intervals after antigen 
challenge in subjects within a given syndrome of EAA at 
a defined stage of disease in both BAL fluid and in the 
peripheral blood. The results of my study show that 
despite some positive changes, there are few significant 
differences in the phenotypes of peripheral blood 
leucocytes in any of the groups of pigeon breeders and 
therefore peripheral blood T cell analysis is of 
limited clinical value in PBD.
9.2 ANALYSIS OF NK CELLS IN PIGEON BREEDERS
Levels of NK cells were analysed in the peripheral blood 
of pigeon breeders to determine the extent to which non­
specific immunity may play a role in the pathogenesis of 
PBD. In addition, given that the proliferation of these 
cells is sensitive to IL2 and IFN/ (Anegon et al, 1988) , 
their levels may also be indicative of the level of the 
immune response. It is also possible that these cells may 
play a role in the pathogenesis of PBD, as the production 
of IFN/ and TNFa by activated NK cells has been 
implicated to play a role in the pathogenic process of 
chronic inflammation in rheumatoid arthritis (Hendrich et 
al, 1991) and in the destructive phase of graft versus 
host disease (Mowat & Felstein, 1987).
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Levels of CD56+ cells were analysed in the peripheral 
blood as a means of assessing NK cell numbers. CD56 
(NCAM1), is expressed by virtually all human NK cells 
(Griffin et al, 1983, Hercend et al, 1985) and by a small 
proportion of "non MHC restricted T cells" (Lanier et al, 
1986a, Schmidt et al, 1986) . Thus, true NK cells can be 
defined phenotypically as CD56+CD3” lymphocytes 
(Robertson & Ritz, 1990). In my initial study, double 
staining was not used to detect the expression of CD3 on 
CD56+ cells and therefore the findings served simply to 
highlight any possible differences which could be 
analysed in more detail later.
This analysis revealed increased absolute numbers of 
CD56+ cells in symptomatic antibody positive pigeon 
breeders who were acutely symptomatic at the time of 
blood sampling compared with controls. This was not 
present in those patients who were not acutely 
symptomatic at the time of blood sampling and so this 
feature paralleled the presence or absence of 
leucocytosis in these groups.
The two groups of symptomatic antibody positive pigeon 
breeders with severe longstanding PBD, were also found to 
have increased absolute numbers of CD56+ cells in their 
peripheral blood compared with their controls. However, 
the difference was only statistically significant in one 
of the groups. The inconsistencies in the two sets of 
results may reflect sampling variation, which reaffirms 
the previous findings of variation in the CD4:CD8 ratios
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in individual pigeon breeders with severe longstanding 
PBD. Again, this raises the question of the clinical 
significance of raised levels of CD56+ cells in 
individual pigeon breeders. Levels of CD8+ cells did not 
correlate with levels of CD56+ cells and therefore CD8+ 
and CD56+ cells may be playing separate roles in the 
pathogenesis of PBD.
Normal levels of CD56+ cells were detected in the 
peripheral blood of the other four groups of pigeon 
breeders, indicating that CD56+ cells appeared to be 
specifically raised only in subjects with severe 
longstanding PBD. Thus, it is possible that these 
lymphocytes may play a role in the pathogenesis of PBD.
To determine whether the raised levels of CD56+ cells 
were true NK cells, two-colour flow cytometry was used 
to differentiate true CD3”CD56+ T cells from CD3+CD56+ T 
cells in the additional group of symptomatic subjects 
with severe longstanding PBD. This revealed no 
statistically significant differences in the percentages 
of either CD3+CD56+ T cells or CD3“CD56+ NK cells in 
pigeon breeders, although there was a slightly increased 
absolute number of CD3“CD56+ NK cells. This suggests that 
some of the pigeon breeders within this group have 
increased numbers of CD56+ NK cells. Analysis of the 
expression of CD8 on the CD56+ cells in these subjects 
revealed no difference in the percentages or absolute 
numbers of CD8+CD56+ or CD8“CD56+ cells. Despite the rise 
in the level of NK cells in some of these pigeon 
breeders, this was not associated with increased
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cytotoxicity of these cells against K562 target cells in 
vitro. This would suggest therefore that if NK cells 
play a role in the pathogenesis of PBD, then it may not 
involve their natural cytotoxic capabilities.
Additional analysis to determine the expression of CD16 
on cells in the peripheral blood of these subjects 
(groups 8 and 9) was also carried out. CD16 is the Fc/jjj 
receptor and is thought to be solely responsible for the 
antibody dependent cellular cytotoxicity of NK cells 
(Perussia et al, 1984, Trinchieri et al ,1984). This 
analysis revealed increased absolute numbers and 
percentages of CD16+ cells in pigeon breeders (group 8) 
compared with controls (group 9) . However, due to the 
wide range of values in both groups, the differences were 
not statistically significant. The increase in the 
percentage of these cells in the symptomatic antibody 
positive pigeon breeders was due to CD3-CD16+ cells and 
therefore NK cells. These were also shown to be 
predominantly CD8” cells and there was no correlation 
between the numbers of CD16+ cells and CD8+ cells in 
individual pigeon breeders. It is possible that CD16+ NK 
cells could become activated in PBD by interacting with 
specific IgG antibody bound to pigeon antigen associated 
with the surface of a cell in the lung. Activation of 
these cells could result in release of various cytokines 
such as IFN/ and TNFa (Anegon et al, 1988), which could 
be involved in the chronic inflammatory response in the 
lung. Another possibility is that these cells mediate 
antibody dependent cellular cytotoxicity (Perussia et al, 
1984). Future studies could assess the functional
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activity of these cells in an ADCC assay. Indeed this 
could be done using pigeon erythrocytes as targets as 
they express antigen on their surface which is recognised 
by IgG from antibody positive pigeon breeders.
I did not examine NK cells in the lung tissue itself. 
However, it has been shown that increased levels of CD57+ 
cells in the lung are mirrored by an increase in the 
levels of these cells in the peripheral blood (Semenzato 
et al, 1986). If the same phenomenon is also true of NK 
cells in general then my study suggests that pigeon 
breeders with severe longstanding PBD have increased 
levels of CD16+ NK cells and CD56+ NK cells in their 
lungs, although this would contradict the findings of a 
number of studies which found normal levels of CD16+ 
cells in BAL fluid of subjects with EAA (Agostini et al, 
1984, Semenzato et al, 1986, Semenzato et al, 1988). 
However, it should be noted that BAL fluid is 
inappropriate for assessing CD16+ cells in the lung, as 
these cells are largely confined to the lung interstitium 
itself (Weissler et al, 1987). This emphasises the need 
to look at all areas of the lung directly.
9.3 JS T CELLS IN PIGEON BREEDERS
In view of the evidence that JS T cells might play a role 
in chronic inflammatory diseases of the lung such as 
sarcoidosis (Balbi et al, 1990) and Farmer's lung 
(Trentin et al, 1990) and due to their proposed role in 
the protection of epithelial surfaces (Janeway et al, 
1988, Janeway, 1988, Raulet, 1989), their possible
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involvement in PBD was investigated in subjects with 
severe longstanding PBD (group 8).
Pigeon breeders with severe longstanding PBD were found 
to have significantly lower percentages of J8 T cells in 
their peripheral blood compared with controls (group 9). 
This result contrasts with reports of increased levels of 
] 8 T cells in the lungs of farmers with EAA (Trentin et 
al, 1990), perhaps indicating that the lower numbers of 
]8 T cells in the blood are secondary to an accumulation 
of these cells in the lung. Although this needs parallel 
examination of peripheral blood and BAL samples, it 
should be noted that, in sarcoidosis, increased levels 
of J 8 T cells are found both in the peripheral blood 
and in the lung (Balbi et al, 1990).
I attempted to examine, indirectly, the possible 
relationship between peripheral blood and lung }8 T cells 
by looking for expression of markers which have been 
associated with }8 T cells in mucosal tissues. ]S T cells 
in the gut of humans are predominately CD8” (Halstensen 
et al, 1989) , but my study showed that percentages of 
both CD8+ and CD8” J S T cells were reduced in the 
peripheral blood of subjects with severe longstanding 
PBD. Thus if the reduction in peripheral blood ]8 T cells 
does reflect recruitment into the lung, then both CD8+ 
and CD8” /8 T cells may be involved in PBD. In coeliac 
disease, the increased numbers of )8 intraepithelial 
lymphocytes are predominantly CD8“ (Halstensen et al,
1989). However, the significance of these findings is 
unclear, as the functional capabilities of CD8+ and CD8”
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J8 T cells are not known.
A second marker 5TCS-1, is found on a small number of 
peripheral blood }8 T cells (Bottino et al, 1988) but on 
most gut J8 T cells (Spencer et al, 1989). In my study, 
both subjects with PBD and controls had very low levels 
of £TCS-1+ T cells and I was unable to discern any 
difference in these subsets between the groups. These 
results are consistent with the possibility that the 
decreased number of JS T cells in PBD, is due to loss of 
the other subset which expresses the disulphide-linked 
form of the J8 TCR and which accounts for more than 90% 
of all JS T cells in the peripheral blood (Bottino et al, 
1988) . It is possible that the <STCS1~ cells are leaving 
the peripheral blood, perhaps as a result of recruitment 
of these cells into the lung. Similar results have been 
reported in sarcoidosis, where the number of £TCS-1+ in 
the peripheral blood and the lung remained the same while 
the total number of Ji T cells increased (Balbi et al,
1990).
Therefore, future studies should look at peripheral blood 
in parallel with BAL using MAb to detect both the 
disulphide linked (BB3) and nondisulphide forms (<STCS1) 
of the JS T cell receptor. In addition, future studies 
could use experimental models of lung inflammation to see 
whether increased levels of these cells in the lung are 
associated with lung pathology.
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9.4 "ACTIVATED" AND/OR "MEMORY" CELLS IN PBD
In an attempt to determine the extent to which a specific 
immune response is involved in the pathogenesis of PBD, I 
examined the levels of "naive" or "memory" T cells in the 
peripheral blood of subjects with severe longstanding PBD 
compared to controls. Double staining immunofluoresence 
was used to phenotype CD4+ cells into "naive" and 
"memory" cell populations based on their respective 
expression of CD45RA and CDw29.
This study revealed increased percentages of CD45RA+ 
cells in the peripheral blood of subjects with PBD 
compared with controls. This was due mainly to an 
increased percentage of CD45R+CD4” cells. In contrast, 
similar percentages of CDw29+ and CDw29+CD4+ cells were 
found. CDw29 (VLA B) (Sanders et al, 1988b), has been 
used to identify a population of T cells similar to that 
defined by CD45RO (UCHL1) (Beverly, 1987). Although its 
expression does not overlap exactly with that of CD45R0, 
CDw29 is present on a population of CD4+ cells roughly 
reciprocal to that of CD45RA (Morimoto et al 1985b). Thus 
my results indicate that subjects with PBD have a normal 
proportion of "memory" CD4+ T cells in their peripheral 
blood. It is interesting that the rise in the level of 
CD4 5RA+ cells was not accompanied by a decrease in the 
level of CDw29+ cells given the roughly reciprocal 
expression of these markers (Morimoto et al, 1985b). This 
suggests that there is an increase in CD45RA+CDw29+ cells 
in these pigeon breeders. CD45RA+CDw29+ cells may 
represent newly activated cells.
219
It is not clear whether the CD45RA+CD4” cells are 
"naive" or "memory" cells, since there is only limited 
evidence to suggest that expression of CD45 isoforms on 
other cells has the same functional relevance 
(Merkenschlager et al, 1989). These CD45RA+CD4” cells 
could be CD8+ T cells or NK cells, which were shown to 
be increased in earlier studies (chapters 3 and 4). It 
is unlikely that these CD45RA+ cells are JS T cells or B 
cells, given the low levels of these cells in the 
peripheral blood, although it is possible that CD8+ T 
cells NK cells, B cells and JS T cells all contribute. 
Therefore, future studies should use double staining 
immunofluoresence using MAb's to CD45RA in conjunction 
with CD8 and MAb's to NK cell markers such as CD56 and 
CD16 to determine the nature of these CD45RA+CD4” cells. 
In addition, analysis of the levels of CD45RO+ cells 
(UCHL1) in these subjects would also provide a useful 
comparison to the levels of "memory" cells detected by 
CDW29.
The finding of increased percentages of CD45RA+ cells in 
the peripheral blood of subjects with PBD contrasts with 
the decreased proportion found in other chronic 
inflammatory conditions, such as rheumatoid arthritis 
(Emery et al, 1987) and multiple sclerosis (Rose et al, 
1985, Morimoto et al, 1987). In addition, increased 
levels of the reciprocal population of UCHL1+ T cells 
were found in the lungs of both symptomatic and 
asymptomatic pigeon breeders by Johnson et al (1989). 
Again it would be important to determine whether
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increased levels of CD45RA+ cells in the peripheral 
blood is reflective of an increase or decrease in the 
level of these cells in the lung. There is some evidence 
to suggest that levels of these cells in the lung do not 
reflect their respective levels in the peripheral blood. 
Barnes et al (1989) found increased levels of CD4+CDw29+ 
cells and normal levels of CD4+CD45RA+ cells in the 
pleural fluid of subjects with tuberculous pleuritis but 
found no change in the levels of these cells in the 
peripheral blood.
9.5 FUNCTIONAL ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES 
IN PBD
The results discussed above have shown that there are 
changes in the the phenotypes of peripheral blood 
lymphocytes in pigeon breeders with severe longstanding 
PBD compared with controls, which suggests that cell 
mediated immunity may play a role in the pathogenesis of 
PBD. However, these experiments did not study the 
stimulus for these changes and the remainder of my thesis 
attempted to investigate whether antigens extracted from 
pigeon material could provoke cell mediated immune 
responses by lymphocytes from pigeon breeders in vitro.
The presence of specific IgG and IgA antibody to 
pigeon antigen in symptomatic and asymptomatic pigeon 
breeders (Patterson et al, 1976a,b), is consistent 
with the presence of antigen-reactive TH cells in the 
peripheral blood of antibody positive pigeon breeders. 
However, antibody levels do not correlate with disease,
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suggesting a possible role of cell mediated immunity 
perhaps directed at the same or related antigens. In my 
first experiments I used crude pigeon serum as a source 
of antigen, since pigeon breeders have antibodies to 
several antigenic constituents of this (Barboriak et al, 
1965, Reed et al, 1965) and it is the most commonly used 
source of pigeon antigen. In my hands, pigeon serum 
stimulated lymphocytes from subjects with PBD and 
controls. This mitogenic activity of pigeon serum has not 
previously been reported, possibly because earlier 
studies either used concentrations of pigeon serum 
protein much lower than those found to have optimal 
mitogenic activity in my study (Hansen & Penny, 1974, 
Moore et al, 1980, Schatz et al, 1976) or did not correct 
their counts for background stimulation of the cells in 
culture without pigeon serum, therefore making their 
results inconclusive (Girard et al, 1978).
In my study 350/zg of pigeon serum protein per well 
(100/xl) was optimal for lymphocyte proliferation. 
However, given that a recent study showed that dust 
collected from one cubic metre of a pigeon loft contained 
on average, only tens of ng of pigeon antigen (Anderson 
et al, 1991), it is likely that the sensitising dose of 
antigen required in vivo, is much less than that 
required for in vitro sensitisation in my study .
Because of the mitogenic effect in controls, I attempted 
to use purified antigen to look for specific cell 
mediated immunity. As there were no previous reports 
using purified antigens in this system, I selected pigeon
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globulin and albumin, as these contain several antigenic 
components found in a variety of pigeon derived material 
including pigeon serum, pigeon droppings and crop and 
saliva fluid (Edwards et al, 1970). My study used pigeon 
serum as a source of these antigens, as it was readily 
prepared and had a higher protein content than pigeon 
droppings.
To explore the possibility that the mitogenic activity of 
pigeon serum was masking an underlying antigenic 
response, pigeon serum was fractionated into a "globulin" 
and an "albumin rich" fraction, using a 33% ammonium 
sulphate precipitation step. The fraction which was 
predominantly globulin, failed to induce a proliferative 
response in lymphocytes from either pigeon breeders or 
controls. In contrast, the fraction containing the other 
serum proteins, of which albumin was one of the main 
components, was found to possess significant 
mitogenicity, although with significantly reduced 
activity, compared with the original serum sample. In 
order to determine whether this mitogenicity was masking 
a specific response of lymphocytes to pigeon serum 
albumin, the other main antigen involved in a humoral 
immune response, I obtained a commercial source of 
relatively pure pigeon serum albumin. This was shown to 
have neither antigenic nor mitogenic activity.
Although this study was unable to identify any specific 
response of lymphocytes from pigeon breeders to pigeon 
serum antigens, the presence of T dependent antibody 
responses to pigeon antigen (Patterson et al, 1976a,b) in
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pigeon breeders indicates the presence of antigen 
specific T cells. It is possible that these cells are 
compartmentalised in the lung and would therefore not be 
detected in sampling of peripheral blood. To explore this 
hypothesis, lymphocytes from BAL fluid could be incubated 
with pigeon serum or purified antigens from pigeon serum. 
Another explanation could be that the T cells which 
responded to pigeon antigen have been tolerised. Holt & 
McMenamin (1989) presented evidence to suggest a distinct 
hierarchy in the immune response to aero-allergens in 
relation to relative susceptibility to tolerance 
induction via low grade inhalation exposure: 
IgE>DTH>IgG>IgA. A similar hierarchy of tolerance 
susceptibility has been suggested in oral tolerance 
(Mowat 1987). This would also explain the lack of 
specific IgE antibody to pigeon antigen in pigeon 
breeders. It is possible that T cells are initially 
required to initiate the inflammatory process and induce 
the production of specific IgG antibody to pigeon 
antigens. Many of the T cells may then become tolerised, 
leaving non-specific immune responses, such as NK cells 
to perpetuate the inflammatory process, perhaps through 
their release of IFNJ and TNFa.
Given the proposed role for a mitogen in the pathogenesis 
of EAA as an initiator of an acute inflammatory reaction 
preceding the onset of EAA (Burrel & Rylander, 1981), I 
attempted to identify the nature of the mitogenic agent 
in pigeon serum, by testing out the hypothesis that it 
could be endotoxin. Endotoxin was chosen since it has 
been shown to have a role in the pathogenesis of other
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respiratory disorders such as byssinosis (Cavagna et al, 
1969, Pernis et al, 1961, Cinkotia et al, 1977, Castellan 
et al, 1984, Rylander et al, 1985) and humidifier fever 
(Westphal & Luderitz, 1961, Rylander et al, 1984, 
Muittari et al, 1980). The endotoxin content of one 
pigeon serum sample was measured in a Limulus lysate 
assay and found to contain 5pg/ml of endotoxin. To 
determine whether this level of endotoxin could have been 
responsible for the mitogenic activity of pigeon serum, a 
commercial source of LPS was obtained and used in the 
proliferation assay, in quantities equivalent to those 
that would be contained in a mitogenic dose of pigeon 
serum. Lymphocyte proliferation was not induced by 
mimicking concentrations of endotoxin. However, since I 
was also unable to obtain lymphocyte stimulation using 
recommended concentrations of endotoxin known to induce 
proliferation of lymphocytes, the results of these 
experiments must remain inconclusive. It is possible that 
the culture conditions for endotoxin induced stimulation 
were not appropriate. If more time had been available, 
various concentrations of LPS over a fuller time course 
would have been tested to obtain a positive control 
response at recommended concentrations of LPS, before 
attempting to use the lower concentrations that would be 
present in a mitogenic dose of pigeon serum.
As an alternative approach, I examined the effects of 
Polymyxin B, a known inhibitor of endotoxin, on the 
mitogenic response to serum. The concentrations of 
Polymyxin B that I used were based on the findings of
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Morrison & Jacobs (1976) who reported that 3.5/xg of 
Polymyxin B inhibits approximately 10/ig of LPS and on the 
level of endotoxin measured in the Limulus lysate assay. 
Using these conditions, I could not find any inhibitory 
affect of Polymyxin B on the proliferation of lymphocytes 
induced by pigeon serum. However, as I was unable to 
induce proliferation by adding exogenous LPS, these 
findings need confirmation by proving that the doses of 
Polymyxin B that I used would inhibit known quantities of 
LPS, in my hands. Therefore I am not able to exclude 
completely the possibility that endotoxin is the 
mitogenic agent in pigeon serum.
Whatever is the mitogen in pigeon serum, is it likely to 
have a role in the pathogenesis of PBD ? One way of 
examining whether the mitogenic agent in pigeon serum 
was likely to have a role in the pathogenesis of PBD was 
to determine whether it was found in a source of pigeon 
material commonly found in the loft environment, such 
as pigeon droppings. Pigeon serum proteins have been 
shown to be excreted in pigeon droppings (Edwards et al, 
1969) so pigeon serum and droppings, contain many 
antigens in common.
The protein derived from pigeon droppings in this thesis, 
was shown by SDS Page gel electrophoresis, under reducing 
conditions, to consist of 4 main protein bands; 116KDa, 
6 OKDa, 4 5KDa and 3 OKDa, similar to that found by
Calvanicco, (1986). Since the major component of PDE has 
been found to be intestinal IgA, (Goudswaard et al, 
1977) , then it is possible that some of the protein bands
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could have represented the heavy and light chains of this 
protein.
The protein extract from pigeon droppings was neither 
antigenic nor mitogenic to lymphocytes. These results are 
in contrast with previous studies which have shown that 
lymphocytes from symptomatic pigeon breeders (Hansen & 
Penny, 1974) and occasionally also from asymptomatic 
pigeon breeders (Schatz et al, 1976, Girard et al, 1978), 
proliferated in response to PDE. However, the results 
from the latter two studies were not convincing, as the 
levels of stimulation were low and the background counts 
were not taken into account in the study by Girard et al 
(1978). All the studies did however agree with my 
findings that there were no mitogenic effects of PDE on 
control lymphocytes (Schatz et al, 197 6, Girard et al, 
1978, Hansen & Penny, 1974).
The lack of mitogenicity in pigeon droppings does not 
rule out the possibility that it is present in some other 
form of pigeon material, such as pigeon bloom, a fine 
waxy substance which coats the feathers and is readily 
dispersed in the loft environment (Banham et al, 1982) or 
in crop or saliva fluid (Edwards et al, 1970). Therefore, 
future studies could look for its presence in these 
sources of pigeon antigen. However, the problem with 
using these sources of pigeon antigens is that they are 
difficult to collect and large quantities would be 
required, to obtain sufficient amounts of antigen.
Chicken serum was incubated with PBMC to determine 
whether serum from other avian species was mitogenic. My
227
study could not detect any mitogenic effect of chicken 
serum on peripheral blood lymphocytes. This is 
interesting, since birds such as chickens and turkeys, 
which do not fly are not associated with significant 
clinical difficulties (Boyd et al, 1982, Elman et al, 
1968). Boyd et al (1982), suggested that the lack of 
clinical difficulties associated with chickens was 
possibly due to their feathers not being well developed 
and the bloom content being much lower than that seen in 
pigeons. However, this study suggests that mitogenicity 
of bird proteins may be an important factor. Future 
studies should look at serum from other bird species in 
relation to the incidence of EAA caused by these birds 
to determine whether the mitogenicity theory holds true.
Animal models of EAA also support the role for a mitogen 
in the pathogenesis of EAA. In most experimental models, 
there is a need for an adjuvant (Richerson et al, 1971, 
Richerson, 1972, Joubert et al, 1976, Bernardo et al, 
1979), mitogen (Moore et al, 1975) or other non specific 
inflammatory agent to induce disease. In addition, 
repeated inhalation challenge with antigen following 
acute disease fails to induce chronic EAA and indeed the 
alveolitic lesions disappear, unless a non specific 
stimulus, such as muramyl dipeptide, is also given 
(Chedid et al, 1978, Richerson et al, 1982). These 
studies suggest that a mitogen may be important not only 
for initiating disease but also in maintaining it.
Alveolar macrophages play a major role, maintaining 
immunological homeostasis at the airway surface by
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inhibiting the inductive phase of local T cell responses 
to incoming antigens (Holt, 1986). This situation can be 
readily reversed by pathogenic antigens which induce 
inflammation and an influx of mononuclear cells from the 
peripheral blood (Holt, 1978). Therefore, it is possible 
that a mitogen is required in EAA, to induce a non 
specific inflammatory response in the lung, resulting in 
macrophage infiltration from the peripheral blood, which 
will be capable of presenting pigeon antigen to T cells 
and thereby induce a specific cell mediated immune 
response.
Future studies should therefore look at the phenotypes of 
peripheral blood cells and BAL cells in parallel, in 
subjects with well defined symptoms, at similar stages of 
disease and at known time intervals after antigen 
exposure. In addition, controlled inhalative challenge 
studies would be useful, using various purified pigeon 
antigens and possibly also mitogens such as LPS to 
explore the nature of the stimulus required to induce the 
peripheral blood cell changes.
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APPENDIX
QUESTIONNAIRE
PIGEON FANCIERS SURVEY
NAME:
ADDRESS:
GPS NAME AND ADDRESS:
UNIT NO:
DATE:
D.O.B:
INSTRUCTIONS: Please tick appropriate answer, or write in 
space provided when indicated.
If in doubt answer "No"
Pigeon Data:
1. Do you keep pigeons at present? YES/NO 
If NOT when did you stop and why?
2. How long have you kept pigeons? YRS/ MTHS
3. Have you kept pigeons continuously? or
periodically?
4. How many pigeons do you generally keep?
5. Have you ever been in regular contact with birds?
YES/NO
If yes, please give details:
6. How many hours, on average, do you spend in contact 
with the pigeons during the season?
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7. Do you ever wear a mask when in contact with pigeons?
YES/NO
Has this helped your chest?
Symptom Data;
8. When in contact with your pigeons have you EVER 
noticed:
a. Shortness of breath
b. Wheezing in your chest
c. A dry cough
d. Sneezing, blocked or running nose
e. Itchy/runny eyes
f. Tightness in chest
9. Have the above symptoms EVER been severe
enough to make you come away from pigeons YES/NO
10. How long after coming into contact with 
pigeons do these symptoms occur?
less than ten minutes
ten to thirty minutes
more than thirty minutes
11. Do these symptoms occur: 
occasionally (once per 3 months) 
sometimes (once per 2 weeks) 
usually (at least twice per week)
12. How long have you had them?
13. Several hours (4 - 8) AFTER being in contact
with pigeons have you EVER experienced 
attacks of, or persistent:
a. Shortness of breath
b. Wheeze
c. Shivering and/or feeling cold
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14.
15.
16.
17.
18.
d. Sweating
e. Fever or temperature
f. Dry cough
g. Tiredness or aching muscles
h. Tightness in chest
How long is it before you feel well again?
Have you ever noticed "flu-like" feelings
in the evening and at night which have
gone by the following morning? YES/NO
How long do these symptoms occur?
occasionally (once per 3 months)
Sometimes (once per 2 weeks)
Usually (at least twice per week)
How long have you had them?
Are these symptoms different -
a. at the weekend WORSE
SAME
BETTER
b. after attending a pigeon show WORSE
SAME
BETTER
c. after a holiday away from home WORSE
SAME
BETTER
d. after cleaning out the loft WORSE
SAME
BETTER
Respiratory Data
19. Do you USUALLY cough first thing in 
the morning in winter? YES/NO
20. Do you USUALLY cough during the day 
in the winter? YES/NO
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Do you cough like this on most days for
as much as three months each year? YES/NO
Do you USUALLY bring up any spit of phlegm
from your chest first thing in the
morning in winter? YES/NO
Do you USUALLY bring up any spit or phlegm
from your chest during the day in the
winter? YES/NO
Do you bring up spit like this on most days 
for as much as three months each year? YES/NO
Do you ever get sgort of breath when walking 
with others of your own age, on level ground?
YES/NO
During the past three years have you ever had 
any chest illnesses which have kept you from 
your usual activities for more that a week?
YES/NO
Have you ever had -
a. heart trouble
b. bronchitis
c. pneumonia/pleurisy
d. tuberculosis
e. asthma
f. other chest illnesses
Have you ever had any illness requiring 
a period in hospital? YES/NO
Give details:
Do you require regular medicines for any 
condition? YES/NO
a. What is the condition?
b. What are the medicines?
Have you ever worked in:
a. a coal mine? 
b any other mine?
c. a quarry?
d. a foundry?
e. a pottery?
f. a cotton, flax of hemp mill?
g. with asbestos?
31. How many cigarettes/cigars do you smoke 
per day?
33. How long have you smoked?
34. If you have ever smoked,
a. How long did you smoke for?
b. How many did you smoke per day?
c. When did you stop?
Allergies
35. Have you ever suffered from
a. hay fever
b. asthma
c. Eczema/Dermatitis
d. Were you chesty as a child?
36. What did you suspect causes the/these 
condition/s in your case?
37. Does any relative have any of the 
conditions listed above?
G LASGOW
UNTVEKSITY
library
YES/NO
YES/NO
YES/NO
YES/NO
YES/NO
YES/NO
yrs
YES/NO
YES/NO
YES/NO
YES/NO
260
